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ABSTRACT
Regulation of Immune Cell Activation and Function
by the nBMP2 Protein and
the CD5 Co-Receptor
Claudia Mercedes Téllez Freitas
Department of Microbiology & Molecular Biology, BYU
Doctor of Philosophy
According to the centers for disease control and prevention (CDC) and the world health
organization (WHO), heart disease and immune related diseases such as diabetes and cancer are
among the leading causes of death around the world. Thus, the regulation of the function of
immune cell plays a key role in health and disease. Calcium (Ca2+) ions play a critical role in
immune cell activation, function and in a robust immune response. Defects in Ca2+ signaling
influences the development of cardiac disease, Alzheimer disease, immune cell metabolism,
muscle dysfunction, and cancer. Each immune cell is unique in its activation and function,
making it relevant to understand how activation of each type of immune cell is regulated. Here
we describe the role of the nBMP2 protein in macrophage activation and function and the role of
the CD5 co-receptor in helper T cell activation and function.
The nuclear bone morphogenetic protein 2 (nBMP2) is the nuclear variant of the bone
morphogenetic protein 2 (BMP2), a growth factor important in heart development, neurogenesis,
bone, cartilage and muscle development. To better understand the function of nBMP2, transgenic
nBMP2 mutant mice were generated. These mice have a slow muscle relaxation and cognitive
deficit caused in part by abnormal Ca2+ mobilization. Mutant nBMP2 mice also have an impaired
secondary immune response to systemic bacterial challenge. Here we have further characterized
macrophage activation and function from mutant nBMP2 mice before and after bacterial
infection. We describe how nBMP2 influences the Ca2+ mobilization response and phagocytosis
in macrophages, revealing a novel role of the nBMP2 protein in immune cell regulation.
CD5 is a surface marker on T cells, thymocytes, and the B1 subset of B cells. CD5 is
known to play an important role during thymic development of T cells. CD5 functions as a
negative regulator of T cell receptor (TCR) signaling and fine tunes the TCR signaling response.
Here we describe our characterization of CD5 regulation of Ca2+ signaling in naïve helper T
cells. We also outline our findings examining how CD5-induced changes in helper T cell
activation influence other biological processes such as immune cell metabolism, the diversity of
the gut microbiome, and cognitive function and behavior. Thus, this work elucidates the
influence of the CD5 co-receptor on the functional outcomes in multiple systems when CD5 is
altered.

Keywords: nBMP2, bone morphogenetic protein, CD5, co-receptor, calcium (Ca2+), metabolism,
behavior, TCR, T cell receptor, microbiome, macrophage, T helper cells
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CHAPTER 1: Calcium Signaling Role in the Immune Response
1.1 Introduction
The immune system protects the host from foreign pathogens and includes cells from
both the innate and adaptive immune systems working together. While innate cells (e.g.
macrophages) recognize and are activated by conserved pathogen associated molecular patterns
(PAMPs) on infectious agents and help trigger a primary immune response, cells from the
adaptive immune system (e.g. T and B lymphocytes) recognize and are activated by pathogen
specific peptides1,2. These innate and adaptive systems are dependent on one another; in fact, it is
normally the innate immune cells that initially activate cells of the adaptive immune system3.
Phagocytes such as macrophages and dendritic cells are antigen presenting cells (APC) that carry
out phagocytosis of foreign pathogens and play an important role in lymphocyte activation (e.g.
T cells)4. T cells recognize foreign peptides presented by major histocompatibility complexes
(MHC) on APCs via the T cell receptor (TCR), a protein complex that play an important role in
signal transduction and leads to T cell activation2,4. Calcium (Ca2+) signaling is a key second
messenger that is involved in transmitting these activation signals and is essential for immune
cell function and differentiation5.
1.2 Activation of Immune Cells
Immune cells are activated upon recognition of foreign pathogens and can also be
activated by altered self-proteins such as those found in cancer cells. Phagocytic cells such as
macrophages and dendritic cells are first responders that act as sentinels to recognize their
environment via surface receptors known as pattern-recognition receptors (PRRs), which
recognize PAMPs on the surface of pathogens1. Upon PRR binding to a PAMP, that macrophage
and dendritic cells are activated and intracellular signals trigger pathogen engulfment and pro1

inflammatory and antimicrobial responses. This is accomplished by secreting molecules such as
cytokines and chemokines, processing and presenting antigen to T cells, and upregulating
costimulatory molecules, all of which play an important role in the activation of the adaptive
immune response3,6.
The adaptive immune system includes T and B cells which expresses a diverse repertoire
of receptors that play an important role in the recognition of self and non-self-peptides2,7. For T
cell activation to occur, innate cells such as APCs engulf, process, and present the antigenpeptide. When this peptide is recognized by the TCR as foreign, together with co-stimulatory
signals, the adaptive immune response is initiated. This starts with an increase in T cell
intracellular Ca2+, metabolic changes, and cytokine production that results in a T cell initiated
immune response4,5,8. Deficiencies in innate and adaptive immune cells are known to increase
susceptibility to infection, autoimmunity and cancer9. For instance, diabetes mellitus, a metabolic
disorder, has been associated with dysregulation of innate immunity (neutrophil function),
humoral immunity, and an aberrant T cell response10-12. Hence, proper activation and interactions
of the innate and adaptive immune cells are key for an efficient immune surveillance (Fig. 1A).
Defective pathogen recognition, intracellular signaling, or metabolic function result in defective
immune surveillance (Fig. 1B).
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Figure 1. Schematic representation of normal and defective immune response.
A. In a normal immune response, innate immune cells (e.g. macrophages or dendritic cells) recognize
foreign pathogens and engulf them. They then process and present antigen to T cells. Upon activation
lymphocytes proliferate and differentiate and provide protection via antibodies and cytokines. B.
Defective immune responses downregulate innate and adaptive immune responses to foreign pathogens.
Defects may be due to ineffective phagocytosis, deficiencies of co-stimulatory signals, calcium signaling
defects, and altered metabolism resulting in impaired antibody and cytokine production.

1.3 Calcium Signaling
Calcium (Ca2+) is a universal second messenger involved in many aspects of cellular life
such as cell activation, motility, and cell death13. Mobilization of a cellular Ca2+ signal involves
multiple intracellular proteins and channels important in Ca2+ regulation; for example, the
calcium release activated calcium channel (CRAC) on the surface of the cell and adenosine
triphosphate (ATP)-driven pumps, and exchanger channels found in intracellular organelles such
as the mitochondria, endoplasmic reticulum (ER), and nucleus all play a critical role in
regulating the Ca2+ signal to initiate gene transcription specifically tailored to the pathogen (Fig.
2)13.
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Figure 2. Schematic representation of the main structures involved in calcium homeostasis.
This model shows an overview of the calcium transporter system within the cell (endoplasmic reticulum,
mitochondria and nucleus).

Intracellular Ca2+ levels are important in both the innate and adaptive immune response14.
As cells are stimulated, intracellular Ca2+ levels play an important role in immune cells fate, as it
influences their activation and function15. The importance of Ca2+ signaling in T cells and
macrophages will be discussed more in depth separately in this chapter.
1.4 Macrophage Ca2+ Signaling
Macrophages are immune cells that engulf pathogens and apoptotic or dead cells and
activate the adaptive immune system by processing and presenting MHC bound peptides to T
cells. In macrophages, there has been less characterization of the Ca2+ pathway compared to T
cells16,17. However, it is known that Ca2+ is important for macrophage activation. It has been
4

suggested that the actin cytoskeleton has a central role in mediating both the physical interaction
of the macrophage with the T cell, and the subsequent signaling pathways leading to T cell
activation18.
In macrophages, engagement of the Fc receptors result in a robust influx of Ca2+ from the
extracellular space19. In a similar manner to T cells, Ca2+ influx is due to store operated Ca2+
entry (SOCE) that is activated by a reduction of Ca2+ in the ER stores and activation of the
CRAC channel via STIM1 (Fig.3)20. It has been shown that murine macrophages lacking Stim1
expression had severely compromised FcγR II/III mediated Ca2+ influx and they seemed to be
impaired in a number of in vivo models of autoantibody and immune complex induced
macrophage function21.
Ca2+ signaling also appears to play an important role in Fc-receptor mediated
phagocytosis and cell migration22,23. In order for phagocytosis to initiate, pathogens, dead cells,
or foreign particles need to be opsonized by antibodies, complement, fibronectin, and mannosebinding lectin and bind to opsonic receptors such as the FcγR found in the membrane of the
phagocyte, and that appears to be regulated by Ca2+

24-26

. It is not clear what the pathways

involved are, however there have been studies suggesting that intracellular Ca2+ elevations
during phagocytosis might regulate other function within the phagocyte such as cytoskeletal
rearrangements, endolysosomal fusion and the oxidative burst24,25,27.

5

Figure 3. Phagocytic receptors involved in Ca2+ signaling.
Initiation of signal transduction in macrophages occurs upon activation of Fc receptors, increasing the
intracellular Ca2+ concentration in the cytoplasm24,25,27,28

1.5 nBMP2
Bone morphogenetic protein 2 (BMP2) is a secreted growth factor that modulates many
essential physiological and developmental processes through extracellular signaling. The
Bridgewater lab identified a novel nuclear variant of BMP2, nuclear BMP2 (nBMP2), which is
translated from an alternative start codon downstream of the signal peptide sequence, eliminating
the N-terminal signal peptide that targets the protein to the secretory pathway, instead allowing
cytoplasmic translation and subsequent translocation to the nucleus by means of a bipartite
nuclear localization signal (NLS) (Fig.4)29.
6

Figure 4. The nBMP2 is translated from a downstream alternative start codon.
The signal peptide sequence (in light gray), in the alternative initiation codon allows translation in the
cytosol rather than in the ER, with subsequent nuclear localization directed by a bipartite NLS. The three
amino acids (RKR) were changed to alanines (AAA) to prevent nuclear localization of nBMP2 in the
mutant mouse model (nBmp2NLStm). Figure reprinted from “The BMP2 nuclear variant, nBMP2, is
expressed in mouse hippocampus and impacts memory” by Cordner RS et al, 201730

In order to better understand the function of nBMP2 in the nucleus, the Bridgewater lab
generated a gene-targeted mutant mouse model (nBmp2NLStm) in which the RKR sequence was
replaced with AAA, thereby inhibiting the translocation of nBMP2 to the nucleus (Fig. 4)31.
Mice with this nBMP2 dysfunction (the nBmp2NLStm mutant) showed altered functions of
skeletal muscle, neurological function and immune response in mice over 6 months of age (Fig.
5)30-32. Dysfunction in the skeletal muscle was demonstrated by a significant increase in the time
required for relaxation following a stimulated twitch contraction (Fig. 5A)31. Muscle relaxation
after contraction is mediated by the active transport of Ca2+ from the cytoplasm to the
sarcoplasmic reticulum by sarco/endoplasmic reticulum Ca2+ ATPase (SERCA), and enzyme
activity assays revealed that SERCA activity in skeletal muscle from nBmp2NLStm mice was
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reduced to approximately 80% of wild type31. These results suggest that nBMP2 plays a role in
the establishment or maintenance of intracellular Ca2+ transport pathways in skeletal muscle.

Figure 5. nBmp2NLStm mice have altered functions related to Ca2+ mobilization
A. Mutant mice have defective muscle relaxation contraction. Figure reprinted from “A Novel Bone
Morphogenetic Protein 2 Mutant Mouse, nBmp2NLStm, Displays Impaired Intracellular Ca2+ Handling in
Skeletal Muscle” by Bridgewater L., et al, 201331 B. Long-term potentiation (a form of synaptic plasticity
dependent on Ca2+ signaling) was defective in mutant mice. Figure reprinted from “The BMP2 nuclear
variant, nBMP2, is expressed in mouse hippocampus and impacts memory” by Cordner RS et al, 201730
C. Mutant mice had a higher mortality than wild type when challenged to a secondary infection Figure
reprinted from “Targeted Mutation of Nuclear Bone Morphogenetic Protein 2 Impairs Secondary Immune
Response in a Mouse Model” by Olsen DS., et al, 201532

Neurological function was also affected in nBMP2 mutant mice. Immunohistochemistry
assays in the hippocampus revealed that nBMP2 was not preset in the nuclei of CA1 neurons30.
The nBMP2 mutant mice also presented significant cognitive deficits related to hippocampal
dysfunction and its electrophysiological measurement suggested a dysregulation in the Ca2+
transport (Fig. 5B)30.
Similarly, nBMP2 mutant mice had an impaired secondary immune response to bacterial
infection (Staphylococcus aureus)32. The mutant mice had smaller spleens than WT and
histological analysis of splenic cells after secondary infection suggested mutant spleens had
fewer hemosiderin-laden macrophages than wild type spleens. We hypothesized that mutant
macrophages had a decreased ability to engulf damaged red blood cells, and we found that the
8

mutant mice did have a deficiency in phagocytosis function this was due to an impaired Ca2+
mobilization response (Fig. 5C)32.
1.6 T cell Ca2+ Signaling
T cells are important because they help orchestrate the immune response and provide
essential cell mediated cytotoxicity33,34. Engagement of the TCR to the peptide and major
histocompatibility complex (pMHC) determines the magnitude of the response and the fate of
the T cell35. This interaction triggers the Ca2+ signaling pathway, important in T cell activation
and the immune response5,36.

Figure 6. T cell Ca2+ signaling cascade.
TCR-pMHC engagement initiates a signaling cascade that leads to T cell activation, differentiation,
proliferation and function. The major steps involving Ca2+ signaling are shown.
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Normally in naïve T cells, the intracellular Ca2+ concentration is maintained lower than
the extracellular Ca2+ concentration and as a T cell is activated upon interaction of the TCRpMHC, intracellular Ca2+ levels increase5. This Ca2+ increase is the result of a cascade of
phosphorylation events by kinases such as ZAP70, LCK, PLCγ1 and others kinases, cleavage of
IP3 and diacylglycerol (DAG), and binding of IP3 to IP3R on the ER (Figure 6)37,38. Binding of
IP3 to the IP3R causes Ca2+ to exit from the ER into the cytoplasm, followed by recognition of
Ca2+ depletion in the ER by stromal interaction molecule 1 (STIM 1). STIM 1 then activates the
CRAC channel on the cell surface and causes a large influx of Ca2+ from outside the cell. The
Ca2+ then binds to cytoplasmic binding proteins such as calmodulin and then calcineurin, traffics
to the nucleus and activates transcription factors such as nuclear factor of activated T cells
(NFAT), nuclear factor-κB (NF-κB), or cyclic-AMP-responsive-element-binding protein
(CREB)5. Thus, Ca2+ signaling patterns, amplitude and duration each play an important role in
regulating T cell activation and effector functions18,37-39.
1.7 CD5 T cell co-receptor
CD5 is a transmembrane glycoprotein that functions as a co-receptor that regulates the
intensity of the TCR-pMHC interaction. CD5 expression in T cells in set during thymic
development and it is linked to the TCR signal strength (high avidity) interaction to self-peptide
MHC (self-pMHC)40. The higher the TCR affinity for self-pMHC, the higher the CD5
expression levels in T cells. TCRs play a critical role in CD4+ T cell activation and function.
Previous studies have reported CD5 has a costimulatory function, as CD5 high (CD5hi)
expression levels in T cells increase intracellular Ca2+, inositol triphosphate, interleukin-2 (IL-2)
secretion, and IL-2R expression, which are associated with higher phosphorylation of TCRζ at
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baseline and ERK upon activation and enhance TCR-mediated activation and T cell
proliferation41,42.
1.7.1 CD5lo (LLO118) and CD5hi (LLO56)
To further examine CD5 expression levels in helper T cell function, our lab uses two
transgenic mouse lines LLO118 and LLO56 with TCRs specific for the same immune dominant
epitope of Listeria monocytogenes (LLO190-205)43. LLO118 and LLO56 T cells have similar
TCRs (Vα2; Vβ2), but they differ by 15 amino acids found mainly in the CDR3 region of their
TCR sequences. They also differ in their in vivo immune responses (LLO118 has a better
primary response and LLO56 has a better secondary response) and in their CD5 expression
levels [LLO118 has low levels of CD5 (CD5lo) and LLO56 has high levels of CD5 (CD5hi)]42,43.
While much has been learned about Ca2+ signaling in lymphocytes and its relationship to T cell
activation and function, there are still many questions regarding how Ca2+ signaling is important
in helper T cell memory formation, and how Ca2+ mobilization can affect other biological
processes such as metabolism, behavior and even gut microbiota diversity.
1.8 Summary of Research Chapters
Chapter 2 is a published research paper in which we characterize the role of nBMP2 in
the Ca2+ response of bone marrow derived (BMD) macrophages and splenic macrophages from
nBMP2 mutant mice before and after bacterial infection. We show that nBMP2 is in the nuclei of
WT BMD and splenic macrophages, while the nBMP2 protein is significantly decreased in the
nuclei of mutant nBMP2 macrophages. We also analyzed the Ca2+ mobilization response and its
effect on macrophage engulfment. Our findings suggest that the Ca2+ mobilization response and
engulfment levels in BMD macrophages are similar before bacterial infection. However, after a
secondary bacterial challenge, splenic macrophages from mutant nBMP2 mice exhibited a
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dysregulated Ca2+ response and decreased levels of engulfment. These observations suggest that
nBMP2 plays an important role in macrophage activation and function. It also highlights the
importance of further addressing the mechanisms of nBMP2 function in other cells in the future.
Chapter 3 is a published review paper describing the importance of the CD5 co-receptor
in Ca2+ signal transduction of the TCR-pMHC interaction in T cells upon activation. Coreceptors are surface molecules found on T cells that play an important role in sustaining or
limiting the strength of the signals that modulate the effects of the TCR-pMHC interaction. Here
we compare the function of the CD5 co-receptor with PD-1 and CTLA-4, two well studied coreceptors with similar regulatory functions. CD5 expression levels in T cells correlates with the
Ca2+ mobilization response in T cells, suggesting that CD5 could be a novel checkpoint used to
modulate T cell function and metabolism. Metabolism can be altered by Ca2+ mobilization,
which also could help in the modulation of T cell inflammatory responses with many potential
effects on health and disease.
Chapter 4 is a published research paper that characterizes calcium mobilization levels in
helper T cells with different CD5 expression levels. CD5 is a co-receptor that plays an important
role in regulating T cell signaling and fate during thymocyte education, and its surface
expression on mature single positive thymocytes correlates with the TCR signal strength for
positive selecting self-ligands. CD5 also plays a role in T cell function after thymic development
is complete. Peripheral T cells with higher CD5 expression respond better to foreign antigen than
those with lower CD5 expression and CD5 high T cells are enriched in memory populations. In
our study, we examined the role of CD5 expression and calcium mobilization in the primary
response of T cells using two Listeria monocytogenes specific T helper cells (LLO118 and
LLO56). These T cells recognize the same immunodominant epitope (LLO190-205) of L.
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monocytogenes and have divergent primary and secondary responses as well as different levels
of CD5 expression. We characterized the role of CD5 expression and calcium influx in these
CD5 high and CD5 low T cells over the course of 8 days. We found significantly different
calcium signaling levels in naïve and day 3 post-stimulation LLO56 and LLO118 T helper cells.
To further investigate the role CD5 expression plays in calcium mobilization, we measured the
calcium influx in T cells from LLO118-CD5 knockout mice versus those from LLO56-CD5
knockout mice. We found that CD5 expression is important in regulating calcium mobilization in
the CD5 high naïve LLO56 T cells during the initial response to antigen, and as CD5 levels
decrease over time, its role in regulating calcium also decreases.
Chapter 5 describes how CD5, a co-receptor that influences Ca2+ regulation, has an effect
in T cell metabolism. We hypothesized that CD5 deficient T cells have different bioenergetic
demands that affect metabolic pathways key to T cell activation and function. We evaluated the
effects of the CD5 co-receptor on metabolism by measuring the metabolic profiles of CD5KO
and wild type T cells. Our preliminary data suggests that CD5KO T cells have higher
mitochondrial respiration than wild type T cells and we are examining the mitochondrial mass in
CD5KO naïve T cells. Thus, CD5 may play an important role in metabolic programing in T cells
and could potentially be useful in modulating the T cell response in the tumor
microenvironment.
Chapter 6 describes our efforts to understand how the CD5 co-receptor, a T cell response
modulator, influences mice cognitive behavior and gut microbiota diversity. The immune system
and the gut microbiota often work in synergy, and previous work has shown that alterations in T
cell metabolism can influence behavior and microbial diversity44. Here we outline our work to
examine the influence of CD5 on behavior and gut microbial diversity. For this study we
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compared wild type mice (CD5WT) and the CD5 co-receptor knock-out (CD5KO). We found
significant differences between CD5KO and CD5WT mice in marble burying rates, elevated plus
maze behavior, and open field activity. These behavioral test results suggest CD5 deficient mice
have altered cognitive function and higher levels of fear and anxiety-like behavior. We also
quantified the gut microbiota diversity of these mice (CD5KO vs. CD5WT) and found
significant differences in microbiota populations. Thus, our data suggests that the CD5 coreceptor plays a critical role in mice cognitive behavior and gut microbiota.
Chapter 7 is the final chapter, here we summarize the main findings for nBMP2 and CD5.
We also propose future research plans to further characterize the importance of nBMP2 in the
Ca2+ signaling pathway and to examine the influence of CD5 in the regulation of cognitive
function, metabolism, and diversity of the gut microbiota.
1.9 Summary of Appendices
Appendix I contains an abstract published in the Journal of Immunology regarding the
influence of the CD5 co-receptor in T cells metabolism and in cognitive behavior. The work for
this abstract was presented as an oral and poster presentation in the annual conference of The
American Association of Immunologist in Austin, TX in May of 2018.
Appendix II has a list of the presentations done during the time of my PhD.
Finally, Appendix III contains a compilation of the work I published during my
dissertation (both as a first author and as a co-author).
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CHAPTER 2: The Nuclear Variant of Bone Morphogenetic Protein 2 (nBMP2) is Expressed in
Macrophages and Alters Calcium Response
The content of this chapter was published in Scientific Reports. Tellez Freitas, C. M. et al. “The
nuclear variant of bone morphogenetic protein 2 (nBMP2) is expressed in macrophages and
alters calcium response.” Scientific Reports 9, 934, doi:10.1038/s41598-018-37329-5 (2019).
It has been formatted for this dissertation, but it is otherwise unchanged.
Abstract
We previously identified a nuclear variant of bone morphogenetic protein 2 (BMP2),
named nBMP2, that is translated from an alternative start codon. Decreased nuclear localization
of nBMP2 in the nBmp2NLStm mouse model leads to muscular, neurological, and immune
phenotypes—all of which are consistent with aberrant intracellular calcium (Ca2+) response. Ca2+
response in these mice, however, has yet to be measured directly. Because a prior study
suggested impairment of macrophage function in nBmp2NLStm mutant mice, bone marrow
derived (BMD) macrophages and splenic macrophages were isolated from wild type and
nBmp2NLStm mutant mice. Immunocytochemistry revealed that nuclei of both BMD and
splenic macrophages from wild type mice contain nBMP2, while the protein is decreased in
nuclei of nBmp2NLStm mutant macrophages. Live-cell Ca2+ imaging and engulfment assays
revealed that Ca2+ response and phagocytosis in response to bacterial supernatant are similar in
BMD macrophages isolated from naïve (uninfected) nBmp2NLStm mutant mice and wild type
mice, but are deficient in splenic macrophages isolated from mutant mice after secondary
systemic infection with Staphylococcus aureus, suggesting progressive impairment as
macrophages respond to infection. This direct evidence of impaired Ca2+ handling in nBMP2
mutant macrophages supports the hypothesis that nBMP2 plays a role in Ca2+ response.
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2.1 Introduction
Our group has reported the existence of a nuclear variant of the growth factor bone
morphogenetic protein 2 (BMP2), designated nBMP2 45. This variant protein is produced by
translation from an alternative downstream start codon that eliminates the N-terminal
endoplasmic reticulum signal peptide, thus preventing the protein’s delivery to the secretory
pathway. Instead, nBMP2 is translated in the cytoplasm and translocated to the nucleus by means
of an embedded bipartite nuclear localization signal (NLS)45. Using immunohistochemistry, we
have detected nBMP2 in skeletal muscle nuclei and in the nuclei of CA1 neurons in the
hippocampus 30,31.
To examine the function of nBMP2, we generated a mutant mouse strain (nBmp2NLStm)
in which a three-amino acid substitution in the NLS inhibits translocation of nBMP2 to the
nucleus while still allowing normal synthesis and secretion of the conventional BMP2 growth
factor 2. The mice appear overtly normal and are fertile. They do, however, lack nBMP2 in
myonuclei, and electrophysiological studies revealed that skeletal muscle relaxation is
significantly slowed after stimulated twitch contraction, a process that is regulated by
intracellular Ca2+ transport. Consistent with impaired intracellular Ca2+ transport,
sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) activity is decreased in skeletal muscle 31.
The mutant mice also lack nBMP2 in CA1 hippocampal neurons, and electrophysiological
studies revealed reduced long-term potentiation (LTP) in the hippocampus 30. LTP is dependent
on intracellular Ca2+ transport and is thought to be the cellular equivalent of learning and
memory 46-48. Behavioral tests revealed that the nBMP2 mutant mice have impaired object
recognition memory 30.

16

Intracellular Ca2+ elevation also regulates the activation and differentiation of several
different types of immune cells including T cells, B cells, dendritic cells, and macrophages
14,19,49,50

. To see if nBmp2NLStm mutants had compromised immune response, mice were

challenged by systemic infection with Staphylococcus aureus. While the mutants’ immune
response to a primary infection appeared normal, their immune response to a secondary infection
challenge 30 days later resulted in higher levels of bacteremia, increased mortality, and failure of
spleens to enlarge normally 32. Although we did not observed differences in the total number of
macrophages in spleen, thymus, or lymph node from wild type compared to mutant mice, we did
observe that after the secondary infection, spleen from nBmp2NLStm mutant mice showed fewer
hemosiderin-laden macrophages than spleen from wild type mice 32. Macrophages in the spleen
accumulate hemosiderin by phagocytosing damaged red blood cells and hemoglobin, which
would be present in the blood stream of S. aureus-challenged mice due to the hemolysins that S.
aureus expresses 51-53. The observation of fewer hemosiderin-laden macrophages in the spleens
of mutant mice after a secondary infection suggested to us that macrophage phagocytic activity
might be impaired in the absence of nBMP2, potentially providing us with an accessible cell type
in which to directly test our hypothesis that intracellular Ca2+ response is disrupted in the
absence of nBMP2.
To interrogate if nBMP2 might play a role in Ca2+ response, we isolated macrophages
from wild type and nBmp2NLStm mutant mice. These macrophages included bone marrow
derived (BMD) macrophages from uninfected mice, and splenic macrophages from mice that had
undergone primary and secondary infections with S. aureus54. Live-cell Ca2+ imaging as well as
bead engulfment assays were performed to measure intracellular Ca2+ response and phagocytic
activity. These analyses revealed deficient Ca2+ response and phagocytosis in splenic
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macrophages isolated from mutant mice after secondary systemic infection with S. aureus, but
not in BMD macrophages from naïve mice, suggesting that as nBmp2NLStm mutant cells
respond to infection over time, Ca2+ response is progressively impaired.
2.2 Materials and Methods
2.2.1 Research Animals
This study was carried out in strict accordance with recommendations in the Guide for
the Care and Use of Laboratory Animals 55. The protocol was approved by the Institutional
Animal Care and Use Committee (IACUC) of Brigham Young University (protocol numbers 150107 and 15-0603).
Mice were housed in a temperature-controlled (21–22°C) room with a 12:12 hour lightdark cycle and fed standard rodent chow and water ad libitum. The nBmp2NLStm mice were
constructed on a Bl6/129 background, as described 31. The homozygous wild type and mutant
mice used in this study were obtained by breeding heterozygotes, and genotyping was performed
as previously described 56. All experiments were performed with male mice at least 6 months of
age.
2.2.2 BMD and Splenic Macrophage Isolation
BMD macrophages were obtained from femurs and tibias of wild type and nBmp2NLStm
mutant mice and were matured in culture at 37°C with 5% CO2 for 7 days in macrophage
medium (DMEM (HyClone), 10% fetal bovine serum (FBS) (HyClone), 20% supernatant from
L929 mouse fibroblast as a source of macrophage colony-stimulating factor (M-CSF), 5% heat
inactivated horse serum (Sigma), 1 mM sodium pyruvate (Gibco by Life Technologies), 1.5 mM
L-glutamine (Thermofisher), 10 u/ml penicillin, 10 µg/ml streptomycin (Gibco by Life
Technologies)) prior to plating for immunocytochemistry, Ca2+ imaging or engulfment assays.
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Spleens from wild type and nBmp2NLStm mutant mice were homogenized in phosphate
buffered saline (PBS). The homogenate was filtered, pelleted at 450 x g for 5 min, suspended in
lysis buffer (155 mM NH2Cl, 10 mM KHCO3, 0.1 mM EDTA) on ice for 3-5 min to lyse
erythrocytes, and then washed with 37°C macrophage media and plated in macrophage medium
in 6-well plates. After 3 days of culture at 37°C in 5% CO2, medium was replaced to remove
non-adherent cells 57. On day 4, 100 ng/ml lipopolysaccharide (LPS) was added to the culture
medium to stimulate differentiation, and cells were incubated for 3-4 more days58. Differentiated
cells were then plated for immunocytochemistry, Ca2+ imaging, or engulfment assays.
2.2.3 Immunocytochemistry
Immunocytochemistry was performed using BMD and splenic macrophages. Following
macrophage isolation and 7-day differentiation as described above, cells were plated on
coverslips that were pre-treated with 0.025% HCl in PBS for 20 min to facilitate cell attachment.
Cells were cultured for 1-2 days to reach 70-90% confluence, then fixed at 37°C in 4%
paraformaldehyde for 10 min. Epitopes were exposed through antigen retrieval using 5%
sodium citrate and 0.25% Tween-20 in ddH2O, pH 6.0, at 95°C for 10 min. Cells were
permeabilized using 0.1% Triton X-100 then blocked for 1.5 hour at room temperature (RT)
using SEA BLOCK blocking buffer (ThermoFisher Scientific, 37527). The samples were then
probed with 1:50 anti-BMP2 antibody (Novus Biologicals, NBP1-19751) diluted in 10% SEA
BLOCK blocking buffer in 0.1% Tween-20/PBS (PBS-T), overnight at 4°C. The probed slides
were then stained with anti-rabbit Alexa Fluor 488 (ThermoFisher Scientific, A-11034) for 1
hour at RT. Afterwards, nuclei were stained by incubating the slides in 1:5000 DAPI in PBS-T
for 15 min., then slides were mounted using ProlongTM Gold Antifade Mountant (Life
Technologies, P10144) and cured overnight prior to microscopic imaging. Cells were imaged
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using a Leica TCS-SP8 confocal microscope with 63X magnification, using the same laser
intensities for all samples. Appropriate laser lines were used such as 405 nm for DAPI and 488
nm for BMP2-Alexa Fluor 488.
Comparison of nuclear BMP2 staining intensity between wild type and mutant cells was
performed on tiff versions of confocal microscope images using ImageJ to create tracings of
DAPI-stained regions and to calculate the mean pixel intensity of nBMP2 staining within each
nucleus. Mean nuclear staining intensity was calculated for each image, and groups were
compared using an unpaired, two-tailed t-test in GraphPad Prism. (Fig 1B).
2.2.4 S. aureus Bacterial Infections
S. aureus ATCC strain 12600 was cultured in tryptic soy broth liquid culture alternating
with standard streak plating on mannitol salt agar (Thermo Fisher Scientific) for counting. To
prepare bacteria for injections, 100 µl of overnight liquid culture was transferred into a new 15
ml broth culture and grown until OD600 reached 1.0, then pelleted and resuspended in 15 ml of
PBS with 20% glycerol, aliquoted, and stored at -80˚C for 3 weeks before injection. Frozen
stock concentration was verified one day before the infection by thawing a single aliquot and
performing standard serial dilution plate counts. On the day of infection, S. aureus was diluted
from the frozen stock to the desired concentration in PBS, and mice received a 200 µl
retroorbital injection using a 1 ml syringe and 27-gauge needle. The injected volume contained a
priming dose of 1 x 104 CFU/g body weight on day 0 (primary infection), and a dose of 3 x 105
CFU/g body weight on day 35 (secondary infection). Macrophages were harvested three days
later.
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2.2.5 Bacterial Supernatant Preparation
Bacterial supernatant obtained from E. coli K12 and S. aureus 12600 was used to
stimulate Ca2+ fluxes in BMD and splenic macrophages 59,60. A single colony was picked from
an agar plate and inoculated into liquid broth overnight culture. The next day, 1 ml of the
overnight culture was inoculated into 15 ml liquid broth and incubated with shaking at 37°C until
culture reach an OD600 of 1-1.3. Cells were then pelleted by centrifugation at 1,800 x g for 12
min at 4°C, and supernatant was collected.
2.2.6 Calcium Imaging
BMD and splenic macrophages were isolated and matured in culture for 7 days as
described above, then seeded on 8-chambered coverglasses (Nunc 155411, Thermo Scientific)
and incubated overnight in macrophage medium at 37°C in 5% CO2. For BMD macrophages, 10
ng/ml LPS from E. coli O55:B5 (Sigma) was included in the overnight incubation to activate
cells. The next day, cells were loaded with 3 μM Fura-2AM (Invitrogen) in Ringers solution
containing Ca2+ to be used as an extracellular source during the Ca2+ imaging assay (150 mM
NaCl, 10mM glucose, 5 mM HEPES, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, pH 7.4) for 30
min at 37°C in 5% CO2, washed with Ringers solution, then incubated for another 30 minutes at
37°C in Ringers solution. Calcium imaging was performed at room temperature using an
Olympus IX51 inverted microscope equipped with a xenon arc lamp. Fura-2AM loaded
macrophages were excited using 340 nm and 380 nm excitation filters, and images of 340 nm,
380 nm, and transmitted light were capture using a florescence microscope camera (Q Imaging
Exi Blue) with a 20x objective (N.A. 0.75) at 3-sec intervals. At the 2-min time point in each
imaging protocol, 20 µl of bacterial supernatant was added to stimulate Ca2+ flux. Ionomycin (1
µM final concentration) was added at the 10-min time point as a positive control. 10-20
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representative cells were selected as regions of interest in each frame, and F340:F380 ratios were
calculated and analyzed using CellSens software from Olympus. Each individual cell’s
fluorescence was normalized to its first recorded value according to the equation (F-Fo)/Fo,
where F is the fluorescence at the specific time point, and Fo is the fluorescence value at time 0
60,61

.

2.2.7 Engulfment Assay
BMD and splenic macrophages were isolated and matured in culture for 7 days as
described above, then seeded in 12-well culture plates for flow cytometry-based engulfment
assays 62-68. 100% FBS was used to resuspend 2.0 µm phycoerythrin-conjugated polychromatic
red latex microspheres (Polysciences, Inc.) to prevent beads from sticking to the cell membranes
during engulfment 62. The ~109 particles/ml concentration was chosen to ensure that beads were
not a limiting factor in phagocytosis rates 62. Macrophages were then activated by adding LPS
from E. coli O55:B5 (Sigma) to a final concentration of 10 ng/ml and incubated for 1 hour at
37°C and 5% CO2. Media was removed and cells were rinsed with cold PBS, then collected and
analyzed by flow cytometry using an Attune flow cytometer (Applied Biosystems by Life
technologies). Cells were pre-treated with anti-CD16/32 antibodies (14-0161-85 eBioscience) to
prevent non-specific antibody binding, then surface stained with APC-conjugated anti-CD11b
antibodies (17-0112-82 eBioscience) and FITC-conjugated anti-F4/80 FITC antibodies (114801-82 eBioscience) to identify mature macrophages. Doublets were removed based on
forward scatter width (FSC-W)/forward scatter area (FSC-A), and the F4/80 and CD11b double
positive population was selected. From within this gate, engulfing macrophages were
distinguished from non-engulfing macrophages based on phycoerythrin fluorescence, and
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macrophages could be further distinguished based on the engulfment of one, two, or three or
more beads. Results were analyzed using FlowJo software (Tree Star).
2.2.8 Data Analysis
All assays were performed as at least three independent repeats, each in triplicate. Area
under the curve (AUC) was determined using GraphPad Prism. Statistical significance was
assessed using unpaired two-tailed Students T test in GraphPad Prism.
2.3 Results
2.3.1 The nuclear variant nBMP2 is expressed in BMD and splenic macrophages from wild type
mice
To determine whether nBMP2 is expressed in macrophages, BMD macrophages and
splenic macrophages were isolated from naïve (uninfected) wild type and nBmp2NLStm mutant
mice and differentiated in vitro, and immunocytochemistry was performed using an anti-BMP2
antibody that binds to both BMP2 and nBMP2. Consistent with our prior observation of
impaired immune response in nBmp2NLStm mutant mice32, nBMP2 was detected in the nuclei
of wild type BMD (Fig. 7a) and splenic (Fig. 7b) macrophages. As expected, nBMP2 was
significantly decreased in macrophage nuclei from nBmp2NLStm mutant mice (Fig. 7a and 7b,
mutant). ImageJ software quantification of immunofluorescence images showed that the density
of nuclear BMP2 staining was significantly more intense in wild type compared to mutant
macrophages in both BMD macrophages (p = 0.0005) and splenic macrophages (p <0.0001)
(Fig. 8). BMP2 staining was visible throughout the cytoplasm of both wild type and mutant
macrophages, as expected, given that nBMP2 is synthesized in the cytosol before being
translocated to the nucleus and that the conventional BMP2 growth factor is synthesized in the
rough ER and translocated through the Golgi before being secreted from the cell.
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Figure 7. BMD macrophages and splenic macrophages express nBMP2, which is decreased in the
nuclei of nBmp2NLStm mutant macrophages.
(a) BMD macrophages and (b) splenic macrophages were stained with anti-BMP2 antibody (green) and
counterstained with DAPI (blue), demonstrating that nBMP2 is expressed and localized to the nucleus in
wild type macrophages, and that nuclear translocation of nBMP2 is inhibited in mutant macrophages.
BMP2 labeling within the cytoplasm is present in both wild type and mutant cells as expected, because
the targeted mutation allows translation of nBMP2 in the cytoplasm but inhibits nuclear translocation, and
it allows normal synthesis and secretion of conventional BMP2.
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Figure 8. Quantification of nBMP2 nuclear staining intensity.
Five images each were analyzed for wild type and mutant BMD macrophages and for mutant splenic
macrophages. Four images were analyzed for wild type splenic macrophages. Each image contained
between 10 and 93 cells, and the number of cells analyzed per group ranged from 100 to 337. ImageJ was
used to outline DAPI-stained regions and quantify BMP2 immunostaining as the sum of pixel intensities
within each nucleus. The mean density of BMP2 immunostaining was then calculated for all nuclei in an
image. An unpaired, two-tailed t-test was performed to compare nuclear staining between wild type and
mutant cells. For BMD wild type vs. mutant macrophages, p = 0.0005. For splenic wild type vs mutant
macrophages, p < 0.0001.

2.3.2 BMD macrophages from uninfected nBmp2NLStm mutant mice and wild type mice have
similar Ca2+ response
Naïve BMD macrophages isolated from femurs and tibias of uninfected mice were
matured and activated in vitro then plated for live-cell Ca2+ imaging. Plated cells were loaded
with Fura-2AM, a UV-excitable ratiometric calcium indicator that changes its excitation in
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response to Ca2+ binding; Fura-2AM emits at 380 nm when Ca2+ is not bound, and at 340 nm
when Ca2+ binds to the dye. The fluorescence ratio (F340/F380), increases as cytosolic Ca2+
levels increase 69. At the 2 min time point, supernatant from Escherichia coli (ECS) cultures was
added to stimulate Ca2+ flux (Fig. 9a) 60,70,71. Following this stimulation, there were no
observable differences between naïve mutant and wild type BMD macrophages in peak Ca2+
response (Fig. 9b) or sustained Ca2+ levels (Fig. 9c).

Figure 9. Naïve bone marrow derived (BMD) macrophages from nBmp2NLStm mutant mice and wild
type mice have a similar Ca2+ response.
Naïve BMD macrophages from wild type (WT) and nBmp2NLStm mutant (MT) mice were loaded with
Fura-2AM for live-cell Ca2+ imaging. During imaging, cells were stimulated at 2 min with E. coli
supernatant (ECS), then at 10 min with ionomycin as a positive control. (a) Average curves showing
intracellular Ca2+ response in wild type and nBmp2NLStm mutant BMD macrophages. Fluorescence
ratios (F340/F380) were measured at 3 sec intervals from 0-12 min (n = 38 cells). Error bars (s.e.m.) are
shown at one min intervals. (b) Average (± s.e.m.) of peak Ca2+ influx (F340/F380) in wild type and
nBmp2NLStm mutant BMD macrophages (n = 38 cells). (c) Area under the curve (AUC) of F340/F380
ratios from minutes 3 to 10 min shows sustained intracellular Ca2+ levels (n = 38 cells). NS, not
significant.

2.3.3 Splenic macrophages isolated from nBmp2NLStm mutant mice after secondary infection
show impaired Ca2+ response
In our prior study, immune deficiencies in nBMP2NLStm mice were detectable only after
the mice received a secondary infection with S. aureus 32. Because our current experiments
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revealed no significant differences in Ca2+ response in naïve BMD macrophages from mutant
compared to wild type mice, we decided to replicate the in vivo conditions of our previous work
by examining splenic macrophage harvested from mice after a secondary infection with S.
aureus, and by using S. aureus supernatant as the stimulus to trigger Ca2+ flux 32. Although S.
aureus is a gram positive bacteria that does not produce LPS, it does produce liphoteichoic acid
(LTA), which is similarly able to activate macrophages72,73. Thirty-five days after primary
systemic S. aureus infections, mice were given a second injection of S. aureus, and splenic
macrophages were isolated 3 days later.
After one week in vitro maturation, splenic macrophages were loaded with Fura-2AM for
live-cell Ca2+ imaging experiments. S. aureus supernatant (SAS) was used to stimulate Ca2+ flux
at the 2-min time point (Fig. 10a). Compared to the lack of a difference in naïve BMD
macrophages, it is particularly striking that peak Ca2+ response was significantly decreased
(p=0.0335) in mutant splenic macrophages after secondary infection (Fig. 10b). Sustained Ca2+
levels as measured by the area under the curve (AUC) from minutes 3-10 was also significantly
decreased (p=0.0008) (Fig. 10c).
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Figure 10. Splenic macrophages collected from nBmp2NLStm mutant mice after secondary infection
have an impaired Ca2+ response.
Splenic macrophages from wild type (WT) and nBmp2NLStm mutant (MT) mice were loaded with Fura2AM for live-cell Ca2+ imaging. During imaging, cells were stimulated at 2 min with S. aureus
supernatant (SAS), then at 10 min with ionomycin as a positive control. (a) Average curves showing
intracellular Ca2+ response in wild type and nBmp2NLStm mutant splenic macrophages. Fluorescence
ratios (F340/F380) were measured at 3 sec intervals from 0-12 min (n = 44 cells). Error bars (s.e.m.) are
shown at one min intervals. (b) Average ± s.e.m. of peak Ca2+ influx (F340/F380) in wild type and
nBmp2NLStm mutant splenic macrophages shows a significant difference (n = 44 cells). (c) AUC of
F340/F380 ratios from minutes 3 to 10 min shows a significant difference in sustained intracellular
Ca2+ levels (n = 44 cells). * = p < 0.05, ** = p < 0.01, *** = p < 0.0001.

2.3.4 BMD macrophages from uninfected nBmp2NLStm mutant mice and wild type mice show
similar phagocytic activity
To test phagocytic activity of naïve BMD macrophages (meaning macrophages that were
isolated from uninfected mice) from nBmp2NLStm mutant compared to wild type mice, we
measured fluorescent bead engulfment by CD11b and F4/80 positive cells with flow cytometry
(Fig. 11a)62-68. We observed no differences in the phagocytic activity of naïve BMD
macrophages from nBmp2NLStm mutant compared to wild type mice (Fig. 11b, 11c, 11d and
11e).
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Splenic macrophages from nBmp2NLStm mutant mice show impaired phagocytic activity
To test phagocytic activity in macrophages isolated from mice after secondary infection,
splenic macrophages were isolated from wild type and nBmp2NLStm mutant mice 3 days after
mice received a second systemic infection with S. aureus, and fluorescent bead engulfment was
measured as described above. While differences between wild type and mutant macrophages did
not reach significance when subgroups that engulfed 1, 2, or 3 or more beads were analyzed
individually (Fig. 12a, 12b and 12c), there was a significant reduction in overall mutant
phagocytic activity (p = 0.0176) when the subgroups were pooled (Fig. 12d). These data suggest
a possible relationship between the decreased Ca2+ response and reduced phagocytosis in
nBmp2NLStm mutant splenic macrophages.
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Figure 11. Naïve bone marrow derived (BMD) macrophages from nBmp2NLStm mutant mice and
wild type mice show similar phagocytic activity.
After incubation with fluorescent microspheres, macrophages were analyzed by flow cytometry. (a) A
representative analysis is shown. The F4/80 and CD11b double positive population was selected, and
from this gate a histogram was produced to identify macrophages that had engulfed 1, 2, or 3 or more
beads. The percentages of total double positive cells represented within each peak are indicated. (b)
Percent of cells engulfing 1 bead, (c) percent of cells engulfing 2 beads, and (d) percent of cells engulfing
3 or more beads. (e) Percent of cells engulfing one or more beads. N=3 pairs of wild type and 3 pairs of
mutant mice. NS, not significant.
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Figure 12. Splenic macrophages collected from nBmp2NLStm mutant mice after secondary infection
show impaired engulfment activity.
After incubation with fluorescent microspheres, macrophages were analyzed by flow cytometry as
described in Figure 3. (a) Percent of cells engulfing 1 bead, (b) percent of cells engulfing 2 beads and, (c)
percent of cells engulfing 3 or more beads. (d) Percent of cells engulfing one or more beads. N=3 pairs
of wild type and 3 pairs of mutant mice. NS, not significant. * = p < 0.05.

2.4 Discussion
The role of BMP2 in macrophages is unknown and remains an area of active research.
BMP2 has been reported to be constitutively expressed in M1 (inflammatory) macrophages 74.
Other studies have shown that BMP2 expression is upregulated as macrophages shift toward the
pro-healing/anti-inflammatory M2 phenotype 75. BMP2 secretion by macrophages promotes
migration of vascular smooth muscle cells, and macrophages in the intestinal muscularis secrete
BMP2 to signal enteric neurons 76,77. Reports of BMP2 expression by hematopoietic cells, in
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particular macrophages, are relevant to this study because nBMP2 can be produced from the
same mRNA as the conventional secreted BMP2 growth factor—any time BMP2 mRNA or
BMP2 growth factor is detected, the potential for nBMP2 synthesis exists 78. Accordingly, we
have demonstrated by immunofluorescence that both BMD macrophages and splenic
macrophages express the nuclear variant of BMP2, nBMP2, and that nBMP2 is decreased in the
nuclei of macrophages from nBmp2NLStm mutant mice.
Previously, we demonstrated that deficiency of nBMP2 in the nucleus impairs secondary
immune response as evidenced by diminished spleen enlargement, poor clearance of S. aureus
from the bloodstream, and increased mortality after secondary infection 32. We have also shown
that deficiency of nBMP2 in myonuclei is correlated with slowed skeletal muscle relaxation after
contraction, and deficiency of nBMP2 in the nuclei of hippocampal neurons is correlated with
learning/memory deficits 56. Each of these phenotypes is consistent with deficiencies in
intracellular Ca2+ transport, but until now, no direct measurements of intracellular Ca2+ have
been performed in cells from nBmp2NLStm mutant mice. The discovery that macrophages
express nBMP2 (Fig. 7) provided an accessible cell type in which to directly address the question
of whether nBMP2 plays a role in intracellular Ca2+ response.
We found that intracellular Ca2+ response was impaired in mutant splenic macrophages
after secondary infection with S. aureus, but not in mutant BMD macrophages isolated from
uninfected mice, even though both macrophage types expressed nBMP2. Recent work has
revealed that innate immune cells can undergo memory-like adaptive responses to increasing
pathogen load, and the deficient Ca2+ response in splenic macrophages after secondary infection
might represent a failure of those adaptive responses 79,80. Alternatively, it may be that the
effects of nBMP2 deficiency in the nucleus are simply cumulative, causing a Ca2+-handling
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phenotype that becomes progressively more severe as cells differentiate and mature. A
progressive phenotype is consistent with our previously reported observation that hippocampal
long-term potentiation (LTP) was normal in 3-week-old nBmp2NLStm mutant mice but deficient
in 3-month-old mice 56. Progressive impairment of intracellular Ca2+ response has received
attention recently as a potential mechanism for both brain and muscle aging 81-83, suggesting that
nBMP2 dysfunction could contribute to premature aging or aging-related diseases.
Deficiency of nBMP2 in the nucleus also produced a significant decrease in the total
phagocytic activity of splenic macrophages from nBmp2NLStm mutant mice, suggesting that
mutant cells may be less effective at clearing pathogens from the blood stream. This is
consistent with prior studies suggesting that intracellular Ca2+ mobilization plays a role in
macrophage phagocytic activity. For example, impaired Ca2+ response in macrophages from
Trpm4 (-/-) mutant mice led to decreased phagocytic activity, resulting in bacterial overgrowth
and translocation to the bloodstream 84. Intracellular Ca2+ levels increase during Fcɣ receptor
(FcR)-mediated phagocytosis 22,85,86, and the loss of CaMKK2, a calcium-dependent kinase, left
macrophages unable to phagocytose bacteria or synthesize cytokines in response to bacterial
lipopolysaccharide (LPS) 87.
Although evidence supports the involvement of Ca2+ response in macrophage phagocytic
activity, the scale of the decreased phagocytosis by splenic macrophages observed in our study
seems insufficient to account for the markedly increased mortality of nBmp2NLStm mutant mice
after secondary infection 56. We cannot rule out the possibility that the bead engulfment assay
did not fully reflect the severity of phagocytosis impairment in splenic macrophages. Liver
macrophages also play a role in bacterial clearance, and it is possible that the absence of nBMP2
in the nucleus affects their function more severely 88,89. In addition, the absence of nBMP2 in the
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nucleus might affect other immune system cell types besides macrophages, and it is possible that
another cell type, or perhaps several cell types together, account for the increased mortality of
nBmp2NLStm mutant mice after secondary infection 56. Indeed, BMP2 (and therefore potentially
nBMP2) is expressed by a specialized endothelial population in the early embryo, termed
hemogenic endothelium, that gives rise to hematopoietic stem cells 90. The absence of nBMP2 at
the earliest stages of hemogenesis could therefore impact a wide range of immune cell types.
BMP2 is also expressed in human cord blood cells, including those that express CD34, a
hematopoietic progenitor cell antigen 91, and acute bleeding triggers upregulation of BMP2
expression in hematopoietic stem cells 92. BMP2 expression is also found in mature B cells,
where it is upregulated in response to infection with Aggregatibacter actinomycetemcomitans 93.
It is possible, therefore, that nBMP2 impacts the activation or function of other immune cell
types in addition to macrophages, and the combined functional deficits account for the increased
mortality in nBmp2NLStm mutant mice after secondary infection.
It will be important, in future work, to elucidate the molecular mechanisms underlying
the Ca2+ response differences between macrophages from wild type and nBMP2 mutant mice.
Differences may stem from impaired uptake or release of Ca2+ from endoplasmic reticulum
stores, as suggested by the decreased SERCA activity observed in skeletal muscle of nBMP2
mutant mice31. Alternatively, transport of Ca2+ could be impaired at the macrophage cell
membrane, consistent with observations that increasing extracellular Ca2+ levels can improve
phagocytosis 94,95. Neurons and muscle cells are excitable cells and are therefore equipped with
a different set of ion channels and transporters than are macrophages, and so it will be important
to examine molecular details of the Ca2+ handling defect in all three cell types. This work has
thus opened the way for future studies into the molecular interactions and activities of nBMP2.
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Questions about how nBMP2 functions from inside the nucleus to affect Ca2+ response
also remain to be answered. The novel protein nBMP2 was first identified from among nuclear
proteins that had been isolated using DNA affinity chromatography, but subsequent experiments
failed to show direct binding of nBMP2 to DNA, and the amino acid sequence of nBMP2
contains no predicted DNA-binding domain 78. It is possible that nBMP2 interacts indirectly
with DNA through a transcription factor, and future studies of nBMP2’s impact on the
expression of genes involved in Ca2+ signaling will be informative.
In summary, this study supports our working hypothesis that aberrant intracellular Ca2+
response is the mechanism that unites the otherwise disparate muscle, neurological, and immune
phenotypes observed in nBmp2NLStm mutant mice 30-32,96-98. In doing so, this study has paved
the way for future work to elucidate the precise molecular nature of the Ca2+ signaling
disruptions in nBMP2 mutant cells and to understand how nBMP2’s interactions in the nucleus
impact Ca2+ signaling.
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CHAPTER 3: T cell Calcium Signaling Regulation by Co-receptor CD5

The content of this chapter was published in the Journal of Molecular Science, Freitas, C.,
Johnson, D. & Weber, K. “T Cell Calcium Signaling Regulation by the Co-Receptor CD5”.
International Journal of Molecular Sciences 19, 1295 (2018). It has been formatted for this
dissertation, but it is otherwise unchanged.
Abstract
Calcium influx is critical for T cell effector function and fate. T cells are activated when
T cell receptors (TCRs) engage peptides presented by antigen-presenting cells (APC), causing an
increase of intracellular calcium (Ca2+) concentration. Co-receptors stabilize interactions
between the TCR and its ligand, the peptide-major histocompatibility complex (pMHC), and
enhance Ca2+ signaling and T cell activation. Conversely, some co-receptors can dampen Ca2+
signaling and inhibit T cell activation. Immune checkpoint therapies block inhibitory coreceptors, such as cytotoxic T-lymphocyte associated antigen 4 (CTLA-4) and programmed
death 1 (PD-1), to increase T cell Ca2+ signaling and promote T cell survival. Similar to CTLA-4
and PD-1, the co-receptor CD5 has been known to act as a negative regulator of T cell activation
and to alter Ca2+ signaling and T cell function. Though much is known about the role of CD5 in
B cells, recent research has expanded our understanding of CD5 function in T cells. Here we
review these recent findings and discuss how our improved understanding of CD5 Ca2+ signaling
regulation could be useful for basic and clinical research
3.1 Introduction
T cells are a critical component of the adaptive immune system. T cell responses are
influenced by signals that modulate the effects of the T cell receptor (TCR) and peptide-major
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histocompatibility complex (pMHC) interaction and initiate the transcription of genes involved
in cytokine production, proliferation and differentiation 99-101. T cell activation requires multiple
signals. First, the TCR engages the pMHC leading to tyrosine phosphorylation of CD3 and
initiation of the Ca2+/Calcineurin/ Nuclear factor of activated T cells (NFAT) or PKCθ/Nuclear
factor-κ-light chain enhancer of activated B cells (NF-κB) or Mitogen-activated protein kinase
(MAP kinase)/AP-1 pathways 102-104. Second, cell surface costimulatory molecules, such as coreceptor CD28, amplify TCR-pMHC complex signals and promote stronger intracellular
interactions to prevent T cell anergy 105,106. Finally, cytokines such as interleukin-12 (IL-12),
interferon α (INFα) and interleukin-1 (IL-1) promote T cell proliferation, differentiation and
effector functions 104.
Co-receptors such as CD4 and CD8 interact with MHC molecules and additional coreceptors interact with surface ligands present on antigen presenting cells (APCs) to regulate T
cell homeostasis, survival, and effector functions with stimulatory or inhibitory signals 107.
Altering co-receptor levels, balance, or function dramatically effects immune responses and their
dysfunction is implicated in autoimmune diseases 108. Stimulatory co-receptors such as CD28,
Inducible T-cell COStimulator (ICOS), 4-1BB, OX40, glucocorticoid induced TNF receptor
(GITR), CD137 and CD77 promote T cell activation and protective responses 109. Co-receptor
signaling is initiated by the phosphorylation of tyrosine residues located in immunoreceptor
tyrosine-based activation motifs (ITAMs) or immunoreceptor tyrosine based inhibitory motifs
(ITIMs) 105,110. The phosphorylated tyrosines serve as docking sites for spleen tyrosine kinase
(Syk) family-members such as zeta-chain-associated protein kinase 10 (ZAP-70) and Syk which
activate the phospholipase C γ (PLCγ), RAS, and extracellular signal regulated kinase (ERK)
pathways in addition to mobilizing intracellular Ca2+ stores 111.
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One of the best described T cell co-receptors, CD28, is a stimulatory T cell surface
receptor from the Ig superfamily with a single Ig variable-like domain which binds to B7-1
(CD80) and B7-2 (CD86) 100. Ligand binding phosphorylates CD28 cytoplasmic domain tyrosine
motifs such as YMNM and PYAP and initiates binding and activation of phosphatidylinositide 3
kinase (PI3K) which interacts with protein kinase B (Akt) and promotes T cell proliferation and
survival 99. CD28 also activates the NFAT pathway and mobilizes intracellular Ca2+ stores
through association with growth factor receptor-bound protein 2 (GRB2) and the production of
phosphatidylinositol 4-,5-bisphosphate (PIP2), the substrate of PLCγ1, respectively 100,112.
Blocking stimulatory co-receptors suppresses T cell effector function. For example, blocking
stimulatory CD28 with anti-CD28 antibodies promotes regulatory T cell function and represses
activation of auto- and allo-reactive T effector cells after organ transplantation 106,113.
T cells also have inhibitory co-receptors which regulate T cell responses 106. The best
characterized are Ig superfamily members cytotoxic T-lymphocyte-associated protein 4 (CTLA4) and programmed cell death protein 1 (PD-1) 106,114. CTLA-4 binds CD80 and CD86 with
greater avidity than CD28, and its inhibitory role refines early phase activation signals for
proliferation and cytokine production 114-117. PD-1, another CD28/B7 family member, regulates
late phase effector and memory response 118. Inhibitory co-receptors such as CTLA-4 and PD-1,
known as “immune checkpoints”, block the interaction between CD28 and its ligands altering
downstream secondary T cell activation signals 117. Therefore, blocking CTLA-4 or PD-1
promotes effector T cell function in immunosuppressive environments 117,119.
There are also a number of co-receptors that have differential modulatory properties. For
example, CD5, a lymphocyte glycoprotein expressed on thymocytes and all mature T cells, has
contradictory roles at different time points. CD5 expression is set during thymocyte development

38

and decreases the perceived strength of TCR-pMHC signaling in naïve T cells by clustering at
the TCR-pMHC complex and reducing TCR downstream signals such as the Ca2+ response when
its cytoplasmic pseudo-ITAM domain is phosphorylated 120-123. The CD5 cytoplasmic domain
has four tyrosine residues (Y378, Y429, Y411 and Y463), and residues Y429 and Y441, are
found in a YSQP-(x8)-YPAL pseudo ITAM motif while other tyrosine residues make up a
pseudo-ITIM domain 121. Phosphorylated tyrosines recruit several effector molecules and may
sequester activation kinases away from the TCR complex, effectively reducing activation
signaling strength 121. Recruited proteins include Src homology-2 protein phosphatase-1 (SHP1), Ras GTPase protein (rasGAP), CBL, casein kinase II (CK2), zeta-chain-associated protein
kinase 70 (ZAP70), and PI3K which are involved in regulating both positive and negative TCRinduced responses 124-126. For example, ZAP-70 phosphorylates other substrates and eventually
recruits effector molecules such as PLC gamma and promotes Ca2+ signaling and Ras activation
which stimulates the ERK pathway and leads to cellular activation 111,127. Conversely, SHP1
inhibits Ca2+ signaling and PKC activation via decreased tyrosine phosphorylation of PLCγ
111,124,128,129

. Further, Y463 serves as a docking site for c-Cb1, a ubiquitin ligase, which is

phosphorylated upon CD3-CD5 ligation and leads to increased ubiquitylation and
lysosomal/proteasomal degradation of TCR downstream signaling effectors and CD5 itself 130.
Thus, CD5 has a mix of downstream effects that both promote and inhibit T cell activation.
Curiously, recent work suggests that in contrast to its initial inhibitory nature, CD5 also costimulates resting and mature T cells by augmenting CD3-mediated signaling 61,123,131,132.
Ca2+ is an important second messenger in many cells types, including lymphocytes, and
plays a key role in shaping immune responses. In naïve T cells, intracellular Ca2+ is maintained
at low levels, but when TCR-pMHC complexes are formed, inositol triphosphate (IP3) initiates
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Ca2+ release from intracellular stores of the endoplasmic reticulum (ER) which opens the Ca2+
release activated Ca2+ channels (CRAC) and initiates influx of extracellular Ca2+ through store
operated Ca2+ entry (SOCE) 5,14,19,133-135. The resulting elevation of intracellular Ca2+ levels
activates transcription factors involved in T cell proliferation, differentiation and cytokine
production (e.g. nuclear factor of activated cells (NFAT)) 5,19. Thus, impaired Ca2+ mobilization
affects T cell development, activation, differentiation and function 136,137. Examples of diseases
with impaired Ca2+ signaling in T cells include systemic lupus erythematosus, type 1 diabetes
mellitus, and others 138,139.
In this review, we will focus on CD5 co-receptor signaling and its functional effects on T
cell activation. First, we will discuss how the inhibitory co-receptors CTLA-4 and PD-1
modulate T cell function. Then we will compare CTLA-4 and PD-1 function to CD5 function,
examine recent findings that expand our understanding of the role of CD5, and assess how these
findings apply to T cell Ca2+ signaling. Finally, we will consider CD5 Ca2+ signaling regulation
in T cells and its potential physiological impact in immunometabolism, cell differentiation,
homeostasis, and behavior.
3.2 Roles of Negative Regulatory T cell Co-receptors
3.2.1 CTLA-4
Cytotoxic T-lymphocyte antigen-4 (CTLA-4, CD152) inhibits early stages of T cell
activation by recruiting inhibitory proteins such as SHP-2 and type II serine/threonine
phosphatase PP2A that interfere with T cell synapse signaling 119,140-142. CTLA-4 binds B7, a
protein on activated APCs, with higher affinity than the stimulatory co-receptor CD28; the
resulting balance between inhibitory and stimulatory signals controls T cell activation or anergy
117,143

. In naïve T cells, CTLA-4 is located in intracellular vesicles which localize at TCR binding
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sites following antigen recognition and intracellular Ca2+ mobilization 117,144. Like CD28, CTLA4 aggregates to the central supramolecular activation complex (cSMAC) where it then
extrinsically controls activation by decreasing immunological synapse contact time 145-147. This
suppresses pro-activation signals by activating ligands (B7-1 and B7-2) and induces the enzyme
Inoleamine 2,3-dioxygenase (IDO) which impairs Ca2+ mobilization and suppresses T cell
activation, ultimately altering IL-2 production and other effector functions in T cells 145,148,149.
CTLA-4 also stimulates production of regulatory cytokines such as transforming growth factor
beta (TGF-β) which inhibit APC presentation and T cell effector function 141,146,147. Compared to
effector T cells (Teff), CTLA-4 is highly expressed in regulatory T cells (Treg) and plays a role in
maintaining Treg homeostasis, proliferation and immune responses 114,150,151. Total or partial
CTLA-4 deficiency inhibits Treg ability to control cytokine production and can cause immune
dysregulation 150,152-154. Thus, CTLA-4 has an important role in the Treg suppressive response 153.
Additionally, CTLA-4 mutations are associated with autoimmune diseases as thoroughly
reviewed by Kristiansen et al 155.
The loss of CTLA-4 results in removal of CTLA-4 competition with CD28 for B7-1 and
B7-2 and is implicated in autoimmunity and cancer 113,156. Because CTLA-4 inhibits TCR
signaling, CTLA-4 deficiency leads to T cell overactivation as measured by increased CD3ζ
phosphorylation and Ca2+ mobilization 157. Thus, modulating CTLA-4 signaling is an attractive
target for immunotherapies that seek to boost or impair early TCR signaling for cancer and
autoinflammatory diseases 158,159. For example, Ipilimunab, an IgG1 antibody-based melanoma
treatment, is a T cell potentiator that blocks CTLA-4 to stimulate T cell proliferation and stem
malignant disease progression by delaying tumor progression and has been shown to
significantly increase life expectancy 117,160,161. Additionally, Tremelimumab, a non-complement
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fixing IgG2 antibody, has been tested alone or in combination with other antibodies such as
Durvalumab (a PD-1 inhibitor) and improves antitumor activity in patients with non-small cell
lung cancer (NSCLC), melanoma, colon cancer, gastric cancer and mesothelioma treatment 162167

.

3.2.2 PD-1
Programmed cell death protein-1 (PD-1, CD279) is a 288-amino acid (50-55 KDa) type I
transmembrane protein and a member of the B7/CD28 immunoglobulin superfamily expressed
on activated T cells, B cells and myeloid cells 117,168,169. PD-1 has two known ligands, PD-L1 and
PD-L2, which inhibit T cell activation signals 170. Like CTLA-4, PD-1 also inhibits T cell
proliferation and cytokine production (INF-γ, TNF and IL-2) but is expressed at a later phase of
T cell activation 117. PD-1 has an extracellular single immunoglobulin (Ig) superfamily domain
and a cytoplasmic domain containing an ITIM and an immunoreceptor tyrosine-based switch
motif (ITSM) subunit critical for PD-1 inhibitory function 171. Upon T cell activation, PD-1 is
upregulated and initiates ITIM and ITSM tyrosine interaction with SHP-2 which mediates TCR
signaling inhibition by decreasing Erk phosphorylation and intracellular Ca2+ mobilization 172,173.
PD-1 can block the activation signaling pathways PI3K-Akt and Ras-Mek-Erk, which inhibit or
regulate T cell activation 172,174. Thus, engagement of PD-1 by its ligand affects intracellular Ca2+
mobilization, IL-2 and TNF-α production, supporting PD-1 inhibitory role in TCR strength
mediated signals 175.
PD-1 signaling also affects regulatory T cell (Treg) homeostasis, expansion, and function
176

. Treg activation and proliferation are impacted by PD-1 expression which enhances their

development and function while inhibiting T effector cells 168,177. PD-1, PD-L and Tregs help
terminate immune responses 178. Thus, PD-1 deficiency results not only in increased T cell
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activation, but in the breakdown of tolerance and the development of autoimmunity in diseases
such as multiple sclerosis and systemic lupus erythematosus 178-182. PD-1 and its ligands protect
tissues from autoimmune attacks by regulating T cell activation and inducing and maintaining
peripheral tolerance 183,184. Studies done in PD-1 deficient mice observed the development of
lupus-like glomerulonephritis and arthritis, cardiomyopathy, autoimmune hydronephrosis, and
Type I diabetes, among other ailments 185,186. PD-1 protects against autoimmunity and promotes
Treg function. 178. Enhancing Treg response with a PD-L1 agonist shows therapeutic potential for
asthma and other autoimmune disorders 178,187. Because PD-1 specifically modulates lymphocyte
function, effective FDA-approved monoclonal antibodies targeting PD-1 are clinically available
(i.e. Pembrolizumab and Nivolumab) to treat advanced malignancies 118. Not only does blocking
PD-1 decrease immunotolerance of tumor cells, it also increases cytotoxic T lymphocyte antitumor activity 118.
3.3 CD5: A Contradictory Co-receptor
3.3.1 Overview of CD5 signaling and Ca2+ mobilization in T cells
CD5, known as Ly-1 antigen in mice or as Leu-1 in humans, is a type I transmembrane
glycoprotein (67 kDa) expressed on the surface of thymocytes, mature T cells, and a subset of B
cells (B-1a) 188,189. Although CD5 was discovered over 30 years ago, it was only in the last
decade that CD5 gained attention as a key T cell activation regulator 190,191. CD5 expression is
set in the thymus during positive selection and correlates with how tightly the thymocyte TCR
binds to self-peptide-MHC (self-pMHC); greater TCR affinity for self-peptide leads to increased
CD5 expression in double positive (DP) thymocytes 192. In other words, DP thymocytes that
receive strong activation signals through their TCR express more CD5 than those DP thymocytes
that receive weak TCR signals 192. CD5 knock out mice (CD5-/-) have a defective negative and
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positive selection process, and therefore their thymocytes are hyper-responsive to TCR
stimulation with increased Ca2+ mobilization, proliferation and cytokine production 121,190. On
the other hand, because of the increased TCR avidity for self-pMHC, mature T cells with high
CD5 expression (CD5hi) (peripheral or post-positive selection T cells) respond to foreign peptide
with increased survival and activation compared to mature T cells with low CD5 expression
(CD5lo) 132,193. Therefore, CD5 is a negative regulator of TCR signaling in the thymus and
modulates mature T cell response in the periphery 40,121,132,192.
While CTLA-4 and PD-1 belong to the immunoglobulin (Ig) family, CD5 belongs to
group B of the scavenger receptor cysteine-rich (SRCR) superfamily and contains three
extracellular SRCR domains 128,188,194. The cytoplasmic tail of CD5 contains several tyrosine
residues which mediate the negative regulatory activity independent of extracellular engagement
192,195,196

. As CD5 physically associates with TCRζ/CD3 complex upon TCR and pMHC

interaction, the tyrosine residues in both TCRζ and CD5 are phosphorylated by tyrosine kinases
associated with the complex 128,197-201. This interaction is so intrinsic to T cell signaling that CD5
expression levels are proportional to the degree of TCRζ phosphorylation, IL-2 production
capacity, and Erk phosphorylation which are critical for CD3-mediated signaling 42,131. It is
unknown whether post-translational modifications, such as conserved domain 1 and domain 2
glycosylations impact CD5 signaling 202,203. CD5 is present in membrane lipids rafts of mature T
cells where, upon activation, it helps augment TCR signaling, increases Ca2+ mobilization, and
upregulates ZAP-70/LAT (linker for activation of T cells) activation 204-206. This suggests that
CD5 is not only a negative regulator in thymocytes, but also appears to positively influence T
cell immune response to foreign antigen 207,208. See Figure 13.
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Figure 13. Effects of CD5 on different stages of T cell development.
CD5 expression on thymocytes is directly proportional to the signaling intensity of the TCR:self-pMHC
interaction. In the periphery, T cells with higher CD5 levels (CD5hi) are better responders to foreignpeptide. Long-lived memory cells populations are enriched for CD5hi T cells 40,132,209.

3.3.2 CD5 as a Ca2+ Signaling Modulator
As previously mentioned, CD5 expression levels are set in the thymus during T cell
development and are maintained on peripheral lymphocytes 207. CD5 expression in T cells plays
an important role during development and primes naïve T cells for responsiveness in the
periphery 42,43,61. CD5hi T cells have the highest affinity for self-peptides and respond with
increased cytokine production and proliferation to infection 35,193,210.
Our laboratory works with two TCR transgenic mouse lines with different levels of CD5
expression: LLO56 (CD5hi) and LLO118 (CD5lo) 42,43,207. While LLO56 (CD5hi) and LLO118
(CD5lo) have similar affinity for the same immunodominant epitope (LLO190-205) from Listeria
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monocytogenes, on day 7 of primary response LLO118 (CD5lo) has approximately three times
the number of responding cells compared to LLO56 (CD5hi), and conversely, on day 4 during
secondary infection LLO56 (CD5hi) has approximately fifteen times more cells than LLO118
(CD5lo) 43. This difference is not due to differential proliferative capacity, rather LLO56 (CD5hi)
has higher levels of apoptosis during the primary response 43. Thus, LLO56 CD5hi and LLO118
CD5lo capacity to respond to infection appears to be regulated by their CD5 expression levels 207.
LLO56 (CD5hi) thymocytes have greater affinity for self-peptide, which primes them to be
highly apoptotic 43.
Recently we reported that in response to foreign peptide, LLO56 (CD5hi) naïve T cells
have higher intracellular Ca2+ mobilization than LLO118 (CD5lo), which correlates with
increased rate of apoptosis of LLO56 (CD5hi), as Ca2+ overloaded mitochondria release
cytochrome c which activates caspase and nuclease enzymes, thus initiating the apoptotic
pathways 61,211,212. LLO56 (CD5hi) naïve T cell increased Ca2+ mobilization also provides
additional support to the idea that CD5hi T cells have an enhanced response to foreign peptide
61,212

. This supports previous research that found that upon T cell activation increased CD5

expression is correlated with greater basal TCRζ phosphorylation, increased Erk
phosphorylation, and more IL-2 production 193.
Thus, unlike CTLA-4 and PD-1 that are expressed only on activated T cells in the
periphery during early and late phases of immune response, respectively, CD5 is set during T
cell development, and influences T cells both during thymic development and during postthymic immune responses 117,193 (See Fig. 14). CD5 not only has an important inhibitory role in
the thymus, but also appears to positively influence the T cell population response; for example,
more CD5hi T cells populate the memory T cell repertoire because CD5hi naïve T cells have a

46

stronger primary response 132,213.CD5 fine-tunes the sensitivity of TCR signaling to pMHC,
altering intracellular Ca2+ mobilization and NFAT transcription, key players in T cell effector
function 117,157,214. As Ca2+ signaling plays a key role in T cell activation and function,
controlling Ca2+ mobilization in T cells through CD5 expression could influence diverse areas of
clinical research including metabolism, cancer treatments and even cognitive behavior.

Figure 14. Inhibiting co-receptors modulate T cell activation.
CD5 is present in naïve T cells and localizes to the TCR-pMHC complex during activation. Initial
activation cascades signal for the release of CTLA-4 from vesicles to the cell surface while the
transcription factor NFAT transcribes PD-1. CTLA-4 provides inhibitory signals during early activation
while PD-1 is expressed later and inhibits later stages of T cell activation. The initial Ca2+ mobilization is
decreased by CTLA-4 and PD-1 downstream signals.

3.4 Physiological Impact of CD5 Expression in T cells
3.4.1 Metabolism
Naive T cells are in a quiescent state and rely on oxidative phosphorylation (OXPHOS)
to generate ATP for survival 215,216. Upon TCR-pMHC interaction, T cells undergo metabolic
reprograming to meet energetic demands by switching from OXPHOS to glycolysis 217.
Glycolysis is a rapid source of ATP and regulates posttranscriptional production of INF-γ, a
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critical effector cytokine 218. Following the immune response, most effector T cells undergo
apoptosis while a subset become quiescent memory T cells. Memory T cells have lower
energetic requirements and rely on OXPHOS and Fatty Acid Oxidation (FAO) to enhance
mitochondrial capacity for maintenance and survival 219.
Ca2+ signaling is a key second messenger in T cell activation and Ca2+ ions also modulate
T cell metabolism through CRAC channel activity and NFAT activation 8,101. During TCRpMHC binding Ca2+ is released from the endoplasmic reticulum where it is absorbed by the
mitochondria and initiates an influx of extracellular Ca2+ 101. First, the rise of cytoplasmic Ca2+
activates stromal interaction molecule 1 (STIM1) located on the ER membrane to interact with
the CRAC channel located on the cell membrane 220. The release of the ER store and resulting
extracellular Ca2+ influx increases the intracellular Ca2+ concentration and promotes AMPK
(adenosine monophosphates activated protein kinase) expression and CaMKK (calmodulindependent protein kinase kinase) activity 101,220,221. AMPK senses cellular energy levels through
the ratio of AMP to ATP and generates ATP by inhibiting ATP-dependent pathways and
stimulating catabolic pathways 222. This indirectly controls T cell fate as AMPK indirectly
inhibits mTOR (mammalian target of rapamycin complex) 223. Because mTOR coordinates the
metabolic cues that control T cell homeostasis, it plays a critical role in T cell fate 224. T cells that
are TSC1 (Tuberous sclerosis complex 1) deficient show metabolic alterations through increased
glucose uptake and glycolytic flux 225.
The rise of cytoplasmic Ca2+ also encourages mitochondria to uptake cytoplasmic
Ca2+ through the mitochondrial Ca2+ uniporter (MCU) 226. This MCU uptake increases Ca2+
influx by depleting Ca2+ near the ER which further activates the CRAC channels and promotes
STIM1 oligomerization 101,227-229. Ca2+ uptake in the mitochondria also enhances the function of

48

the tricarboxylic acid cycle (TCA), which generates more ATP through OXPHOS 230,231.
OXPHOS is maintained by a glycolysis product, phosphoenolpyruvate (PEP), which sustains
TCR-mediated Ca2+-NFAT signaling by inhibiting the ER SERCA pump, thus promoting T cell
effector function 232,233. Downregulation of calmodulin kinase, CaMKK2, which controls NFAT
signaling decreases glycolytic flux, glucose uptake, and lactate and citrate metabolic processes
87

. Ca2+ may also orchestrate the metabolic reprogramming of naïve T cells by promoting

glycolysis and OXPHOS through the SOCE/calcineurin pathway which controls the expression
of glucose transporters GLUT1/GLUT3, and transcriptional co-regulator proteins important for
the expression of electron transport chain complexes required for mitochondria respiration 8.
Co-receptor stimulation plays a pivotal role in T cell metabolism and function. A
decrease in T cell Ca2+ signaling represses glycolysis and affects T cell effector function 230. PD1 and CTLA-4 depress Ca2+ signaling and glycolysis while promoting FAO and antibodies
against CTLA-4 and PD-1 increase Ca2+ mobilization and glycolysis during T cell activation
234,235

. Like CTLA-4 and PD-1, CD5 modulatory function has the potential to influence T cell

metabolism. Analysis of gene families modulated by CD5 in B cells found that CD5 upregulates
metabolic related genes including VEFG, Wnt signaling pathways genes, MAPK cascade genes,
I-kB/NF-kB cascade genes, TGF β signaling genes, and adipogenesis process genes 236.
Therefore, proliferation differences correlated with CD5 expression in T cells may be caused by
improved metabolic function as CD5lo T cells seem to be more quiescent than CD5hi T cells 237.
Although not much is known about how CD5 alters metabolic function in T cells, signaling
strength differences of CD5hi and CD5lo T cell populations correlate with intracellular Ca2+
mobilization during activation and influence their immune response 42,43,61. This implies that
different metabolic processes may be initiated which would influence proliferation, memory cell
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generation, and cytokine production. Fig. 15 summarizes how Ca2+ may be mobilized in CD5hi
and CD5lo naïve T cells and the role Ca2+ may play on metabolism.

Figure 15. CD5 expression levels in naïve T cells may influence T cell metabolism and function.
Differential levels of CD5 results in differences in Ca2+ mobilization in naïve T cells. CD5hi naïve T cells
have higher Ca2+ influx than CD5lo naïve T cells upon TCR:pMHC interaction 61. Ca2+ signaling plays a
significant role in T cell activation and influences metabolism and T cell function. Differential Ca2+
mobilization, and expression of calcineurin and NFAT affects glycolysis and mitochondrial respiration,
suggesting CD5 expression may affect metabolic reprograming during T cell activation 8.

3.4.2 Neuroimmunology
The field of neuroimmunology examines the interplay between the immune system and
the central nervous system (CNS) 238. The adaptive immune system does influence the CNS as
cognition is impaired by the absence of mature T cells 239. In wild type mice, there is an increase
in the number of T cells present in the meninges during the learning process, in stark contrast to
mice with T helper 2 cytokine deficiencies (such as IL-4 and IL-13) who have decreased T cell
recruitment and impaired learning 240. Furthermore, regulation of T cell activation and cytokine
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production critically assists neuronal function and behavior, suggesting that manipulation of T
cells could be a potential therapeutic target in treating neuroimmunological diseases 241,242.
T cells go through several microenvironments before reaching the CNS 243. Many of the
signal interactions present in these microenvironments affect T cell function and involve changes
in intracellular Ca2+ levels 243,244. In experimental autoimmune encephalitis (EAE), a model for
human multiple sclerosis, autoreactive T cells have Ca2+ fluctuations throughout their journey to
the CNS 243. Prior to reaching the CNS, T cells interact with splenic stroma cells that do not
display the cognate auto-antigen and this interaction produces short-lived low Ca2+ mobilization
spikes 243. Following entrance into the CNS T cells encounter autoantigen-presenting cells and
have sustained Ca2+ mobilization which results in NFAT translocation and T cell activation
243,245

. EAE mice display reduced social interaction and cognition demonstrating that

autoimmune response impairs neuronal function and organismal behavior 246.
Inhibitory T cell co-receptors are implicated in CNS dysregulation and disease. Varicella
zoster virus (VZV) infection is characterized by lifelong persistence in neurons. VZV increases
the expression of CTLA-4 and PD-1 in infected T cells which reduces IL-2 production and
increases T cell anergy 247,248. PD-1 deficient mice (Pdcd1-/-) have increased T cell activation,
leading to greater intracellular Ca2+ mobilization, and as previously discussed, increased
glycolysis 179. PD-1 deficiency causes elevated concentration of aromatic amino acids in the
serum, specifically tryptophan and tyrosine, which decreases their availability in the brain where
they are important for the synthesis of neurotransmitters such as dopamine and serotonin;
consequently, there is an increase in anxiety-like behavior and fear in Pdcd1-/- mice 179.
Therefore, increased T cell activation caused by PD-1 deficiency can affect brain function and
thus, effects cognitive behavior 179.
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3.4.3 Cancer
T cells are critical components of the immune response to cancer. Helper T cells directly
activate killer T cells to eradicate tumors and are essential in generating a strong antitumor
response alone or in concert with killer T cells by promoting killer T cell activation, infiltration,
persistence, and memory formation 249-254. Tumor-specific T cells may not mount a robust
response towards cancerous cells because the tumor microenvironment has numerous
immunosuppressive factors; cancerous cells also downregulate cell surface co-stimulatory and
MHC proteins which suppresses T cell activation 255-259. Potent anti-tumor immune checkpoint
blockade therapies using CTLA-4 and PD-1 monoclonal antibodies augment T cell response by
suppressing the co-receptors inhibitory signals, thereby promoting increased Ca2+ mobilization,
glycolysis and activation 260,261. CTLA-4 monoclonal antibodies such as ipilimumab (Yervoy)
and tremelimumab block B7-interaction and have been used to treat melanoma 141,262,263. The
monoclonal antibody pembrolizumab is highly selective for PD-1 and prevents PD-1 from
engaging PD-L1 and PD-L2, thus enhancing T cell immune response 117,264,265. Further research
will address whether combining anti-CTLA-4 and anti-PD-1 antibodies will improve cancer
treatments 117.
As previously mentioned, Ca2+ is critical for T cell activation and immune response.
Manipulating Ca2+ signaling to enhance T cell-directed immune response against cancer is an
intriguing notion, yet the means to target the Ca2+ response of specific cells without tampering
with the metabolic processes of other cells remains elusive 266. Anti-tumor activity of tumor
infiltrating lymphocytes (TIL), is inversely related to CD5 expression 191. CD5-levels in naïve T
cells are constantly tuned in the periphery by interactions with self pMHC complexes to maintain
homeostasis; therefore, CD5 expression on TILs can be downregulated in response to low
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affinity for cancer-antigens 267-269. Thus, the majority of TILs are CD5lo which increases their
reactivity while CD5hi TILs do not elicit a Ca2+ response and become anergic and are unable to
eliminate malignant cells 191,269. While downregulation of CD5 on TILs enhances anti-tumor T
cell activity, CD5lo T cells are also more likely to experience activation induced cell death
(AICD) as CD5 protects T cells from overstimulation 121. To maximize TIL effectiveness, the
inhibitory effects of CD5 could be blocked by neutralizing monoclonal-antibodies or soluble
CD5-Fc molecules combined with soluble FAS-Fc molecules to reduce the inherent AICD
121,270,271

. Soluble human CD5 (shCD5) may have a similar effect but avoid targeting issues by

blocking CD5-mediated interaction via a “decoy receptor” effect. Mice constitutively expressing
shCD5 had reduced melanoma and thyoma tumor cell growth and increased numbers of CD4+
and CD8+ T cells 272. Wild type mice treated with an injection of recombinant shCD5 also had
reduced tumor growth 272. Finally, CD5-deficient mice engrafted with B16-F10 melanoma cells
have slower tumor growth compared to wild type C57BL/6 mice 273. This evidence suggests that
CD5, along with PD-1 and CTLA-4, may be a potential target to specifically modulate T cell
Ca2+ mobilization in an immunosuppressive tumor setting.
3.4.4 Microbiome
The gut microbiome, including the bacteria and their products, forms a dynamic
beneficial symbiosis with the immune system influencing host genes and cellular response. The
gut microbiome shapes and directs immune responses while the immune system dictates the
bacterial composition of the gut microbiome 274. As the gut is the major symbiotic system
intersecting the immune system and microbiota, understanding their connection has implications
for immune system development and function as the gut microbiome is involved in protecting
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against pathogens, influencing states of inflammation, and even affecting cancer patient
outcomes 275,276.
The gut microbiome primes immune responses 277. Alteration in the microbial
composition can induce changes in T cells function in infectious disease, autoimmunity and
cancer 278. For example, mice treated with antibiotics which restrict or reduce the microbial
environment exhibit impaired immune response because their T cells have altered TCR signaling
and compromised intracellular Ca2+ mobilization in infectious disease and cystic fibrosis models
279-281

. In contrast, administering oral antibiotics to mice with EAE increases the frequency of

CD5+ B cell subpopulations in distal lymphoid sites and confers disease protection 282. In cancer,
the microbiome also influences patient response to immune checkpoint inhibitors such as CTLA4 and PD-1 283,284. Mice and melanoma patients immunized or populated with Bacteriodes
fragilis respond better to treatment with Ipilimumab, a monoclonal antibody against CTLA-4 275.
Similarly, tumor-specific immunity improved when anti-PD-1/PD-L1 monoclonal antibodies
where used in the presence of Bifidobacterium 285.
Though little is known about how CD5 influences T cell interaction with the microbiome,
some tantalizing details are available. As specific bacterium promotes cancer regression during
CTLA-4 and PD-1 checkpoint blockades, a CD5 blockade in conjunction with bacterial selection
may also improve immune response. Such studies would lead to novel immunotherapeutic
treatments for cancer and autoimmune diseases.
3.5 Conclusions
CD5, widely known an inhibitory co-receptor in the thymus, appears to modulate the
signaling intensity of peripheral T cells by increasing Ca2+ signaling activity and efficacy of
CD5hi T cells. CD5 expression levels in the periphery correlates with intracellular Ca2+
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mobilization, suggesting that CD5 promotes peripheral T cell activation and immune
response. As such, CD5 may be a novel checkpoint therapy to regulate T cell activation and
metabolism through altering Ca2+ mobilization, and could be used to affect neurological
behavior, alter microbiome interactions, and treat cancer and autoinflammatory diseases. While
this paper focuses on the role of co-receptor CD5 effects on calcium signaling and activation of
T cells, CD5 itself may be regulated through post-translational modifications, such as Nglycosylation, which may affect Ca2+ mobilization, T cell metabolism, activation and function.
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CHAPTER 4: Naïve Helper T Cells with High CD5 Expression have Increased Calcium
Signaling

The content of this chapter was published in PLOS One, Freitas, C. M. T., Hamblin, G. J.,
Raymond, C. M. & Weber, K. S. Naive helper T cells with high CD5 expression have increased
calcium signaling. PloS one 12, e0178799, doi:10.1371/journal.pone.0178799 (2017). It has been
formatted for this dissertation, but it is otherwise unchanged.
Abstract
The adaptive immune response is orchestrated by T helper cells and their function is
dependent upon interactions between the T cell receptor (TCR), peptide MHC (pMHC) and coreceptors. TCR-pMHC interactions initiate calcium signaling cascades which determine T cell
activation, survival, proliferation and differentiation. CD5 is a co-receptor that plays an
important role in regulating T cell signaling and fate during thymocyte education. CD5 surface
expression on mature single positive thymocytes correlates with the TCR signal strength for
positive selecting self-ligands. CD5 also plays a role in T cell function after thymic development
is complete. Peripheral T cells with higher CD5 expression respond better to foreign antigen than
those with lower CD5 expression and CD5-high T cells are enriched in memory populations. In
our study, we examined the role of CD5 expression and calcium signaling in the primary
response of T cells using two Listeria monocytogenes specific T helper cells (LLO118 and
LLO56). These T cells recognize the same immunodominant epitope (LLO190-205) of L.
monocytogenes and have divergent primary and secondary responses and different levels of CD5
expression. We found that each T cell has unique calcium mobilization in response to in vitro
stimulation with LLO190-205 and that CD5 expression levels in these cells changed over time
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following stimulation. LLO56 naïve T helper cells, which expresses higher levels of CD5, have
higher calcium mobilization than naïve LLO118 T cells. Three days after in vitro stimulation,
LLO118 T cells had more robust calcium mobilization than LLO56 and there were no
differences in calcium mobilization 8 days after in vitro stimulation. To further evaluate the role
of CD5, we measured calcium signaling in CD5 knockout LLO118 and LLO56 T cells at these
three time points and found that CD5 plays a significant role in promoting the calcium signaling
of naïve CD5-high LLO56 T cells.
4.1 Introduction
Helper T cells play a critical role in adaptive immunity by orchestrating and regulating
the immune response 286,287. In large part, the binding properties of the T cell receptor (TCR)
regulates the development, activation, and proliferative response of T lymphocytes 288,289. In the
thymus, T cells are selected according to their avidity for self-peptide/MHC complexes. The
TCR must be able to recognize self-peptide/MHC complexes with enough affinity to transduce a
signal during positive selection while not binding so tightly that they are negatively selected 289291

. TCR avidity and signal strength plays a key role in T cell function (calcium signaling,

cytokine production, T cell proliferation and differentiation) 292-294. In addition to the TCR and its
interaction with peptide MHC (pMHC), multiple receptors such as CD4, CD8, PD-1, and CTLA4 play a key role in determining whether TCR:pMHC binding results in T cell activation or
anergy. CD5 is known to be a negative regulator of TCR signaling in developing thymocytes and
its expression level in naïve T cells is determined during thymic development. CD5 levels are set
during positive selection according to the strength of the TCR-self-peptide/MHC interaction.
Typically, the stronger the avidity for self-peptide/MHC the higher the CD5 surface expression
120,191,295,296

. After completing thymic development, T cells with higher CD5 expression respond
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better to foreign antigen than those with lower CD5 expression and CD5-high T cells are
enriched in memory populations 193,297. Although there are studies examining the role of T cell
CD5 expression during thymic development and CD5-high cells are enriched in memory cell
populations, it is not clear how CD5 is involved in calcium signaling during a helper T cell
primary response. To better understand the role of CD5 in a T cell primary response to foreign
antigen, we examined the in vitro calcium responses of CD5-high and CD5-low T helper cells
that respond to the same epitope of Listeria monocytogenes.
Calcium (Ca2+) is a ubiquitous second messenger important for a wide range of cellular
functions. Ca2+ signaling plays an important role in T cell activation, cytokine production,
proliferation and cell fate and is determined by TCR interactions with the pMHC complex as
well as additional co-receptors 207,294. Ca2+ signaling has been well characterized in lymphocytes
and the calcium signal for specific helper T cell subsets has been identified, suggesting a strong
relationship between Ca2+ mobilization in T helper cells and their functional response 19,298. TCR
engagement with pMHC initiates signal transduction pathways that result in a dramatic increase
of intracellular Ca2+ 5,134. Increases in intracellular Ca2+ enables transcription factors to enter the
nucleus and turn on genes that play a critical role in immune responses. For example, NFAT,
NF-κB, AP-1, and the Oct family transcription factors initiate transcription of the interleukin-2
(IL-2) gene 299. IL-2 production is important for T cell proliferation and survival and plays a key
role in promoting effector and memory cell differentiation 300-302. Thus, TCR-dependent Ca2+
signals are essential for robust T cell primary and secondary immune responses.
The TCR avidity for self-peptide/MHC complex during selection affects the function and
maintenance of these cells in the periphery and how they respond to infection 42,43. CD5 is a
monomeric cell surface glycoprotein expressed on thymocytes, mature T cells, and a subset of B
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cells. High TCR avidity for self-peptide/MHC results in high surface expression of CD5 on
double positive and single positive thymocytes, whereas lower avidity is correlated with lower
surface expression of CD5 295. CD5 has been shown to negatively regulate the TCR signal during
thymic development 190. CD5 expression and Ca2+ mobilization correlate with TCR signal
strength and T cell fate 209,288,290. However, mature naïve T cells with higher expression levels of
CD5 appear to respond better to foreign ligands, suggesting that CD5 influences T cell
responsiveness at the post-selection level 41,193,207. Thus, it appears that the negative regulatory
effect of CD5 in the thymus may not depend on the extracellular region of CD5 whereas the
positive co-stimulatory effect of CD5 in the periphery is dependent on extracellular engagement
of an endogenous ligand (CD5 or CD5L) 195,303,304. While the exact function of these CD5
ligands is unclear, there is evidence that CD5L (CD72; a C-type ligand) binds to CD5 and that
CD5 is homophillic and may bind to CD5 on other cells 305. Thus, CD5 has a critical and
divergent role in regulating T cell activation depending on the time and location of activation.
LLO56 and LLO118 are two T helper cells that recognize the same immunodominant
epitope (LLO190-205) of L. monocytogenes and have divergent primary and secondary responses.
They differ by 15 amino acids in their TCR sequences and have unique responses to L.
monocytogenes infection in vivo, LLO118 has a better primary response whereas LLO56 has a
more robust secondary response 43. Previous analysis of thymocytes and T cells revealed that
LLO56 has higher levels of CD5 and a more robust IL-2 response in addition to a reduced
primary response caused by increased cell death compared to LLO118 T cells 42,43. In order to
better understand how CD5 levels affect T cell activation in cells that have completed thymic
development, we determined to evaluate calcium signaling in LLO56 (CD5-high) and LLO118
(CD5-low) T cells. We also measured calcium signaling in CD5 knockout LLO118 and LLO56
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T cells to better elucidate the role of CD5 in calcium signaling after thymic development is
finished. This was accomplished by measuring LLO118 and LLO56 calcium mobilization at
three different time points during the T cell response: Naïve T helper cells, day 3 poststimulation, and day 8 post-stimulation. We also measured calcium signaling in CD5 knockout
LLO118 and LLO56 T cells at these time points and found CD5 plays a significant role in
promoting the calcium signaling of naïve CD5-high T cells, but does not alter calcium
mobilization levels at later time points.
4.2 Materials and Methods
4.2.1 Mice
LLO56 (B6 Thy-1.1+ Rag1−/−), LLO118 (B6 Ly5.1+ Rag1−/−) and CD5 knockout (KO)
LLO56 and LLO118 were bred and housed in pathogen free conditions 42,43. All mice used in
these experiments were 5-12 weeks old. All use of laboratory animals was done with approval of
the Animal Care and Use Committee (IACUC protocol #15-801) at Brigham Young University.
4.2.2 T cell Isolation and Activation
CD4+ T cells were isolated from the spleens of LLO56 and LLO118 TCR transgenic (Tg)
mice 42. Spleen single cell suspensions from LLO56 and LLO118 mice were purified using a
negative selection CD4+ T cell isolation kit (Miltenyi Biotec) 298. T cells were isolated from the
spleen of LLO56, LLO118, LLO56-CD5KO, and LLO118-CD5KO mice. Spleens were
homogenized and passed through a nylon mesh cell strainer. The single-cell suspension was
resuspended in R10 medium containing RPMI 1640, 10% of FBS (HyClone), 1% Glutamax
(Gibco by Life Technologies), and 0.5% Gentamicin (Life Technologies), then transferred to a 6well plate (1x106 cell/ml) and loaded with 1 μM of Listeria monocytogenes peptide LLO190-205.
For T cell isolations, mice were euthanized using CO2 inhalation.
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4.2.3 Antigen Presenting Cell isolation
Bone marrow derived macrophages (BMDM) were obtained from B6/C57 mouse femurs
and tibias and were cultured at 37°C and 5% CO2 and matured for 7 days in macrophage medium
with DMEM (HyClone), 10% FBS (HyClone), 20% supernatant from L929 mouse fibroblast as
a source of macrophage colony-stimulating factor (M-CSF), 5% heat inactivated horse serum
(Sigma), 1 mM Na Pyruvate (Gibco by Life Technologies), 1.5 mM L-glutamine (Thermofisher),
1100X Penicillin/Sreptomycin (Gibco by Life Technologies). Harvested cells were plate in an 8chamber cover glass where they were loaded with the Listeria monocytogenes peptide LLO190-205
overnight. For bone marrow derived macrophage isolations, mice were euthanized using CO2
inhalation.
4.2.4 Calcium Imaging
Naïve T cells were incubated with 1 µM of Fura-2AM (Invitrogen) for 30 minutes at
37°C and 5% CO2 in Ringers imaging solution (150 mM NaCl, 10mM glucose, 5 mM of
HEPES, 5 mM of KCl, 1mM MgCl2, and 2 mM CaCl2, pH 7.4), washed, and then incubated in
Ringers solution for another 30 minutes at 37°C. 200,000 Fura-2AM loaded naïve CD4+ T cells
were pipetted onto 200,000 bone marrow derived macrophages that were previously incubated
with 1 µM of Listeria monocytogenes peptide LLO190-205 overnight. Imaging was performed in
Nunc 8-chamber covered glass slides (155411, Thermo Scientific). For day 3 and day 8
stimulation time points, LLO118 or LLO56 splenocytes were incubated overnight with 1 µM of
Listeria monocytogenes peptide LLO190-205. Calcium imaging was performed at room
temperature using an Olympus IX51 inverted microscope equipped with a xenon arc lamp. Fura2AM loaded T cells were excited at 340 nm and 380 nm excitation filters and capture by a
florescence microscope camera (Q Imaging Exi Blue) using a 20x objective (N.A. 0.75). Images
61

(340/380/transmitted) were recorded at 3 second intervals over 20 minutes. Each individual cell
fluorescence was normalized with the first recorded value according to the equation (F-Fo)/Fo
where F is the fluorescence at the specific time point, and Fo is the fluorescence value at time 0
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.

4.2.5 Flow Cytometry
Calcium mobilization was also measured using flow cytometry and the high affinity
calcium indicator Fluo-4 (ex:470–490 nm and em: 520–540 nm). Cells were surface stained with
an anti-CD4+-APC antibody (17-0041; eBioscience). T cells were loaded for 30 mins as
previously published with pluronic acid and 1mM Fluo-4-acetoxymethyl ester (Invitrogen) in
Ringer solution (150 mM NaCl, 10 mM glucose, 5 mM of HEPES, 5 mM of KCl, 1 mM MgCl2,
and 2 mM CaCl2, pH 7.4) 306. Intracellular calcium mobilization was initiated by adding 50
ng/ml of PMA (phorbol 12-myristate 13-acetate) and 1 μg/mml of ionomycin 307. For further
analysis done in FlowJo, the lymphocyte population was gated in a forward and side scatter gate
and singlets. From this gate a second gate was created specific for CD4+ T cells 308. Intracellular
calcium flux was measured in the CD4+ T cell gate using the FlowJo kinetics tool.
For CD5 expression analysis, spleen single cell suspensions from naïve and stimulated
(day 3 and day 8) were stained with anti-CD5-PE (12-0051; eBioscience), and anti-CD4-APC
(17-0041; eBioscience) and analyzed on the flow cytometer (BD Accurri C6).
4.2.6 Data Analysis
Live cell calcium imaging data was analyzed using CellSens Software from Olympus and
the 340:380 ratio calculations were performed on randomly selected cells. The standard
deviation of the calcium levels from the regression line was determined using GraphPad Prism.
For calcium flow cytometry measurements, FlowJo kinetics tool was used to determine the area
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under the curve (AUC) 306,309,310. All assays were performed at least three times in triplicate and
significant values were determined using student T test in GraphPad Prism.
4.3 Results
4.3.1 LLO118 and LLO56 T helper cells have different responses to antigen and CD5 expression
levels
To examine the role of CD5 in regulating calcium signaling in the primary response of
helper T cells, we used LLO56 and LLO118 T cells which are specific for the same epitope of
Listeria monocytogenes (listeriolysin O, LLO190-205) 43. These LLO118 and LLO56 T cells differ
in their in vivo responses upon L. monocytogenes infection; LLO118 helper T cells have a better
primary response and LLO56 helper T cells exhibit a better secondary response 43. Additionally,
naïve LLO56 T cells have higher levels of CD5 and produce more IL-2 upon stimulation
compared to those from LLO118 T cells 42,43. We hypothesized that these differences in CD5
levels and T cell function would allow us to better understand the role of CD5 in calcium
signaling and T cell activation in a primary response (See Table 1).
Table 1. Summary of differences between LLO56 and LLO118 T cells
Primary Response

LLO56
+

LLO118
+++

Secondary Response

+++

+

IL-2 Response

+++

++

CD5 Expression (naïve T cells)

+++

+
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4.3.2 LLO56 naïve helper T cells have higher calcium mobilization in vitro
To determine how CD5 plays a role in the primary immune response of LLO56 and
LLO118 T cells, we first analyzed the calcium signaling of naïve T cells isolated and purified
from the spleens of LLO56 and LLO118 TCR Tg mice. Calcium mobilization was measured
using live cell imaging after loading the T cells with Fura-2AM and adding them to 8-chamber
slides containing antigen presenting cells loaded overnight with the L. monocytogenes peptide
(LLO190-205). A calcium profile was generated by combining measurements (40+ cells) from 4
different experiments taking readings every 3 seconds over a 20-minute time span (Fig 16A).
Upon stimulation with LLO190-205 peptide, LLO56 T helper cells have higher peak calcium influx
levels compared to LLO118 T cells (Fig 16B). There are not any significant differences in the
mean calcium levels and variability (standard deviation) of the calcium signal between LLO56
and LLO118 T cells (Fig 16C and 16D) 311. Thus, naïve LLO56 (CD5-high) and naïve LLO118
(CD5-low) T cells have significantly different peak calcium mobilization profiles.
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Figure 16. LLO56 naïve helper T cells have higher calcium mobilization in vitro.
Naïve T cells from LLO56 and LLO118 TCR transgenic mice were obtained from the spleen using
negative selection and calcium levels were measured using live cell microscopy. T cells were added to
antigen presenting cells (bone marrow derived macrophages) that were loaded overnight with the L.
monocytogenes peptide (LLO190-205). A. Average curves of intracellular Ca2+ mobilization from LLO56
and LLO118 naïve T cells (340/380 ratios) (n=40+). Error bars show the SEM at the influx peak and
every 5 minutes after the peak (n=40+). B. Statistical analysis of peak calcium influx of stimulated LLO56
and LLO118 naïve T helper cells (n=40+). C. Statistical analysis of the sustained intracellular Ca2+ levels
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(Average 340/380 values between minutes 5 and 20) after initial stimulation response (n=40+). D.
Standard deviation was determined by linear regression analysis and shows variability in the calcium
signal for each group (n=40+). (* = p<0.05; NS = not significant).

4.3.3 LLO56 naïve T helper cells have higher levels of CD5 surface expression
Previous work has shown that naïve LLO56 T cells have higher expression of CD5
compared to naïve LLO118 T cells 43. We wanted to know what happened to the levels of CD5
at the post-stimulation time points (day 3 and day 8) that we examined in this study. As
previously reported, LLO56 naive T helper cells showed higher CD5 expression than naïve
LLO118 T helper cells. However, upon stimulation, the CD5 expression differences between
LLO56 and LLO118 T cells decrease over the course of 8 days of stimulation (Figs 17A and
17B). To further confirm CD5 expression a mean fluorescent intensity (MFI) profile was done,
which confirmed significant CD5 expression levels differences between naïve LLO56 T cells
with Day 3 and Day 8, however LLO56 did not have significant differences between Day 3 and
Day 8 (Figs 17C and 171D).
4.3.4 LLO118 T cells have higher peak calcium influx on day 3 post-stimulation
To determine whether the Ca2+ influx difference seen in naïve T cells were maintained
over the course of a primary response to infection, we measured calcium influx for LLO118 and
LLO56 T helper cells 3 days post-stimulation with L. monocytogenes peptide (LLO190-205) (Fig
18A). In contrast to naïve T cells, day 3 post-stimulated LLO118 T cells have significantly
higher peak levels of calcium influx than LLO56 T helper cells (Fig 18B). While there were no
differences in mean Ca2+ levels (Fig 18C), LLO118 did have significantly higher variability in
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the calcium signal (standard deviation). Thus, on day 3 post-stimulation LLO56 T cells had
significantly lower peak calcium influx and lower variability compared to LLO118 T cells.

Figure 17. Naïve LLO56 T helper cells have higher levels of CD5
Flow cytometry analysis of CD5 expression of LLO56 and LLO118 T helper cells was done using
LLO118 and LLO56 splenocytes at different time points after stimulation with the LLO190-205 peptide
from L. monocytogenes. A. Gating strategy for measuring CD4 and CD5 mean fluorescent intensity on
LLO118 and LLO56 T cells. B. CD5 levels of naïve T cells, T cell stimulated for 3 days, and T cells
stimulated for 8 days. T helper cells from LLO56 (red line) overlaid with the CD5 levels from LLO118
(shaded blue). Unstained cells are also included (black dots). C-D. Comparison of mean fluorescence
intensity (MFI) profiles for LLO56 and LLO118 expression levels of CD5 at different time points were
determined by flow cytometry quantitative analysis. (* = p<0.05; ** = p<0.01; *** =p<0.001; NS = not
significant).
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Figure 18. LLO118 helper T cells have higher calcium signaling on day 3 post stimulation.
LLO56 and LLO118 splenocytes were isolated and cultured with the LLO190-205 peptide from L.
monocytogenes for 72 hours in vitro. 24 hours before live imaging, a second set of splenocytes were
isolated and cultured in an 8-chamber slide loaded with LLO190-205 peptide of L. monocytogenes for use as
antigen presenting cells. T cells were stained with Fura-2AM, added to the antigen presenting cells and
Ca2+ influx was measured. A. Average curves of intracellular Ca2+ mobilization from stimulated LLO56
and LLO118 splenocytes (340/380 ratios; n=30) on day 3 post stimulation. Error bars show the SEM at
the influx peak. B. Statistical analysis of peak calcium influx of stimulated LLO56 and LLO118 naïve T
helper cells (n=30+). C. Statistical analysis of the sustained intracellular Ca2+ levels (Average 340/380
values between minutes 5 and 20) after initial stimulation response (n=30+). D. Standard deviation was
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determined by linear regression analysis and shows variability in the calcium signal for each group
(n=30+). (** = p<0.01; *** =p<0.001; NS = not significant).

4.3.5 LLO56 and LLO118 have similar in vitro calcium responses on day 8 post stimulation
To further characterize the LLO118 and LLO56 Ca2+ response, we isolated splenocytes
and co-cultured them with the L. monocytogenes peptide for 8 days. On day 8 post-stimulation,
the average Ca2+ profiles were similar to each other (Fig 19A). Upon evaluation, there were no
significant differences between LLO118 and LLO56 T cells in calcium peak, mean, or standard
deviation on day 8 post-stimulation (Fig 19B-D).

Figure 19. No calcium differences between LLO56 and LLO118 on day 8 post stimulation.
LLO56 and LLO118 transgenic splenocytes were isolated and cultured with the LLO190-205 peptide for a
week. 24 hours before live imaging, a second set of splenocytes were isolated and cultured in an 8chamber slide loaded with LLO190-205 peptide of L. monocytogenes for use as antigen presenting cells. 8
days stimulated T cells were stained with Fura-2AM and Ca2+ influx was measured using live imaging
microscopy. A. Average curves of intracellular Ca2+ mobilization from stimulated LLO56 and LLO118
splenocytes (340/380 ratios; n=30) on day 8 post stimulation. Error bars show the SEM at the influx peak.
B. Statistical analysis of peak calcium influx of stimulated LLO56 and LLO118 naïve T helper cells
(n=30+). C. Statistical analysis of the sustained intracellular Ca2+ levels (Average 340/380 values between
minutes 5 and 20) after initial stimulation response (n=30+). D. Standard deviation was determined by
linear regression analysis and shows variability in the calcium signal for each group (n=30+). (NS = not
significant).
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4.3.6 Calcium Flow Cytometry data correlates with calcium microscopy data
To confirm the results obtained in live cell calcium microscopy and evaluate the role of
TCR independent calcium signaling, we isolated LLO56 and LLO118 T cells and measured Ca2+
mobilization using flow cytometry. Cells were labeled with Flou-4AM and stimulated with PMA
and ionomycin. Flou-4AM fluorescence was examined before and after stimulation.
Measurements were collected for naïve T helper cells, day 3, and day 8 post-stimulated T cells.
The data was consistent with our previous live cell imaging findings in which naïve LLO56 T
helper cells and day 3 post-stimulated LLO118 T cells had higher Ca2+ mobilization compared to
their counterparts while no calcium mobilization differences were seen at day 8 between
LLO118 and LLO56 T cells (Fig 20A-C and Table 2). Collectively, these data show CD5
expression levels and calcium signaling changes over the course of a primary response in
LLO118 and LLO56 T cells (Table 2, Fig. 17, and Fig. 19). Our live cell microscopy calcium
imaging and flow cytometry calcium analysis differ in the parameters measured and the
stimulation used (cells were stimulated in a TCR-dependent manner for live cell calcium
imaging and in a TCR-independent manner for flow cytometry analysis). This calcium data is
consistent with the TCR independent cytokine production differences between LLO118 and
LLO56 identified by Persaud et al, in which they demonstrated that the LLO118 and LLO56
naive T cell response was set during thymic selection. Naive LLO56 T cells have higher
expression of CD5, suggesting increased affinity for self-peptide, and produce higher levels of
IL-2 even when stimulated in a TCR independent manner 42.
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Figure 20. Flow cytometry calcium analysis confirms improved calcium mobilization for naïve
LLO56 T cells and higher calcium mobilization for LLO118 T cells at day 3 post-stimulation.
LLO56 and LLO118 splenocytes were isolated and cultured at different time points with the LLO190-205
peptide. Calcium levels were quantified using the FlowJo kinetics tool to determine the area under the
curve (AUC) for each sample. Calcium mobilization levels for LLO118 and LLO56 are quantified (mean
± SEM of the area under the curve). A. Statistical analysis of naïve LLO118 and LLO56 T helper cell
calcium mobilization after activation with PMA and Ionomycin. B. Statistical analysis of day 3 post
stimulated LLO118 and LLO56 calcium mobilization and C. Statistical analysis of day 8 post stimulated
LLO118 and LLO56 calcium mobilization. (NS = not significant).
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Table 2. Summary of CD5 and calcium findings for LLO56 and LLO118
LLO56
CD5 Expression

2+

Ca influx

LLO118
CD5 Expression

Ca2+
mobilization

Naïve T cell

+++

+++

+

+

Day 3

++

++

+

+++

Day 8

++

++

+

++

4.3.7 CD5 expression in naïve LLO56 T helper cells is correlated with higher Ca2+ mobilization
To further investigate the role CD5 expression plays in Ca2+ mobilization, we measured
the calcium signal in T cells from LLO118-CD5 knockout and LLO56-CD5 knockout mice. We
found in the LLO118 T cells (CD5-low) that calcium mobilization was not significantly different
from LLO118-CD5 knockout T cells at any of the three time points (Fig. 21A-C). Conversely,
naïve LLO56-CD5 knockout T helper cells had significantly lower calcium levels compared to
the naïve LLO56 T cells (CD5-high) (Fig. 21D). There was no calcium mobilization difference
between LLO56 and LLO56-CD5 knockout T cells at day 3 or day 8 post-stimulation (Fig. 21E
and 21F). Thus, in naïve LLO118 T cells (CD5-low), CD5 does not appear to play a strong role
in regulating calcium mobilization at any of the time points. However, CD5 expression is
important in regulating calcium mobilization in the naïve LLO56 T cells (CD5-high) during the
initial response to antigen, but as CD5 levels decrease over time, its role in regulating calcium
also decreases.
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Figure 21. CD5 expression in naïve LLO56 T helper cells is correlated with higher Ca2+ mobilization
Flow cytometry analysis was performed to determine Ca2+ mobilization levels in LLO56, LLO118,
LLO56-CD5 knockout and LLO118-CD5 knockout T cells stimulated with the L. monocytogenes peptide
(naïve, day 3, and day 8 time points). Calcium levels were quantified using the FlowJo kinetics tool to
determine the area under the curve (AUC) for each sample (mean ± SEM). A-C. Statistical analysis of
calcium mobilization of LLO118 and LLO118-CD5 knockout T cells stimulated with PMA/Ionomycin.
Data is shown for naive (A), day 3 post stimulation (B) and day 8 post stimulation (C). D-F. Statistical
analysis of calcium mobilization of naïve LLO56 and LLO56-CD5 knockout T cells stimulated with
PMA/Ionomycin. Data is shown for naive (D), day 3 post stimulation (E) and day 8 post stimulation (F).
(* = p<0.05; NS = not significant).

4.4 Discussion
In this study, we examined the role of CD5 in regulating T cell activation during a
primary response using two T helper cells, LLO56 and LLO118, which bind to the same L.
monocytogenes epitope and have different levels of CD5 on the surface upon completion of
thymic development 42,43. Because of the described negative regulatory role of CD5 in the
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thymus and the prevalence of CD5-high cells in memory cells, we wondered how CD5
influences T cell immune response at a post-thymic level. We found significantly different Ca2+
signaling levels between LLO56 and LLO118 T helper cells at the naïve and day 3 time points.
The distinct Ca2+ mobilization patterns of LLO56 and LLO118 likely influence their particular
responses to antigen, similar to observations made in B cells in which unique Ca2+ mobilization
controls distinct B cell activation phenotypes 312,313. Previous work has defined the important role
of CD5 during T cell thymic development and that CD5-high cells are enriched in memory T cell
populations, but how CD5 functions during the primary response stage of T helper cells has not
been well defined. Here we characterized the role of CD5 expression and calcium mobilization
in these CD5-high and CD5-low T cells over the course of 8 days. We found that naïve LLO56 T
helper cells (CD5-high) have significantly higher calcium mobilization compared to the LLO56CD5 knockout T cells, but at later time points the removal of CD5 did not significantly alter
LLO56 calcium mobilization. Naïve LLO118 T helper cells (CD5-low) exhibit no differences in
Ca2+ mobilization relative to their CD5 knockout counterpart. Thus, we found naive CD5-high T
cells have improved calcium mobilization to an antigen they have never seen before.
T cell development shapes the T cell population by removing strongly self-reactive cells
and helping determine future immune responses. T cells that are moderately self-reactive may
be able to pass positive selection and evade negative selection and circulate in the periphery.
These self-reactive cells, marked by high levels of CD5, appear to be primed to be the best
responders to foreign antigens42. CD5 is a known negative regulator of TCR signaling during
thymocyte development and its expression is correlated to the relationship of TCR avidity for
self-pMHC 42,43,121,209. Analysis in thymocytes showed that LLO56 and LLO118 CD5 knockout
T cells had increased p-ERK and IL-2 production, providing additional evidence that CD5 has a
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negative regulatory effect in developing thymocytes 42. However, additional work has
demonstrated that CD5-high and CD5-low T cells respond differently to self and foreign
antigens, suggesting that CD5 has an important role in thymocyte selection and peripheral T cell
function and fate 41,209.
Recent studies suggest that developing T cell CD5 levels affect naïve T cell responses to
foreign antigens in the periphery 297,314. While the negative regulatory function of CD5 in the
thymus does not appear to be dependent upon engagement with a ligand, the positive costimulatory effect of CD5 in the periphery is likely due to CD5 engagement of a ligand (CD5 or
CD5L) 195,303-305. As previously reported, anti-CD5 antibodies enhance TCR-mediated activation
and proliferation in peripheral T cells 41,201,315. This calcium difference observed in naïve T cells
is supportive of the previously published finding that LLO56 T cells have significantly higher
phosphorylation levels of pERK and production of IL-2 before exposure to antigen, suggesting a
role for self-peptide affinity in altering CD5 levels and naive T cell responses. CD5-high T cells
respond strongly upon stimulation in vitro and have increased IL-2 secretion and greater Erk
phosphorylation compared to CD5-low T cells 42. Since CD5 expression is set by self-peptide
reactivity in the thymus, our finding that naïve CD5-high LLO56 T cells have higher calcium
influx is consistent with other studies that have shown that increased reactivity to self-peptides
results in T cells with improved reactivity to foreign antigens 193,209.
We found that CD5 expression plays an important role in intracellular Ca2+ mobilization
for naïve LLO56 helper T cells (CD5-high). CD5-high T cells have stronger avidity for selfpeptide. It has been suggested that the enhanced activation response to foreign pathogens of
CD5-high T cells could be due to their ability to more efficiently use self-peptide as a co-agonist
peptide in the periphery 297. Additionally, CD5-high cells have better basal TCR signaling and
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improved functional characteristics which correlate with better response to foreign peptide 209.
Studies in naïve cytotoxic T cells suggest that the gene expression profile of CD5-high T cells
transcriptionally engage into proliferative and effector functions faster than CD5-low T cells 35.
Furthermore, CD5 appears to help with CD5-high naïve T cell survival after antigen recognition
316

. In fact, T cells with high CD5 levels may maintain diversity within the memory population,

which may outweigh the cost of increased self-reactivity 297. Additionally, T cells with high CD5
expression are enriched in memory cell populations, suggesting that when designing vaccines,
CD5 levels and self-peptide and foreign peptide interactions are an important consideration
193,297

.
The data presented here helps to elucidate the role that CD5 plays in regulating calcium

signaling in naïve cells early after cell activation during an in vitro primary response. We plan to
further investigate whether the unique Ca2+ profiles of LLO56 and LLO118 T cells are consistent
in an in vivo model and further quantify the role CD5 plays in effector and memory T cells.
These future studies will help elucidate how CD5 influences naïve T cell responses and its
potential role in memory T cell generation and maintenance.
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CHAPTER 5: The Role of CD5 Co-receptor in T cells Metabolism

The following chapter is a work in progress and will be submitted for scientific review upon
completion. Current data and future directions for this project are presented here.
Abstract
During activation, T cells undergo metabolic reprogramming, which helps determine
their distinct functional fates. CD5 is a co-receptor found on T cells and plays a significant role
in regulating T cell thymic development, signaling, and cytokine production. Although CD5 is
known best for its function as a regulatory coreceptor during selection in T cell development, it
has been reported to play a regulatory role similar to PD-1 and CTLA-4 in mature T cells upon
activation. We have previously discovered that CD5 levels influence Ca2+ mobilization and T
cell activation. Differential calcium mobilization, calcineurin function, and nuclear factor of
activated T cell (NFAT) activity are known to affect glycolysis and mitochondrial respiration.
Previous studies have shown that CD5 knockout mice (CD5KO) have increased T cell activation,
leading to elevated levels of cytokine production and T cell proliferation. These functional
changes suggest that CD5 may be affecting T cell metabolic reprograming. We hypothesized that
CD5 deficient T cells have different bioenergetic demands that alter metabolic pathways key to T
cell activation and function. We evaluated the effects of the CD5 co-receptor on metabolism by
measuring the metabolic profiles of CD5KO and wild type T cells. Our preliminary data suggests
that CD5KO T cells have higher mitochondrial respiration than wild type T cells and we are
currently examining other mechanisms that can affect T cell mitochondrial respiration. Thus,
CD5 may play an important role in metabolic reprograming in T cells and could potentially be
useful in modulating the T cell response in cancer immunotherapy treatments.
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5.1 Introduction
Helper T cells are key regulators of the adaptive immune system and play an important
role in protecting against foreign peptides and cancer. During an immune response, activated T
cells undergo metabolic changes transitioning from mitochondrial respiration [oxidative
phosphorylation (OXPHOS) and fatty acid oxidation (FAO)] to glycolysis. This significant
metabolic shift affects T cell activation, proliferation and function216,235,317. Naïve T cells remain
relatively quiescent and rely predominantly on OXPHOS to meet basal metabolic needs219,318. As
T cells become activated, they have different energy demands and switch to aerobic glycolysis
which supports effector T cells functions such as differentiation and cytokine synthesis219,319.
T cell activation involves the interaction between the T cell receptor (TCR) and the peptide
major histocompatibility complex (TCR-pMHC), the signal strength initiated by this interaction
is modulated by co-stimulatory or co-inhibitory receptors. Thus, these co-receptors contribute to
a metabolic switch according to the energy requirements of the cell140,219,235,320. CD5, is a T cell
co-receptor that negatively regulates T cell activation during T cell development in the thymus. It
belongs to the group B scavenger-receptor cysteine-rich (SRCR) superfamily, and is associated
with the TCR/CD3 complex121,203. CD5 expression levels correlate with the strength of the
signal between the TCR-self-pMHC, and help fine tune the TCR repertoire by altering the
strength of the antigen receptor signal during the selection process in the thymus196,321. This
regulation appears to be independent of SHP-1 and CD5 dependent signal transduction appears
to be dependent on specific tyrosine and serine motifs that allow for regulation of T cell
activation132,304. In mature cells, it appears CD5 may function in a scaffolding role for the
ubiquitin ligases CBL and CBLB322.
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The main characterized co-receptors that negatively regulate T cell responses are PD-1
and CTLA-4; they mediate a defective transmission of the TCR-pMHC signal which correlates
with decreased Ca2+ mobilization and proliferation145,175. Upon activation T cells undergo
metabolic changes from OXPHOS to glycolysis323. Signals such as those from cytokines and the
TCR signal strength determines the magnitude of the glycolytic switch324. CD5, like the PD-1
and CTLA-4 co-receptors, negatively regulates the T cell response by affecting the TCR signal
strength and glucose metabolism140,235. CD5 also influences the immune response due to its
ability to regulate the TCR signaling response and T cell functions207. Previous publications
showed that T cells with different CD5 expression levels have different primary and secondary
immune responses and different calcium (Ca2+) mobilization responses43,61. It has also been
reported that CD5 deficient T cells are hyperproliferative, have enhanced AICD, and produce
higher levels of cytokines upon stimulation321. These reported inhibitory functions of CD5
suggest that like PD-1 and CTLA-4, the CD5 co-receptor might influence the T cell metabolic
response321.
To determine if the CD5 co-receptor does in fact alter T cell metabolism, we compared
the metabolic profiles of T cells from CD5WT and CD5KO mice. Our preliminary data suggests
that the mitochondrial respiration and spare respiratory capacity (SRC) of CD5KO naive T cells
is significantly higher than CD5WT. We also observed that naïve CD5KO T cells have higher
metabolite consumption. While this project remains a work in process, these initial findings
suggest an important role of CD5 in T cell metabolism. If confirmed, then CD5 might potentially
be useful in immunotherapy to modulate T cell metabolic responses in the tumor
microenvironment.
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5.2 Materials and Methods
5.2.1 T cell Isolation
CD4+ naïve T cells were isolated from the spleens of CD5WT and CD5KO mice42.
Splenic single cell suspensions from CD5WT and CD5KO mice were purified using a negative
selection CD4+ T cell isolation kit (Miltenyi Biotec)298. Spleens were homogenized and passed
through a nylon mesh cell strainer. The single-cell suspension was resuspended in R10 medium
containing RPMI 1640, 10% of FBS (HyClone), 1% Glutamax (Gibco by Life Technologies),
and 0.5% Gentamicin (Life Technologies), then transferred to a 6-well plate (1x106 cell/ml). For
T cell isolations, mice were euthanized using CO2 inhalation.
5.2.2 T cell Activation and Culture
Isolated CD4+ T cells were initially plated into 24-well plates and stimulated with 4.5 µm
diameter dynabeads coated with anti-CD3 and anti-CD28 (11456, Thermo Fisher Scientific), in a
bead to cell ratio of 1:1 as per manufacture instructions. The cells were cultured for 24 hours, 96
hours and 120 hours at 37 °C, 5% CO2. For cultures longer than 24 hours, 30 U/mL of IL-2 was
added after 72 hours (402-ML-100, R&D).
5.2.3 Metabolism Assays
The extracellular acidification rate (ECAR) and oxygen consumption rate (OCR) were
measured using an Extracellular Flux Analyzer XFp (Agilent Technologies, Santa Clara, CA,
USA). The culture medium was changed to Seahorse XF RPMI Base Medium (Cat#103336-100)
before the analysis. Briefly, 150,000 T cells were seeded onto a Poly-d coated seahorse 8-well
plate allowing the adhesion of T-cells and were pre-incubated at 37 °C for 60 min in the absence
of CO2. Mitochondrial stress and glycolytic parameters were measured via oxygen consumption
rate (OCR) (pmoles/min) and extracellular acidification rate (ECAR) (mpH/min), respectively,

80

with use of real-time injections: oligomycin, fluorocarbonyl cyanide phenylhydrazone (FCCP),
rotedone/antimycin, glucose, and 2-deoxy-glucose (2-DG).
For mitochondrial stress, cells were resuspended in XF assay media supplemented with
25 mM glucose, 2 mM L-glutamine and 1 mM sodium pyruvate under basal conditions, and in
response to 1 μM oligomycin, 1.5 μM fluorocarbonyl cyanide phenylhydrazone (FCCP), and
0.5 μM rotenone/antimycin A (XFp mito stress test kit; cat#103010-100; Agilent Technologies).
For glycolysis, cells were resuspended in XF assay media. The ECAR were measured at
the baseline and in response to 10 mM glucose, 1 μM oligomycin and 50 mM 2-DG (XFp
glycolysis stress test kit; cat#103017-100; Agilent Technologies). All chemicals were purchased
from Seahorse Bioscience (North Billerica, MA). Calculations for individual parameters
represents the average of individual well calculations for each assay group. Error bars are
calculated based on the individual well calculation for each parameter (Report Generator User
guide, Agilent Seahorse).
5.2.4 Metabolite Analysis
Naïve T cells were isolated under the indicated culture conditions at 1 × 106cells / ml
per well in six-well culture plates. After 1 hour of culture, 1× 106 cells/ml cells were
harvested separately, flash-frozen in liquid nitrogen and stored at −80 °C. A total of four
replicate samples for CD5KO and CD5WT were generated and analyzed via Gas
chromatography–mass spectrometry (GC/MS). Metabolomics analysis was performed at the
Metabolomics Core Facility at the University of Utah which is supported by 1 S10
OD016232-01, 1 S10 OD021505-01 and 1 U54 DK110858-01 grants. Samples preparation
and analysis was as described below:
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5.2.5 Metabolite Extraction
To each sample was added cold 90% methanol (MeOH) solution containing the internal
standard d4-succinic acid (Sigma 293075) to give a final concentration of 80% MeOH to each
cell pellet. Samples were then briefly vortexed, sonicated for 5 min and incubated at -20 ˚C for 1
hour. After incubation the samples were centrifuged at 20,000 x g for 10 minutes at 4˚C. The
supernatant was then transferred from each sample tube into a labeled, fresh micro centrifuge
tube. Pooled quality control samples were made by removing a fraction of collected supernatant
from each sample and process blanks were made using only extraction solvent and no cell
culture. The samples were then dried en vacuo.
5.2.6 GC-MS Analysis
All GC-MS analyses were performed at the Metabolomics Core Facility at the University
of Utah was done with an Agilent 7200 GC-QTOF and an Agilent 7693A automatic liquid
sampler. Dried samples were suspended in 40 µL of a 40 mg/mL O-methoxylamine
hydrochloride (MOX) (MP Bio #155405) in dry pyridine (EMD Millipore #PX2012-7) and
incubated for one hour at 37°C in a sand bath. 13 µL of this solution was added to auto sampler
vials. 60 µL of N-methyl-N-trimethylsilyltrifluoracetamide (MSTFA with 1%TMCS, Thermo
#TS48913) was added automatically via the auto sampler and incubated for 30 minutes at 37 °C.
After incubation, samples were vortexed and 1 µL of the prepared sample was injected into the
gas chromatograph inlet in the split mode with the inlet temperature held at 250°C. A 5:1 split
ratio was used for analysis for the majority of metabolites. For those metabolites that saturated
the instrument’s detector at the 5:1 split concentration, a split of 50:1 was used for analysis. The
gas chromatograph had an initial temperature of 60°C for one minute followed by a 10°C/min
ramp to 325°C and a hold time of 10 minutes. A 30-meter Agilent Zorbax DB-5MS with 10
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meters Duraguard capillary column was employed for chromatographic separation. Helium was
used as the carrier gas at a rate of 1 mL/min.
5.3 Preliminary Results
5.3.1 CD5KO naïve T cells have higher amounts of metabolites involved in glycolysis and
mitochondrial respiration compared to CD5WT naïve T cells
Naïve T cells are quiescent cells and their energy demands are supplied by the OXPHOS
of intracellular metabolites generated from the tricarboxylic acid (TCA) cycle and β-oxidation
using fatty acids to help in their homeostatic survival217,325. The metabolic state of the quiescent
cells is also regulated by genes and/or proteins with specific roles such as the co-receptors in T
cells216. CD5 is an important co-receptor during T cell development and negative regulates TCRself peptide MHC interaction. Differences in CD5 expression levels [CD5 high (CD5hi) and CD5
low (CD5lo)] in naïve T cells are known to affect gene expression related with cytokine
interaction326. To examine the role of CD5 in naïve T cells metabolism we isolated CD4+ T cells
from CD5WT and CD5KO mice and compared metabolites within these cells. We observed in
our preliminary data that the intracellular metabolites levels from the glycolytic pathway:
glucose-6-P, fructose-6-P and D-glucose (Fig. 22A), the OXPHOS pathway in specifically the
tricarboxylic acid cycle (TCA): citric acid, succinic acid and fumaric acid (Fig. 22B) and amino
acids from the amino acid metabolic pathway: tyrosine, tryptophan, alanine, glutamic acid and
glycine (Fig. 22C), from CD5KO T cells were higher compared to those of the CD5WT T cells,
suggesting that CD5 influences the metabolic response in naïve T cells.
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Figure 22. CD5KO T cells have higher intracellular levels of metabolites.
Analysis of metabolites of naïve CD4+ T cells isolated from the spleen of CD5WT and CD5KO mice. A.
Metabolites involved in glycolysis: glucose-6-P, fructose-6-P and D-glucose. B. Metabolites involved in
OXPHOS/mitochondrial respiration: citric acid, succinic acid and fumaric acid. C. Metabolites involve in
amino acid metabolism: tyrosine, tryptophan, alanine, glutamic acid and glycine. The amounts of the
indicated metabolites in naïve T cells were plotted in whisker boxes. n=4 (* = p<0.05; *** = p<0.001;
ns = not significant).

5.3.2 CD5KO naïve T cells have increased glycolytic profile
To examine whether CD5 inhibits glycolysis in T cells, we isolated naïve CD4+ T cells
isolated from CD5WT and CD5KO mice and measured their glycolytic profile. We observed that
naïve CD5KO T cells have a higher ECAR rate in contrast of the CD5WT naïve T cells which is
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associated with increased glycolysis, reflected in the extracellular acidification response in the
cells upon glucose addition (Fig. 23A-B). We wondered if upon stimulation, the same glycolytic
phenotype would remain. CD4+ T cells were stimulated using dynabeads coated with anti-CD3
and anti-CD28 at different time points (24 hours, 96 hours and 120 hours). We observed that in
contrast to naïve T cells, upon stimulation the CD5WT T cells ECAR levels (glycolytic profile)
was either the same after 24 hours, or higher as seen at the 96 hour and 120 hour time points
(Fig. 23B-H), suggesting that CD5 influences the glycolytic function of naïve and effector T
cells in a divergent manner over time.
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Figure 23. CD5KO naive T cells have increased levels of ECAR (higher glycolytic profile) and
CD5KO effector cells have equivalent or decreased ECAR levels (decreased glycolytic profile).
Seahorse extracellular acidification rate (ECAR) was measured in CD4+ isolated T cells from naïve and
activated T cells using the glycolytic stress test from Agilent. Activated T cells were stimulated with
dynabeads coated with anti-CD3/CD28 at different time points (24 hours, 96 hours and 120 hours). A, C,
E and G Show the ECAR at different time points. B, D, F and H show the differences in glycolysis
response between CD5WT and CD5KO upon glucose stimulation. (* = p<0.05; ** = p<0.01, ns = not
significant).
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5.3.3 CD5KO naïve and effector T cells have increased mitochondrial respiration and SRC
To investigate how mitochondrial respiration of CD4+ naive T cells and activated T cells
is regulated by the CD5 co-receptor via TCR/CD3 and CD28 stimulation we measured the
oxygen consumption rate (OCR), an indicator of OXPHOS, and spare respiratory capacity (SRC)
which is the difference between the maximum respiratory capacity and basal respiratory
capacity327. In other words, when energy demand exceeds supply, like in increased work or
stress, the reserve mitochondrial capacity or SRC has the potential to provide that energy
supply327,328. While unstimulated naïve T cells are metabolic quiescent [they rely on
mitochondrial respiration (OXPHOS) for their bioenergetic demands], we observed that CD5KO
naïve T cells OCR and SRC was increased in comparison to CD5WT naïve T cells (Fig. 24 AB). This suggests that naïve CD5KO CD4+ T cells have a greater reserve of energy before
activation. To examine if the OCR and SRC changed after activation, we stimulated T cells using
dynabeads coated with anti-CD3 and anti-CD28 at different time points (24 hours, 96 hours and
120 hours), and we observed that CD5KO T cells had equivalent or higher OCR and SRC than
CD5WT after 24 hours, and significantly different at 96 hours (Fig. 24 E and F). These data
suggested that CD5 plays an important role in the bioenergetic properties of T cells.
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Figure 24. CD5KO naive T cells have higher mitochondrial respiration profile
Seahorse oxygen respiratory capacity (OCR) and spare respiratory capacity (SRC) was measured in CD4+
isolated T cells from naïve and activated T cells. Activated T cells were stimulated with dynabeads coated
with anti-CD3/CD28 at different time points (24 hours, 96 hours and 120 hours). A, C, E and G Show the
OCR at different time points. B, D, F and H show the differences in SRC. (* = p<0.05; ns = not
significant).
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5.4 Conclusions and Future Direction
Upon activation, T cell metabolism shifts from mitochondrial respiration to a rapid
increase in aerobic glycolysis216. In fact, naïve T cells rely on glycolysis for their activation,
even in the presence of oxygen, to help with the proliferation, effector, and differentiation
functions219,329. T cells from PD-1 deficient mice, a co-receptor with similar regulatory functions
as CD5, have an increase in lymphocyte activation330. This increase in lymphocyte sustained
activation induces metabolic changes, and affects T cell function179. During an immune
response, T cells change their metabolic programing upon activation when energy demands
increase331.
Ca2+ signaling pathways are involved in T cell metabolic homeostasis101. CD5KO
thymocytes and T cells are hyperresponsive to TCR stimulation, have increased proliferation,
and their signaling pathways lead to an increase in intracellular Ca2+190,191. We previously
reported that CD5 expression levels in T cells alter Ca2+ mobilization responses61, and since Ca2+
levels are known to influence the T cell metabolic switch332, we wondered about the metabolic
role of CD5 in T cells (Fig 25). Here we described work examining the impact of the CD5 coreceptor in T cell metabolism by comparing the bioenergy demands of naïve and activated CD4+
T cells from CD5KO and CD5WT mice. CD5 is a T cell co-receptor that plays a critical role
during T cell early development by negative regulating the signal strength interaction between
the TCR and self-pMHC complex, and participating in the positive selection process. Evidence
of CD5 importance in T cells signaling is evident in CD5KO thymocytes which are
hyperresponsive to TCR stimulation, and in CD5KO T cells that produce higher cytokines
levels321 333. Therefore, we hypothesized that CD5 regulatory functions alter T cells metabolism.
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CD5 regulatory role in metabolic function is supported by our preliminary data, which
suggests that CD5KO and CD5WT T cells have significantly different metabolic demands. We
observed that while CD5KO naïve T cell have a higher ECAR, OCR and SRC in comparison to
CD5WT T naïve cells, the ECAR from activated CD5KO T cells was equivalent or lower than
CD5WT activated T cells. T cell co-receptors are important during the switch of energy as
costimulatory and inhibiting signals are the ones regulating proliferation, differentiation and
cytokine production334,335. Without costimulatory signals, T cells metabolic mechanisms will be
affected, and T cells will not be fully activated or will be anergic.

Figure 25. Summary of how CD5 influences metabolic function.
CD5KO naive T cells have higher mitochondrial respiration and glycolytic profiles. Representation of
CD5KO naïve T cells upon activation and the effect on T cells metabolism.
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On the other hand, when co-inhibitory signals are not present, there is no control of the
activation upon stimulation of the T cell leading to hyperactivation of metabolic pathways such
as glycolysis, mitochondrial respiration (OXPHOS) and lipid biosynthesis336,337.
Co-inhibitory signals such as CD5 affect naïve T cells activation responses by negatively
modulating TCR signaling338. Inadequate inhibitory signals result in altered T cell activation and
immune tolerance339. Altered T cells in autoimmune diseases show low levels of metabolites
involved in glycolysis, mitochondrial respiration, and amino acid metabolism in serum, implying
a higher use of these metabolites by the T cells235,340. We observed in our preliminary data that
naïve CD5KO T cells had higher concentrations of intracellular metabolites involved in
glycolysis, mitochondrial respiration (OXPHOS) and in amino acids synthesis, compared to
CD5WT naïve T cells. Previous studies have shown that CD5KO thymocytes are
hyperesponsive190. We propose that such effects in activation are also maintained in the
periphery in CD5KO naïve T cells, as suggested by the concentration of intracellular metabolites
in these cells133. This observation suggests a relevant role of CD5 in T cell metabolic immune
homeostasis not only during T cell development, but also peripheral naïve T cell maintenance.
In addition, we observed that CD5KO naïve T cells have a higher mitochondrial
respiration response (OCR) and a higher SRC than CD5WT naïve T cells. Previous work done in
T cells from mice deficient in mitochondrial proteins (mitofusin 1 and optic atrophy1)
demonstrate abnormalities in their mitochondrial mass, elevate mitochondrial membrane
potential (generate by proton pumps in the ETC), and ATP depletion341. Interestingly, they also
show a sustained mitochondrial respiration (OXPHOS) similar to that observed in memory T
cells342. Furthermore, elevated SRC (a measurement of the reserve mitochondrial capacity
available to the cell for energy production in response to increased work or metabolic stress)
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allows memory T cells to maintain ATP levels and improve survival230,343. Increased SRC
promotes mitochondrial biogenesis and the expression of CPT1 (carnitine palmitotransferase
1a)344. CPT1, is a transmembrane protein of the mitochondrial outer membrane that converts
long-chain acyl-CoA such as palmitoyl to acyl carnitine, and enters the mitochondrial matrix
where it undergoes fatty acid oxidation345. To better understand the increased SRC in CD5KO
naive T cells, it would be useful to measure CPT1 expression levels since CPT1 impairment
affects SRC in T cells328. While it is not clear what the influencing factors are for the higher
OCR and SRC in CD5KO naïve T cells, we propose that mitochondria function in these cells
plays an important role. Thus, measurement of mitochondrial mass should be performed as
increased mitochondrial mass is connected with fatty acid use in OXPHOS328,343. Mitochondrial
mass has also been connected to increase SRC and a reduction of mitochondrial mass increases
dependency on glycolysis328. In our preliminary data we observed that CD5KO T cells seemed to
have an equivalent or decreased glycolytic profile after activation in comparison to CD5WT.
This could support previous claims in which CD5 modulatory signals also influence T cell
immune responses to foreign peptide, meaning CD5 influences the T cell metabolic response not
only in development, but also in peripheral T cells upon activation207,346.
Finally, besides fatty acids metabolism, mitochondrial respiration (OXPHOS) is also
involved in amino acid metabolism235,347,348. Amino acid synthesis rates increase during T cell
activation and it is important for proliferation and cell growth317,348,349. Since, amino acid
availability is important for cell proliferation and is related to OXPHOS, amino acid availability
might also affect SRC of the cell. One way to measure CD5KO and CD5WT T cell ability to
utilize amino acids is by targeting glutamine. Glutamine is essential for T cell function as it helps
in nucleotide synthesis350. SNAT1 and SNAT2 are glutamine transporters, and their expression is
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upregulated during T cell activation as increased levels of glutamine are needed to support
proliferation350. Measurement of these glutamine transporters would provide additional insight in
the role of CD5 in amino acid biosynthesis and support the important role of CD5 in T cell
metabolism.

93

CHAPTER 6: CD5 Affects Cognitive Behavior and the Microbiome

The following chapter is a work in progress and will be submitted for scientific review upon
completion. Current data and future directions for this project are presented here.
Abstract
The immune system helps in the maintenance of central nervous system (CNS)
homeostasis and the CNS is influenced by immune cells and cytokines. T cells are key regulators
of the adaptive immune response, and they respond to CNS injuries and can affect learning and
behavior. While our understanding of immune-CNS interactions remains incomplete, the role of
T cells in the CNS is known to be critically important. Previous work has shown that the absence
or hyperactivation of T cells affects cognitive behavior. Additionally, there is evidence that T
cell hyperactivation leads to changes in the diversity of the microbiome population. CD5, a coreceptor found on T cells, modulates T cell signaling, activation and proliferation. We
hypothesized that because CD5KO T cells have altered activation and proliferation profiles, they
would also alter cognitive behavior and microbiome diversity in mice. To evaluate the influence
of CD5 influence on behavior and the microbiome, we used CD5KO and CD5WT mice. We
found that CD5KO mice had significant behavioral differences when compared to CD5WT, in
marble burying rates and open field activity. We also found that CD5KO mice have significantly
different microbiome diversity, compared to CD5WT mice. These results suggest that CD5
deficient mice have altered cognitive function (higher levels of fear and anxiety-like behavior)
and altered bacterial populations in the gut microbiota.
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6.1 Introduction
The immune system, the central nervous system (CNS) and the gut microbiota, are not
only individual entities, but are in fact, systems that often work in synergy. Systemic immune
activation is believed to be affected by the gut microbiota and to have behavioral effects351,352. T
cells, as part of the adaptive immune response, are important in cognition and behavior238,239,353.
Autoreactive T cell hyperactivation, proliferation, and cytokine production (IFNγ) have been
shown to affect neuronal plasticity and alter behavior354,355. Similarly, depletion of T cells from
meningeal spaces results in impairment of learning and memory, which can be reversed by
injection of wild-type T cells356. Hence, T cells can have protective or harmful effects as they
infiltrate the CNS in several autoimmune and infectious diseases settings and affect cognitive
behavior357,358.
Microbial colonization starts during delivery as the neonate moves from what is believed
to be a “sterile” location and is exposed to the mother’s microbes in the birth canal359. This
exposure affects neonate’s metabolism and maturation of the immune system352,360,361. The
microbiome, consisting of hundreds of bacterial species, has been implicated in the regulation of
inflammatory, infectious and metabolic diseases362. Interactions between the gut microbiota and
the immune system are numerous, with multiple effects on T cells responses363-365. While the
microbiota can influence immune cell function, studies performed in T cell deficient mice have
found significantly altered microbiota populations, suggesting that T cells also influence
microbiome composition366,367. Gut microbiota also contributes to the development and
maturation of the brain, affecting locomotive and cognitive functions368. In fact, microbiota
acquired during birth often forms a “core microbiome” during the first 2-3 years old of life,
contribute to nervous system development, and have a direct impact on cognition and behavior
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later in life369,370. Furthermore, germ-free mice have been shown to have impaired brain
development and function, as well as impaired immune responses and alterations in their
CD4+/CD8+ T cell populations363,371,372.
PD-1, is an inhibitory co-receptor found on the surface of activated T cells and regulates
T cell activation and promotes self-tolerance181. Studies performed in PD-1 deficient mice
showed T cell dysregulation resulting in hyperactivation, increased production of IFNγ, and
upregulated proliferation that leaded to impairment of the gut barrier, increased inflammation,
and defects in IgA regulation, all of which impacted gut microbial composition373,374. In addition,
increased T cell responses in mice that lack the inhibitory receptor PD-1 were associated with
depletion of amino acids necessary for the synthesis of neurotransmitters such as serotonin and
dopamine, that may be responsible for altered cognitive functions and an increase in fear based
behavior179. Thus, an alteration in a T cell co-receptor can significantly influence multiple
systems in the organism.
Similar to PD-1, CD5 is a T cell co-receptor that plays an important regulatory function
in T cell activation and immune responses. It is known to play an important role during T cell
development, immune homeostasis, regulation of activation induced cells death (AICD) and
tolerance121. T cells from CD5KO mice are hyper-responsive, have higher rates of proliferation
and increased calcium mobilization124. Because alterations in T cell activation have been
associated with altered cognitive behavior and dysbiosis in the gut microbiota, we endeavored to
examine the role of CD5 in cognitive behavior and microbiome diversity179,374. To do this, we
compared CD5 knock out (CD5KO) to CD5 wild type (CD5WT) mice. Our preliminary data
suggests that there is an impairment in cognitive behavior of CD5KO mice resulting in an
increase in the anxiety-like response in the marble burying test and elevated plus maze. We also
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observed gut microbiota differences in CD5KO from CD5WT mice, suggesting that CD5 also
influences the diversity of the gut microbiota.
6.2 Materials and Methods
6.2.1 Mice
CD5 wild type (CD5WT) and CD5 knockout (KO) mice (C57BL/6 genetic background)
were bred and housed in pathogen free conditions and fed with standard chow42,43. All mice used
in these experiments were 9-12 weeks old. All use of laboratory animals was done with approval
of the Animal Care and Use Committee (IACUC protocols #18-0303, 18-0707, and 18-0708) at
Brigham Young University. For the behavioral protocols, mice were maintained on a 12 hour
light/dark cycle.
6.2.2 Behavior assessments
6.2.2.1 Marble burying Test
The marble burying test measures anxiety-like behavior375. Mice were individually
housed and placed in a clear plastic cage filled with approximately 4-cm-deep bedding of “CeluNest bedding” (by Shepherd Specialty Paper Company) lightly pressed to give a flat surface375.
Twenty glass marbles were placed on the surface in five rows of four marbles each. The number
of buried marbles (to 2/3 their depth) were recorded during the 10-minutes test, and later
quantified by 8 -10 individuals unaware of the groups.
6.2.2.2 Open field activity test
The open field activity test measures locomotor activity and anxiety-like behavior376. The
open field consisted of a white PVC arena (50 cm × 50 cm). Mice were brought into the
experimental room 30 minutes before testing. Each mouse was placed in one of the corner
squares facing the wall, observed and recorded for 10 minutes. The total distance traveled,
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movement duration and time spent in the center area and outer area over the 10 minutes were
recorded and quantified using the Noldus EthoVision XT software. After each test, the arena was
cleaned with 70 % ethanol to attenuate and homogenize olfactory traces.
6.2.2.3 Elevated-plus maze test
The elevated-plus maze test measures fear-based and anxiety-like behavior377. The
elevated-plus maze test was conducted as previously described377. The maze (O’Hara & Co)
consists of two open arms (30 cm × 5 cm) and two closed arms of the same size, with dark walls
(15 cm). The arms and center square (5 cm × 5 cm) are made of white plastic plates elevated to a
height of 30 cm above the floor. 3-mm-high plastic ledges decrease open arm falls. Individual
mice were placed in the center square facing a closed arm, and activity was recorded or 10
minutes and quantified using the Noldus EthoVision XT software.
6.2.2.4 Morris Water Maze (MWM)
The Morris Water Maze (MWM) measures cognitive function238,240. Mouse cognitive
function was examined using the MWM for 7 days (n = 17). Mice were given three, 2-minutes
trials a day for 7 consecutive days for training to locate a 12 cm diameter circular platform,
which was placed 1 cm below water level in an open round pool. The water and room
temperature were kept constant between 26.5°C and 27.5° C. An initial day of training was
given where the mice were given 2 minute trials to locate the platform which was revealed at the
end of the trial.
During the acquisition phase of the task, each mouse was allowed a maximum of 2
minutes to locate and climb onto the platform. Once the mouse had located the platform, it was
given 5 seconds to remain on the platform, then briefly washed in warm (40°C) water before
returning to its home cage. Mice that failed to locate the platform, within 2 minutes were gently
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guided to the platform and allowed to acclimatize for 5 seconds before returning to the home
cage.
During days 1 – 4, mice were placed in the Southeast quadrant with the platform hidden
in the opposing Northwest quadrant. On the fifth day, a probe trial was performed with the
platform removed to test reference memory. Each mouse was given only one trial and maximum
of 2 minutes in the MWM. On days 6 and 7, the platform was placed in the quadrant opposite the
original training quadrant (Northwest), and the mouse was retrained for 3 sessions/trials each
day.
Data were recorded using the Noldus EthoVision XT software using a Basler ace
acA1300-60gm GigE camera in an isolated environment with only four visual references in the
MWM to facilitate the testing subject’s learning and memory: A red star on the north end, green
triangle on south end, blue square on east end, and yellow circle on west end. 12 ounces of white
non-toxic Art-Time Tempera Paint (Sargent Art) was used to make the MWM opaque.
Statistical Analysis of behavioral experiments
Groups were tested the same day, and done in successive training days as in the case of
MWM. For MWM Two-way measures ANOVA was used for statistical analyses, with a
Bonferroni post hoc test used for individual time point comparisons. Statistical analyses for the
other behavioral test (marble burying, open field, and elevated plus maze) were performed using
unpaired Student t test. All testing was performed between 9am and 1pm, (during the first 4
hours of the lights-off phase). All groups were between the ages of 9 and 12 weeks during the
behavior tests. p<0.05; *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.
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6.2.3 Metagenomics analysis of gut microbiota
6.2.3.1 Bacterial DNA extraction, isolation, and purification protocol
Bacterial DNA was isolated and purified from fecal pellets stored at -80°C using a
previously published extraction protocol378, with the following changes: samples were
homogenized in the Next Advance Bullet Blender Storm (Next Advance, Averill Park, NY)
using 3.2 mm stainless steel beads (SSB32; Next Advance, Averill Park, NY). Cells were then
disrupted with 0.1 mm glass beads (GB01; Next Advance, Averill Park, NY). After isolation,
purified DNA was suspended in 10mM Tris (pH 8.5) and stored at -20°C.
6.2.3.2 Purity and concentration checks
DNA concentration was measured by absorbance at 260 nm (A260) and purity was
estimated by measuring the A260/A280 ratio with a Nanodrop spectrophotometer (Nanodrop
Technologies, Wilmington DE). Integrity of purified DNA was checked using 0.8% agarose gel
electrophoresis with ethidium bromide staining.
6.2.3.3 Bacterial DNA library preparation and sequencing
16S rDNA gene libraries were prepared using the protocol379 from the John Chaston Lab
(Brigham Young University). Amplicon primer sequences (Table 2) were used to amplify the V4
region of the 16S rDNA using the protocol found in Table 4. Integrity of PCR product was
checked on 1.2% agarose gels. Following PCR, SequalPrep normalization plates (Invitrogen,
Frederick, MD) were used for DNA clean-up and normalization of all samples. Paired-end
sequencing was performed on the Illumina Hi-Seq 2500 platform in the BYU DNA Sequencing
Center.
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Table 3. Amplicon primer sequences
Forward
Primer

Sequence

v4.SB501

AATGATACGGCGACCACCGAGATCTACACCTACTATATATGGTAATTG
TGTGCCAGCMGCCGCGGTAA
AATGATACGGCGACCACCGAGATCTACACCGTTACTATATGGTAATTG
TGTGCCAGCMGCCGCGGTAA
AATGATACGGCGACCACCGAGATCTACACAGAGTCACTATGGTAATT
GTGTGCCAGCMGCCGCGGTAA
AATGATACGGCGACCACCGAGATCTACACTACGAGACTATGGTAATT
GTGTGCCAGCMGCCGCGGTAA
AATGATACGGCGACCACCGAGATCTACACACGTCTCGTATGGTAATTG
TGTGCCAGCMGCCGCGGTAA
AATGATACGGCGACCACCGAGATCTACACTCGACGAGTATGGTAATT
GTGTGCCAGCMGCCGCGGTAA
AATGATACGGCGACCACCGAGATCTACACGATCGTGTTATGGTAATTG
TGTGCCAGCMGCCGCGGTAA

v4.SB502
v4.SB503
v4.SB504
v4.SB505
v4.SB506
v4.SB507
Reverse
Primer

Sequence

v4.SA701

CAAGCAGAAGACGGCATACGAGATAACTCTCGAGTCAGTCAGCCGGA
CTACHVGGGTWTCTAAT
CAAGCAGAAGACGGCATACGAGATACTATGTCAGTCAGTCAGCCGGA
CTACHVGGGTWTCTAAT
CAAGCAGAAGACGGCATACGAGATAGTAGCGTAGTCAGTCAGCCGGA
CTACHVGGGTWTCTAAT
CAAGCAGAAGACGGCATACGAGATCAGTGAGTAGTCAGTCAGCCGGA
CTACHVGGGTWTCTAAT
CAAGCAGAAGACGGCATACGAGATCGTACTCAAGTCAGTCAGCCGGA
CTACHVGGGTWTCTAAT
CAAGCAGAAGACGGCATACGAGATCTACGCAGAGTCAGTCAGCCGGA
CTACHVGGGTWTCTAAT
CAAGCAGAAGACGGCATACGAGATGGAGACTAAGTCAGTCAGCCGG
ACTACHVGGGTWTCTAAT
CAAGCAGAAGACGGCATACGAGATGTCGCTCGAGTCAGTCAGCCGGA
CTACHVGGGTWTCTAAT
CAAGCAGAAGACGGCATACGAGATTAGCAGACAGTCAGTCAGCCGGA
CTACHVGGGTWTCTAAT
CAAGCAGAAGACGGCATACGAGATTCATAGACAGTCAGTCAGCCGGA
CTACHVGGGTWTCTAAT
CAAGCAGAAGACGGCATACGAGATTCGCTATAAGTCAGTCAGCCGGA
CTACHVGGGTWTCTAAT

v4.SA702
v4.SA703
v4.SA704
v4.SA705
v4.SA706
v4.SA708
v4.SA709
v4.SA710
v4.SA711
v4.SA712
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Table 4. Protocol used to amply the V4 region of the 16s rDNA
Baseline
Sample
1 Sample
13.2
4
0.5
3
0.3
2
23

Amplicon PCR
Reagents
Your # of
Samples ↓
35
dd H₂0
462
10x Buffer
140
50mM MgSO₄
17.5
2.5 mM dNTP's 105
Platinum PFX
10.5
Template
(7ng/ul)
Master mix (2ul)
DNA/well

6.2.3.4 Sequence analysis
16S rDNA sequences were analyzed using the QIIME2/2018.6. Software package380.
Read joining, denoising, demultiplexing, and feature assignments were accomplished using the
Dada2 plug-in381. Forward and reverse reads were not trimmed. Reverse reads were truncated at
230 base pairs to insure overlap of reads. Samples from the created BIOM table382 were then
filtered to remove features that appear in less than 2 total samples (singletons) and features not
assigned to at least phyla level. Phylogenetic distances were computed using q2-featureclassifier383 with naïve-bayes fit384. Alpha (how many different species could be detected within
microbial ecosystem) and beta (how different is the microbial composition between CD5WT and
CD5KO) diversity were calculated using core metrics rarefied to a sampling depth of 5000.
Principle coordinate analysis (PCoA) visualizations were created using EMPeror385,386.
Permutation Multivariate Analysis of Variance (PERMANOVA)387 was used to compare
differences in beta diversity between groups. Alpha diversity was calculated using Faith’s
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Phylogenetic Diversity (PD) and Kruskal-Wallis one-way analysis of variance388,389. Taxonomy
was assigned using q2-feature-classifier plug-in using Greengenes13_8 99% classifier390,391.
6.2.3.5 Statistical analysis of microbiome
Alpha diversity (microbial diversity) of microbiota data was analyzed using KruskalWallis one-way ANOVA 388. Permutation Multivariate Analysis of Variance (PERMANOVA)
and Bray– Curtis distance metric was used to compare differences in beta diversity between
groups. 387. Significance levels were assigned as p<0.05; *p<0.05, **p<0.01, ***p<0.001,
****p<0.0001.
6.3 Preliminary Results
6.3.1 CD5 does not influence learning and memory
Previous studies have reported the importance of T cells in learning and memory, as well
as how altered immune responses could impair such behavior392,393 . CD5 modulates T cell
activation, and CD5KO T cells are known for their hyperactivation upon peptide stimulation124.
Because CD5KO T cells have increased proliferation and cytokine production, we wondered if
these T cell alterations would influence the learning and memory in CD5KO mice. In order to
answer this question, CD5KO and CD5WT mice were trained on the Morris water maze test
(MWM). We observed that both strains recorded similar swimming distances and took similar
amount of time to locate the platform during the first 4 days, ruling out deficiencies in simple
learning/training behavior (Fig. 26A). We next tested the probe trial performance (Day 5;
platform removed from water maze), in which the time spent in the original platform quadrant of
the pool is measured and which is part of the memory assessment of the MWM238. We found that
there were not significant differences in the frequency that the mice entered the quadrant where
the probe had been, suggesting that CD5 does not affected memory (Fig. 26B). On days 6 and 7,
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we examined complex or reversal learning by placing the platform in a different (reversal)
quadrant. On day 6 CD5KO mice had significantly improved abilities to find the platform than
CD5WT mice, however, at day 7 there were no significant differences between CD5KO and
CD5WT mice in finding the reversed probe (Fig. 26C). In summary, in contrast to previous
behavioral findings with SCID, nude, Rag1-/- and Rag2-/-mice, we did not observe significant
learning and memory differences between CD5KO and CD5WT mice in the Morris water maze
test (Fig. 26).

Figure 26. CD5 deletion in mice is not associated with abrogated spatial learning.
A. As a control for cognitive differences during simple learning measurements (days 1-4), mice were
tested on the distance they swam. All groups traveled similar distances during the acquisition phase of the
task. B. On day 5 a no-platform trial was used to test memory. Frequency and time spent in the NW
quadrant (location of the platform on days 1-4) was measured using the student-t test. C. Complex
learning or reversal assessment was measured on days 6 and 7 by placing the platform in the quadrant
opposite the original training quadrant. Two-way measures ANOVA was used for statistical analyses,
with a Bonferroni post hoc test used for individual time point comparisons (n = 17 mice per
group;**p<0.01). Results are representative of three independent experiments.
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6.3.2 CD5KO mice did not exhibit increased anxiety-like or fear-based behavior in the elevated
plus maze test
While CD5 did not show to affect memory or learning behavior, we wanted to address if
CD5KO mice showed elevated fear-based behavior using a plus maze test. This test measured
responses to unconditioned anxiety-related behavior, based on an approach-avoidance conflict,
forcing the mouse to decide between the desire to explore a novel environment and the fear that
comes from being in an elevated open area394. Mice were placed in the center of the maze facing
closed arms, and were allowed to freely explore for 10 minutes. There were no significant
differences in the time spent in the open arms or frequency in open arms (Fig. 27A-B), the time
spent in the closed arms (Fig. 27C), the frequency of visits to the closed arms (Fig. 27D), and the
total distance traveled between CD5KO and CD5WT mice (Fig. 27E).
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Figure 27. Elevated-plus maze results for CD5WT and CD5KO mice.
A. Total time nice spent in the open arms. B. The frequency of times mice entered the open arms. C. Total
time spend in the close arms. D. The frequency of times mice entered the closed arms. E. The total
distance traveled by the mice (n = 12 for all figures) ns = no significant differences (two-tailed unpaired ttest)

6.3.3 CD5KO mice have increased marble-burying behavior
We determined to examine the anxiety-like behavior in the CD5WT and CD5KO mice
using marble-burying tests and found that CD5KO mice buried a significantly higher number of
marbles compared with CD5WT mice (Fig. 28). We also observed in the CD5KO cage an
extensive scattering of marbles from their initial locations, and disturbed bedding which
suggested a higher burying and even digging activity by the CD5KO mice in comparison to the
CD5WT mice.
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Figure 28. CD5KO mice have increased marble-burying behavior.
The bar graphs show the total number of buried marbles measured during the 10 min marble-burying test.
**p<0.01 two-tailed unpaired t-test, (n = 13 per group)

6.3.4 CD5KO mice have decreased locomotion levels compare to CD5WT mice in the open field
test
To further corroborate the anxiety-like behavior phenotype we used the open field
activity test179,395. Distance traveled on the box area in the 10 minutes was how locomotor
activity was measured. There were no significant differences in the time spent in the outer area
(Fig. 29A) or the center area (Fig. 29B) compared with the CD5WT mice. However, CD5KO
mice did travel significantly less distance in the 10 minutes than the CD5WT mice (Fig. 29C).
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Figure 29. Open field test measuring locomotion activity of CD5KO and CD5WT mice.
Open-field test results for CD5KO and CD5WT mice. A. Time spent by CD5KO and CD5WT mice in the
outer area. B. Time spent by CD5KO and CD5WT mice in the center area. C. Total distance traveled by
the CD5KO and CD5WT mice in 10 minutes. (n = 13/group) *P < 0.05, (two-tailed unpaired t-test).

6.3.5 CD5KO have significantly different microbiome composition than CD5WT mice
There is increased evidence of the influence of the gut microbiota in behavior and the
immune responses179,396,397. In fact, changes in the microbiome and immune systems have been
shown to significantly affect behavior and are suggested to play a role in autism spectrum
disorders and anxiety398. It appears that the gut microbiota influences the homeostasis of the
immune response by inducing the polarization of specific T cells, such as Th17 and Th1399,400.
Although, alterations in the microbiota can trigger inflammatory diseases, studies done in Rag 1108

/- mice (fail to perform V (D) J recombination and do not have mature B or T cells) have found
that these mice have altered microbiota, suggesting a mutual relationship between gut microbiota
and the immune cells401-403. Because it is known that CD5 deficiency dramatically alters T cell
function, we decided to test if CD5KO and CD5WT mice differed in their microbiota. We
examined the bacterial composition found in the fecal samples from CD5WT and CD5KO mice
that were fed with normal chow by metagenomics analysis (Fig. 30A). Our data from the
unweighted unifrac PCoA plot suggested that there is a significant separation in the microbial
communities between CD5WT and CD5KO (Fig. 30B). Furthermore, we observed when
comparing CD5KO to CD5WT samples, Phylum Firmicutes is more abundant,
phylum Bacteroidetes is reduced, and in CD5KO samples there was no detectable levels of the
phylum Verrucomicrobia compared while there were detectable levels in the CD5WT samples
CD5WT (Fig. 30C). Akkermansia muciniphila is a mucin-degrading bacterium with antiinflammatory function, is the sole member of the Verrucomicrobia phylum, and is known to be
more abundant in the gut of healthy individuals404. It has also been suggested that the presence of
A. muciniphila could be involved in the microbiota-immunity symbiotic loop, since it seems to
influence the transcriptional modulation of several immune genes405. Thus, these data suggest
that there is dysbiosis found in the gut microbiota composition of CD5KO mice, and that this
alteration could be influenced by the immune system.
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Figure 30. Microbiome analysis of CD5KO and CD5WT mice.
A. Experimental outline for the metagenomics analysis (Figure adapted from “Altered Gut Microbiota
Composition in Rag1-deficient Mice Contributes to Modulating Homeostasis of Hematopoietic Stem and
Progenitor Cells” by Kwon, O., et al, 2015)402. B. Principal coordinate analysis plot (PCoA) based upon
unweighted unifrac metrics of fecal microbiota between CD5WT and CD5KO. The axes explain that
there is a 12.52% and a 20.04% of data variation in the gut microbiota respectively, further analysis with
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the Bray-curtis test shows a high compositional dissimilarity based in their genotypes with a p-value of
p<0.001. Clustering shows this separation of groups (Marked by the ovals: blue for CD5WT and pink for
CD5KO)(n = 29). C. Bacterial phyla distribution on CD5WT and CD5KO mice. Verrucomicrobia
Phylum was present in CD5WT but not in CD5KO mice. D. There was significant more Bacteroidetes in
CD5WT than in CD5KO mice. E. There was a significant amount of Firmicutes species in CD5KO than
in CD5WT mice *P < 0.05, **p<0.01 two-tailed unpaired t-test. (n = 29).

6.4 Conclusions and Future directions
Studies done in the RAG-1−/− mice model that lacks of mature lymphocytes, support the
theory that altered immune system function influences cognitive behavior and gut microbiota406408

. In fact, RAG-1−/− mice have a significant increase in anxiety-like behavior in behavioral

tests such as the open field and the marble-burying tests409.
PD-1 is a co-receptor that negatively regulates T cell immune responses, suppressing
proliferation and cytokine production in activated T cells338. Deletion of PD-1 in T cell leads to
hyperactivation of T cells which depletes amino acids necessary for neurotransmitter synthesis,
resulting in altered cognitive function and behavior179. The CD5 co-receptor has a similar coinhibiting function in T cells as PD-1. The modulatory role of CD5 impacts T cells function
during development and in the periphery and has an important role in T cell immune homeostasis
and tolerance132. CD5KO T cells have increased levels of cytokine production and proliferation,
affecting the role of T cells in immune responses, auto reactivity, and activation induced cell
death (AICD)321,410. T cells are known to influence cognitive function238. T cells producing
higher amounts of inflammatory cytokines such as TNF-α have been associated with increased
depression in humans and laboratory animals under chronic stress411,412. Because of the CD5
costimulatory function on T cells, we sought to examine if there is a direct connection between
CD5 deficiency and mice cognitive function and behavior.
Work in other models systems with altered T cell function [SCID (Rag1/2 -/-) and nude
(deficient in mature T cells)] used the Morris water maze test (MWM) to evaluate the effect of
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lymphocytes in memory and learning, and found that an absence of functional T cells leaded to
cognitive dysfunction239. Here we used the CD5KO mouse model in which the T cell have
increased rates of cytokine production and proliferation321. We did not see a significant
impairment in the learning or memory response of CD5KO mice in the MWM test as was seen in
studies in mice with a T cell deficiency (SCID and nude mice). Thus, a deficiency of functional
T cells appears to initiate impaired cognitive function in the MWM test. While T cells from
CD5KO mice have altered function, they do still have functional T cells which could explain
why no learning and memory differences were observed in MWM.
We next decided to perform different tests that could evaluate anxiety-like behavior in
these mice. First, we use the elevated plus maze test which measures the fear response to open
spaces, our results showed not significant differences. In the open field test we found that the
CD5KO mice traveled a significantly shorter distance than the CD5WT mice. We also
performed the marble-burying test and observed that CD5KO mice had significantly increased
the marble burying activity compared to their counterpart the CD5WT mice, suggesting that the
CD5KO mice have increased anxiety-like behavior. The idea of altered T cell function
influencing cognitive function and behavior has been seen before. Behavioral research performed
on experimental autoimmune encephalomyelitis (EAE) mice, suggest that T cells alterations
influence mice anxiety-like behavior and can influence serotonin levels413,414. In addition, PD-1
deficiency in T cells has been associated with depletion of essential amino acids precursors of
neurotransmitters such as serotonin and dopamine in the brain, affecting cognitive behavior,
again supporting the important role a T cell co-receptor plays in cognitive function and
behavior179.
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Additional studies have also demonstrated that gut microbiota can affect behavior and
also the influence immune cells function415,416. For example, dysfunction in gut microbiota can
affect the balance of Tregs and Th17cells altering the immune response which leads to chronic
inflammation and contributes to neurological disorders such as depression415,416. RAG-1−/− mice
have altered gut microbiota including decreased representation of bacterial species such as
Lactobacillales and Enterobacteriales in neonate mice, and increased amount of
Verrucomicrobiales (A. muciniphila at the species level) in both neonatal and adult mice,
suggesting that the adaptive immune system can alter the microbiome population as well408.
Studies have found that altered T cell function from PD-1 deficiency causes
hyperactivation, increased production of IFNγ and impairment of the gut barrier373.These
alterations in immune function also lead to an increase in inflammation, and defects in IgA
regulation that impacted gut microbial composition373,374. Our CD5 microbiome data analysis
revealed that while the microbial composition of CD5WT and CD5KO mice share specific
phylum such as Bacteroidetes, Firmicutes, and Proteobacteria, they are found in significantly
different quantities (Fig. 32C). One dramatic difference was the Verrucomicrobia; in specific
Akkermansia muciniphilia which is known for its protective anti-inflammatory effects was not
found in CD5KO mice but was found in CD5WT mice417. A. muciniphila is a gram-negative
anaerobic bacterium and the only isolated representative of the Verrucomicrobia phylum. It can
degrade mucin and A. muciniphila altered expression of mucus genes related to altered immune
response and homeostasis418. Furthermore, presence of A. muciniphila has been shown to
improved anti-PD-1 blockage therapy, underlining even more the important role that this bacteria
has in the immune response419. The myriad of interactions between the innate and adaptive
immune cells and gut microbiota, demonstrated the importance of the immune cells in the
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development of gut microbiota. There is not only a cause-effect relationship, but also a
cooperative connection among these two different systems420.
Our data indicate that CD5WT and CD5KO differ significantly in gut microbiota
diversity and that deficiency of CD5 might play a role in gut microbiota dysbiosis. At the current
stage of our study we cannot prove that there is a direct connection between the CD5 co-receptor
and the anxiety-like behavior or the microbiome observed in CD5KO mice. We do see a
correlation suggesting CD5 is influencing T cells function resulting in alteration in cognitive
function, behavior and gut microbiota diversity. A number of previous studies have linked
altered T cell responses in inflammation and infection and the cause of neurological disorders as
in bacterial dysbiosis402,421-423. Our understanding of how immune dysfunction influences
cognitive function, behavior and gut microbiome is still in early development. This research aims
to contribute to this work, by showing how the CD5 co-receptor plays a role in the immunemicrobiota-brain axis synergy.
Further studies are needed to evaluate the role of T cells in behavior and gut microbiota
of CD5KO mice (Fig. 31). The following question have to be addressed: Is it the microbiome or
the T cells responsible for altered behavior in CD5KO mice? We could address this question by
cohousing CD5KO and CD5WT mice (this will allow for them to have similar gut microbiota),
or T cell adoptive transfer (Transfer of CD5WT T cells to CD5KO mice) and upon behavioral
testing provide or discard microbial or T cell influence392,424. Such answer will direct the
functional association between CD5 co-receptor in T cells and altered emotional behavior and
gut microbiota.
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Figure 31. Summary of the potential effect of CD5 in microbiome and behavior.
CD5KO T cells are hyper activation increases cytokine release, proliferation and intracellular Ca2+
concentration, which could potentially influence cognitive behavior and gut microbiota.
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CHAPTER 7: Concluding Remarks and Future Directions

The work presented in this dissertation summarizes research performed to understand the
function of two main proteins: 1) nBMP2, a nuclear variant of the BMP2 and 2) CD5, a T cell
co-receptor. Both of these proteins influence cellular Ca2+ mobilization responses. Concluding
remarks and future directions for each of these two proteins will be addressed in individual
sections.
7.1 nBMP2 role in immune cells
The Bone morphogenetic protein 2 (Bmp2) is a secreted growth factor important in
embryonic development425. The nBMP2 is a nuclear variant of the BMP2, translated from an
alternative start codon downstream of the signal peptide sequence, which allows a bipartite
nuclear localization signal (NLS) to direct translocation to the nucleus31. To better understand
the role of the nBMP2, studies in muscle, hippocampal neurons and behavior were done in six
month old mice (age when phenotype was most pronounced) and the results suggested an
impairment in intracellular Ca2+ transport30-32. Additional work examining the role of nBMP2
on immune cells function found that nBMP2 mutant mice have an impaired secondary
response. Here we described work testing the hypothesis that this impaired secondary immune
response is due to altered intracellular Ca2+ mobilization32,50. The impaired immune response
in nBMP2 mutant mice was to a systemic bacterial challenge and it appeared these mice had
reduced phagocytic activity by macrophages in the spleen. We determined to examine the role
that nBMP2 played in macrophages activation and phagocytosis. Our findings revealed a Ca2+
mobilization impairment in splenic macrophages from nBmp2NLStm mutant mice after
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secondary infection along with a decreased phagocytic response, supporting the hypothesis
that intracellular Ca2+ response played a role426.
Macrophages are phagocytic cells activated by cytokines such as IFN-γ that are
produced by innate and adaptive immune cells including natural killer cells, cytotoxic T cells,
and helper T cells427. Altered Ca2+ regulation in these cells affects their metabolism,
proliferation, cytokine production and cytotoxicity as well428. Future work should examine if
the nBMP2 dependent Ca2+ impairment observed in macrophages is also present in these other
innate and adaptive immune cells after secondary infection.
In addition, it would be important to address if the nBMP2 plays a role in the SERCA
activity of macrophages and other immune cells. Sarco/endoplasmic reticulum Ca2+-ATPases
(SERCAs) pump Ca2+ into the endoplasmic reticulum. It was observed that the SERCA
activity in skeletal muscle from nBmp2NLStm mutant mice was impaired31. In fact, previous
studies have suggested that the mechanism for reduced intracellular Ca2+ mobilization upon
activation is due to increased sarco/endoplasmic reticulum Ca2+ ATPase (SERCA)-mediated
reuptake rather than changes in Ca2+ influx capacity, meaning that the alterations in Ca2+
mobilization response could be due to an altered SERCA function429. To accomplish this, test
such as the Ca2+ pumping activity (which measure Ca2+-ATPase pumps activity and Ca2+
transport) could be used430. For this purpose it is relevant to inhibit the plasma membrane
Ca2+ pumps (PMCA) activity to determine if the defect observed in Ca2+ mobilization from
nBmp2NLStm mutant mice is dependent of SERCA activity in the cell431. In addition, the
SERCA pump is encoded by a family of 3 genes (SERCA1 (ATP2A1), -2 (ATP2A2), and -3
(ATP2A3)), and defects in any of them will affect SERCA activity432,433. Expression
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measurement of these genes will help to elucidate specific components of the SERCA pump
where the nBMP2 protein is playing a relevant role.
7.2 CD5 Modulatory Response
CD5 functions as an inhibitory co-receptor in the thymus, and has a modulatory role in
the signaling intensity of peripheral T cells by controlling Ca2+ signaling activity according to
the CD5 expression levels in the T cells. CD5 promotes peripheral T cell activation and
immune response by increasing Ca2+ signaling in CD5hi T cells as they come in contact to a
foreign peptide. Thus, CD5 may be a novel checkpoint to regulate T cell activation and
metabolism by altering Ca2+ mobilization (chapter 5). CD5 also appears to affect cognitive
function and behavior and alter microbiome interactions (Chapter 6). Detailed molecular
characterization of the mechanisms of CD5 function could potentially lead to novels
immunotherapies.
7.2.1 CD5 role in T cell metabolism
Co-receptors are signaling domains that can influence the T cell activation and
metabolic responses434. CD5 is a co-receptor with negative regulatory role during positive
selection in the thymus and modulatory function in naïve and mature T cell activation as T
cells with distinctive CD5 expression levels respond differently to foreign peptide. Previous
studies suggest that differences in proliferation and survival in T cells with different CD5
expression levels are due to differences in the TCR signaling strength which will affect their
metabolic state230,294. Additional work suggested that CD5 levels influence T cell
differentiation and effector cytokine production by demonstrating that ex vivo activated
murine CD5lo CD4+ T cells produce relatively greater amounts of the Th1 cytokine IFNγ
compared to their CD5hi counterparts435. Our work has shown that CD5 expression levels in T
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cells affects their activation response which we measured looking at Ca2+ mobilization upon
activation61,320. Ca2+ plays an important role in T cell metabolism, as it directs the metabolic
reprogramming of naive T cells by regulating the expression of glucose transporters,
glycolytic enzymes, and metabolic regulators through the activation of nuclear factor of
activated T cells (NFAT) and the PI3K-AKT kinase-mTOR nutrient-sensing pathway8.
In order to address if CD5 influenced T cell metabolic response, we worked with
CD5KO mice T cells, and used as a control CD5WT mice (C57/BL6). Our preliminary data
suggests that CD5KO naïve T cells have a significantly higher mitochondrial respiration
profile, increased SRC, higher usage of metabolites involved in glycolysis, and increased
mitochondrial respiration and amino acids metabolism (See Fig 22 and Fig. 24A-B). To better
understand this preliminary data, future research should look into the possible causes that lead
to an increase SRC in T cells. One possible cause includes a higher presence of mitochondrial
mass in CD5KO T cells. As T cells undergo metabolic changes they also change in
mitochondrial content which provide them with a substantial SRC to produce energy in
response to increase stress328. This can be tested by using MitoTracker, a fluorescent
mitochondrial stain used to quantify mitochondrial density, and the mitochondrial membrane
potential which is a major component of the proton motive force that increases during ATP
synthesis436,437.
Another hypothesis related to the SRC increase in CD5KO T cells is related with a
possible enhancement in the fatty acid metabolism during increase mitochondrial biogenesis
(growth and division of mitochondria)328,438. SRC promotes mitochondrial biogenesis and the
carnitine palmitoyl transferase (CPT1a) expression328. CPT1a is a metabolic enzyme that
controls fatty acid oxidation (FAO)328,439. Measurement of differences of the mRNA of CPT1a
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expression between CD5KO and CD5WT T cells would help to elucidate if FAO metabolism
plays a role in the higher SRC levels of the CD5KO T cells. Another way to examine if the
enhanced SRC in CD5KO is FAO dependent is to run a Mito stress test by adding an extra
injection of an CPT1 inhibitor (Etomoxir). CD5KO and CD5WT naïve T cells will be exposed
to the etomoxir to block mitochondrial FAO before or after FCCP injection, if SCR in
CD5KO T cells is FAO dependent we should expect that addition of etomoxir will decrease
the SRC observed in CD5KO T cells328. It would also be valuable to examine metabolic
function in the CD5KO and CD5WT T cells by measuring levels of key amino acids such as
glutamine and the glutamine transporters from the SNAT family SNAT1 (SLC38A1) and
SNAT2 (SLC38A2) that are important in T-cell activation235. Finally, it would be important
to obtain measurements of the GLUT1 (glucose transporters) and glucose uptake rates since
glucose fuels mitochondrial FAO and OXPHOS440. All this information together can help to
elucidate the importance of CD5 in T cell metabolism.
7.2.2 CD5 role in cognitive behavior
Studies done in PD-1 deficient mice showed a connection between T cell hyperactivation
and behavior, suggesting that T cell hyperactivation affected systemic metabolism by decreasing
free amino acids important for neurotransmitter synthesis which resulted in the increased fear
response179. Because CD5KO T cells also have a hyperactive phenotype, we determined to see if
the cognitive function in CD5 mice was altered. We performed behavioral analysis to
characterize the phenotype of CD5KO mice using the Morris water maze (MWM), the elevated
plus maze, the open field test and the marble burying test to observe any learning and memory
impairment and fear-based or anxiety-like behavior. There were no differences in the learning
and memory in the MWM although it was observed that the CD5KO mice appeared to be
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swimming faster than CD5WT mice (empirical observation not measured). In future research it
would be important to measure swim speed in the MWM. The elevate plus maze test did not
show any significant differences between CD5WT and CD5KO mice. In the marble burying test
the CD5KO mice had buried a significantly higher number in marbles than the CD5WT mice,
suggesting increased anxiety-like behavior in the CD5KO mice. Thus, our results indicate that
CD5KO mice have impaired cognitive behavioral function reflected in elevated fear-based and
anxiety-like behavior.
Future work will need to elucidate the connection between the CD5 co-receptor in T cells
and its influence in cognitive behavior by first performing adoptive T cell transfers from
CD5WT T cells to CD5KO mice and evaluate if this recues the fear-based and anxiety-like
behavioral responses. Adoptive T cell transfers have restored cognitive function and behavior in
SCID, nude and Rag1 -/-mice, providing a means to determine if CD5 deficiency is in fact
connected to cognitive function and behavior392. It would be important to measure free amino
acids levels in serum before and after the T cell adoptive transfer. In the PD-1 study the
decreased amino acids levels of tryptophan and tyrosine affected synthesis of monoamine
neurotransmitters which were the mechanism of the altered behavioral response.
If amino acids levels are low in the serum of CD5KO mice another approach would be to
measure the total amount of tryptophan in tissue (brain and liver) and plasma441. Tryptophan is
an essential amino acid, and an important precursor of serotonin442. When tryptophan is limited
in mice it has been shown to result in a defensive behavioral response, suggesting that tryptophan
restriction alters the emotional response to stress443. It is also possible to address whether the
CD5KO phenotype is due to altered amino acid levels is to feed CD5KO mice a tryptophan
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supplemented chow (or oral administration) and then measure behavior to see if fear and anxietylike behavior decreased in CD5KO mice444,445 .
7.2.3 CD5 role in gut microbiota
There is increased evidence that host-microbe interactions play a key role in maintaining
homeostasis and alterations in gut microbial composition is associated with marked behavioral
changes446. Dysfunction of the microbiome-brain-gut axis has been implicated in stress-related
disorders such as depression, anxiety and irritable bowel syndrome and neurodevelopmental
disorders such as autism447. Studies done in Rag-/- mice showed that they have a distinct
microbiota, suggesting that lymphocytes play an important role in the microbiome
composition406. Since we have documented altered behavior in our CD5KO mice, we
hypothesized that an additional component that could affect behavior is microbiome dysbiosis.
Our data analysis showed significant differences between the microbial populations composition
from CD5WT and CD5KO mice (Fig. 32B). Further characterization of these differences
revealed that the phylum Verrucomicrobia (Akkermansia muciniphila is the only identified
member of this phylum) was not present in the CD5KO gut microbiota (Fig. 32C). This is an
important finding considering that Akkermansia muciniphila is considered a hallmark of healthy
gut due to its anti-inflammatory and immune-stimulant properties and its ability to improve gut
barrier function448.
Of note, hyperactivation of the immune cells increases production of pro-inflammatory
cytokines which then increase the permeability of the gut-blood barrier and affect the diversity
and composition of gut microbiota449. In fact, PD-1 deficient T cells hyperactivity has influenced
the selection of IgA plasma cells and leads to gut microbiota dysbiosis373,374. CD5 has similar
function than PD-1 in terms of regulating T cell activation and it would be of great interest to see
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if CD5 deficiency also impacts IgA levels. This can be done by determining any differences in
the number of IgA plasma cells in the lamina propia, total levels of IgA, or differences in IgA
bacterial binding capacity between CD5WT and CD5KO373,374.
To further establish the role of CD5KO microbiota on mouse behavior, it would be useful
to do a fecal transplant. This can be done in mice by cohousing CD5KO and CD5WT mice. Cohousing allows for normalization of the composition of the gut microbiota to see if it will
alleviate the fear and anxiety-like behavior in CD5KO mice450.
Future work should also address if there are changes in gut microbiota after adoptive T
cell transfer from CD5WT to CD5KO mice. In addition, it could be ideal to have a group of mice
that will be co-housed following adoptive transfer451. In this way, it is possible to better elucidate
the associations and mechanism of action between the CD5 coreceptor in T cells, the
microbiome, and behavior.
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APPENDIX I: CD5 Expression Influences T cell Metabolism and Mice Behavior

The following appendix contains a published abstract in the journal of Immunology Freitas, C.
T., Cox, T., Johnson, D. & Weber, K. S. CD5 expression influences T cell metabolism and mice
behavior. The Journal of Immunology 200, 108.116-108.116 (2018). The data for this abstract
was presented at the American Association of Immunologist (AAI) Annual Meeting in Austin,
TX, 2018 .
Abstract
T cells are key players in the adaptive immune response and undergo metabolic changes
upon activation. CD5 is a co-receptor found on T cells and plays a significant role in regulating T
cell thymic development, intracellular signaling and cytokine production. Previous studies have
found that naïve T cells with high CD5 expression (CD5hi) have increased TCR signal strength
and enhances immune response to foreign peptide in the periphery. Additionally, we have
reported that CD5hi naïve T cells have higher calcium mobilization and improved T cell
activation compared to CD5lo T cells. Calcium influx levels can modulate and influence
metabolic changes in T cells. Thus, we hypothesized that CD5hi, CD5lo and CD5 deficient T cells
have different bioenergetic demands that affect metabolic pathways and T cell activation. We
evaluated the effects of CD5 levels on metabolism using CD5 deficient mice vs wild type
controls and found CD5 deficient T cells had significant differences in metabolic function.
Recently published work has described a connection between increased T cell metabolism and
altered cognitive function in PD-1 deficient mice. We have also found significant differences
between CD5 deficient and wild type mice in marble burying rates, elevated plus and water maze
behavior and open field activity.
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These behavioral test results suggest CD5 deficient mice have altered cognitive function and
higher levels of anxiety. Thus, CD5 deficiency alters T cell metabolic and cognitive function.

170

APPENDIX II: Presentations
1

Freitas CMT, Cox TD, Franson JJ , Bridgewater LC, and Weber KS. CD5 co-receptor
influences T cell metabolism, gut microbiota and cognitive behavior. Tri-Branch
American Society of Microbiology Meeting. April 13, 2019. Provo, UT

2

Freitas CMT, Cox T, Dunne A, and Weber KS. CD5 co-receptor plays a role in T cell
metabolism. Midwinter Immunology Conference. Jan 26-29, 2019. Asilomar CA

3

Townsend MH, Bitter EK, Larsen D, Freitas CMT, Piccolo SR, Weber KS, Robison
RA, O’Neill KL. HPRT impact on immune regulation influences the tumor
microenvironment. Midwinter Immunology Conference. Jan 26-29, 2019. Asilomar CA

4

Townsend MH, Ewell ZD, Freitas CMT, Larsen DJ, Lawrence EL, Bennion KB,
Piccolo SR, Weber KS, Robison RA, and O’Neill KL. HPRT Overexpression May
Contribute to the Immunosuppressive Tumor Microenvironment. American Association
for Cancer Research Annual Meeting. March 29- April 3 Atlanta, GA

5

Freitas CMT, Cox TD, Johnson DK, and Weber KS. CD5 expression influences T cell
metabolism and mice behavior. The American Association of Immunologists Annual
Meeting. May 4-8, 2018. Austin, TX (Poster and Oral presentations)

6

Cox TD, Freitas CMT, Yorgason JT, Franson JJ , Bridgewater LC, Steffensen SC, and
Weber KS. CD5 deficient mice exhibit altered cognitive function in behavioral studies.
TriBranch American Society of Microbiology Meeting. April 7, 2018. Durango, CO

7

Johnson DK, Freitas CMT, Hancock JC, Tueller JA, Myers SJ, Hamblin GJ and Weber
KS. CD5 expression influences helper T cell metabolic state. Tri-Branch American
Society of Microbiology Meeting. April 7, 2018. Durango, CO

8

Freitas CMT, Cox TD, Johnson DK, Franson JJ , Bridgewater LC, and Weber KS. Role
of CD5 expression on T cell metabolism. Tri-Branch American Society of Microbiology
Meeting. April 7, 2018. Durango, CO

9

Cox TD, Freitas CMT, Yorgason JT, Franson JJ , Bridgewater LC, Steffensen SC, and
Weber KS. CD5 deficient mice exhibit altered cognitive function in behavioral studies.
BYU College of Life Science Poster Competition. March 29, 2018. Provo, UT

10

Garland KS, Kener K, Hancock J, Freitas CMT, Bickman B, Hancock C, Weber KS,
and Tessem J. The effects of Nr4a1 full-body knockout in mice. Utah Conference on
Undergraduate Research. February 9, 2018. Cedar City, UT

11

Freitas CMT and Weber KS. nBMP2 Mutant Macrophages have impair calcium
mobilization. BYU Microbiology and Molecular Biology Graduate Retreat. August,
2017. Provo, UT

171

12

Cox TD, Freitas CMT, Yorgason JT, Franson JJ, Bridgewater LC, Steffensen SC, and
Weber KS. CD5 deficient mice exhibit altered cognitive function in behavioral studies.
Autumn Immunology Conference 46th Annual Meeting. November 17-20, 2017.
Chicago, IL

13

Johnson DK, Freitas CMT, Hancock JC, Tueller JA, Myers SJ, Hamblin GJ and Weber
KS. CD5 expression influences helper T cell metabolic state. Autumn Immunology
Conference 46th Annual Meeting. November 17-20, 2017. Chicago, IL

14

Freitas CMT, Hamblin GJ, Larsen CM, Weber KS. Naïve Helper T Cells with high CD5
expression have increased calcium signaling. American Society for Microbiology
Intermountain Branch Meeting. April 15, 2017. Ogden, UT

15

Freitas CMT, Hamblin GJ, Larsen CM, Weber KS. Naïve Helper T Cells with high CD5
expression have increased calcium signaling. Midwinter Immunology Conference. Jan
28-31, 2017. Asilomar, CA

16

Freitas CMT and Weber KS. CD5 expression in T cells affect calcium mobilization.
BYU Microbiology and Molecular Biology Graduate Retreat. August, 2016. Provo, UT

17

Hamblin GJ, Freitas CMT, Steadman N, Williams K, and Weber KS. Calcium Signaling
in Primary and Secondary Responses of Listeria specific T helper cells. 10th Annual Utah
Conference on Undergraduate Research. February 19, 2016. Salt Lake City, UT

18

Hamblin GJ, Freitas CMT, Steadman N, Williams K, and Weber KS. Calcium Signaling
in Primary and Secondary Responses of Listeria specific T helper cells. Autumn
Immunology Conference 44th Annual Meeting. November 20-23, 2015. Chicago, IL

19

Freitas CMT and Weber KS. The importance of Calcium signaling in T cells and
macrophages. BYU Microbiology and Molecular Biology Graduate Retreat. August,
2015. Provo, UT

20

Freitas CMT, Williams KR, and Weber KS. Calcium Signaling in T helper cell Primary
and Secondary Responses. Midwinter Conference of Immunologists. January 24-27,
2015. Asilomar, CA

21

Freitas CMT and Weber KS. Calcium signaling in macrophage and T cell activation.
BYU Microbiology and Molecular Biology Graduate Retreat. August, 2014. Provo, UT

22

Freitas CMT, Williams KR, Weagel EG, O’Neill KL, and Weber KS. Macrophage
polarization by necrotic and apoptotic cancer cells. American Society for Microbiology
Intermountain Branch Meeting. March 8, 2014. Provo, UT

172

APPENDIX III: Compiled Publications
The following are the compiled published work of first author and co-author papers. (See next
pages)

173

RESEARCH ARTICLE

Naïve helper T cells with high CD5 expression
have increased calcium signaling
Claudia M. Tellez Freitas, Garrett J. Hamblin, Carlee M. Raymond, K. Scott Weber*
Department of Microbiology & Molecular Biology, Brigham Young University, Provo, Utah, United States of
America
* scott_weber@byu.edu

Abstract
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111

OPEN ACCESS
Citation: Freitas CMT, Hamblin GJ, Raymond CM,
Weber KS (2017) Naïve helper T cells with high
CD5 expression have increased calcium signaling.
PLoS ONE 12(5): e0178799. https://doi.org/
10.1371/journal.pone.0178799
Editor: Jon C.D. Houtman, University of Iowa,
UNITED STATES
Received: February 7, 2017
Accepted: May 18, 2017
Published: May 31, 2017
Copyright: © 2017 Freitas et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.

The adaptive immune response is orchestrated by T helper cells and their function is dependent upon interactions between the T cell receptor (TCR), peptide MHC (pMHC) and coreceptors. TCR-pMHC interactions initiate calcium signaling cascades which determine T
cell activation, survival, proliferation and differentiation. CD5 is a co-receptor that plays an
important role in regulating T cell signaling and fate during thymocyte education. CD5 surface expression on mature single positive thymocytes correlates with the TCR signal
strength for positive selecting self-ligands. CD5 also plays a role in T cell function after thymic development is complete. Peripheral T cells with higher CD5 expression respond better
to foreign antigen than those with lower CD5 expression and CD5-high T cells are enriched
in memory populations. In our study, we examined the role of CD5 expression and calcium
signaling in the primary response of T cells using two Listeria monocytogenes specific T
helper cells (LLO118 and LLO56). These T cells recognize the same immunodominant
epitope (LLO190-205) of L. monocytogenes and have divergent primary and secondary
responses and different levels of CD5 expression. We found that each T cell has unique calcium mobilization in response to in vitro stimulation with LLO190-205 and that CD5 expression
levels in these cells changed over time following stimulation. LLO56 naïve T helper cells,
which expresses higher levels of CD5, have higher calcium mobilization than naïve LLO118
T cells. Three days after in vitro stimulation, LLO118 T cells had more robust calcium mobilization than LLO56 and there were no differences in calcium mobilization 8 days after in vitro
stimulation. To further evaluate the role of CD5, we measured calcium signaling in CD5
knockout LLO118 and LLO56 T cells at these three time points and found that CD5 plays a
significant role in promoting the calcium signaling of naïve CD5-high LLO56 T cells.
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Introduction
Helper T cells play a critical role in adaptive immunity by orchestrating and regulating the
immune response [1, 2]. In large part, the binding properties of the T cell receptor (TCR) regulates the development, activation, and proliferative response of T lymphocytes [3, 4]. In the
thymus, T cells are selected according to their avidity for self-peptide/MHC complexes. The
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TCR must be able to recognize self-peptide/MHC complexes with enough affinity to transduce
a signal during positive selection while not binding so tightly that they are negatively selected
[4–6]. TCR avidity and signal strength plays a key role in T cell function (calcium signaling,
cytokine production, T cell proliferation and differentiation) [7–9]. In addition to the TCR
and its interaction with peptide MHC (pMHC), multiple receptors such as CD4, CD8, PD-1,
and CTLA-4 play a key role in determining whether TCR:pMHC binding results in T cell activation or anergy. CD5 is known to be a negative regulator of TCR signaling in developing thymocytes and its expression level in naïve T cells is determined during thymic development.
CD5 levels are set during positive selection according to the strength of the TCR-self-peptide/
MHC interaction. Typically, the stronger the avidity for self-peptide/MHC the higher the CD5
surface expression [10–13]. After completing thymic development, T cells with higher CD5
expression respond better to foreign antigen than those with lower CD5 expression and
CD5-high T cells are enriched in memory populations [14, 15]. Although there are studies
examining the role of T cell CD5 expression during thymic development and CD5-high cells
are enriched in memory cell populations, it is not clear how CD5 is involved in calcium signaling during a helper T cell primary response. To better understand the role of CD5 in a T cell
primary response to foreign antigen, we examined the in vitro calcium responses of CD5-high
and CD5-low T helper cells that respond to the same epitope of Listeria monocytogenes.
Calcium (Ca2+) is a ubiquitous second messenger important for a wide range of cellular
functions. Ca2+ signaling plays an important role in T cell activation, cytokine production,
proliferation and cell fate and is determined by TCR interactions with the pMHC complex as
well as additional co-receptors [9, 16]. Ca2+ signaling has been well characterized in lymphocytes and the calcium signal for specific helper T cell subsets has been identified, suggesting a
strong relationship between Ca2+ mobilization in T helper cells and their functional response
[17, 18]. TCR engagement with pMHC initiates signal transduction pathways that result in a
dramatic increase of intracellular Ca2+ [19, 20]. Increases in intracellular Ca2+ enables transcription factors to enter the nucleus and turn on genes that play a critical role in immune
responses. For example, NFAT, NF-κB, AP-1, and the Oct family transcription factors initiate
transcription of the interleukin-2 (IL-2) gene [21]. IL-2 production is important for T cell proliferation and survival and plays a key role in promoting effector and memory cell differentiation [22–24]. Thus, TCR-dependent Ca2+ signals are essential for robust T cell primary and
secondary immune responses.
The TCR avidity for self-peptide/MHC complex during selection affects the function and
maintenance of these cells in the periphery and how they respond to infection [25, 26]. CD5 is
a monomeric cell surface glycoprotein expressed on thymocytes, mature T cells, and a subset
of B cells. High TCR avidity for self-peptide/MHC results in high surface expression of CD5
on double positive and single positive thymocytes, whereas lower avidity is correlated with
lower surface expression of CD5 [10]. CD5 has been shown to negatively regulate the TCR signal during thymic development [27]. CD5 expression and Ca2+ mobilization correlate with
TCR signal strength and T cell fate [3, 5, 28]. However, mature naïve T cells with higher
expression levels of CD5 appear to respond better to foreign ligands, suggesting that CD5
influences T cell responsiveness at the post-selection level [14, 16, 29]. Thus, it appears that the
negative regulatory effect of CD5 in the thymus may not depend on the extracellular region of
CD5 whereas the positive co-stimulatory effect of CD5 in the periphery is dependent on extracellular engagement of an endogenous ligand (CD5 or CD5L) [30–32]. While the exact function of these CD5 ligands is unclear, there is evidence that CD5L (CD72; a C-type ligand)
binds to CD5 and that CD5 is homophillic and may bind to CD5 on other cells [33]. Thus,
CD5 has a critical and divergent role in regulating T cell activation depending on the time and
location of activation.
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LLO56 and LLO118 are two T helper cells that recognize the same immunodominant epitope (LLO190-205) of L. monocytogenes and have divergent primary and secondary responses.
They differ by 15 amino acids in their TCR sequences and have unique responses to L. monocytogenes infection in vivo, LLO118 has a better primary response whereas LLO56 has a more
robust secondary response [25]. Previous analysis of thymocytes and T cells revealed that
LLO56 has higher levels of CD5 and a more robust IL-2 response in addition to a reduced primary response caused by increased cell death compared to LLO118 T cells [25, 26]. In order to
better understand how CD5 levels affect T cell activation in cells that have completed thymic
development, we determined to evaluate calcium signaling in LLO56 (CD5-high) and LLO118
(CD5-low) T cells. We also measured calcium signaling in CD5 knockout LLO118 and LLO56
T cells to better elucidate the role of CD5 in calcium signaling after thymic development is finished. This was accomplished by measuring LLO118 and LLO56 calcium mobilization at three
different time points during the T cell response: Naïve T helper cells, day 3 post-stimulation,
and day 8 post-stimulation. We also measured calcium signaling in CD5 knockout LLO118
and LLO56 T cells at these time points and found CD5 plays a significant role in promoting
the calcium signaling of naïve CD5-high T cells, but does not alter calcium mobilization levels
at later time points.

Materials and methods
Mice
LLO56 (B6 Thy-1.1+ Rag1−/−), LLO118 (B6 Ly5.1+ Rag1−/−) and CD5 knockout (KO) LLO56
and LLO118 were bred and housed in pathogen free conditions [25, 26]. All mice used in these
experiments were 5–12 weeks old. All use of laboratory animals was done with approval of the
Animal Care and Use Committee (IACUC protocol #15–801) at Brigham Young University.

T cell isolation and activation
CD4+ T cells were isolated from the spleens of LLO56 and LLO118 TCR transgenic (Tg) mice
[26]. Spleen single cell suspensions from LLO56 and LLO118 mice were purified using a negative selection CD4+ T cell isolation kit (Miltenyi Biotec) [17]. T cells were isolated from the
spleen of LLO56, LLO118, LLO56-CD5KO, and LLO118-CD5KO mice. Spleens were homogenized and passed through a nylon mesh cell strainer. The single-cell suspension was resuspended in R10 medium containing RPMI 1640, 10% of FBS (HyClone), 1% Glutamax (Gibco
by Life Technologies), and 0.5% Gentamicin (Life Technologies), then transferred to a 6-well
plate (1x106 cell/ml) and loaded with 1 μM of Listeria monocytogenes peptide LLO190-205. For T
cell isolations, mice were euthanized using CO2 inhalation.

Antigen presenting cell isolation
Bone marrow derived macrophages (BMDM) were obtained from B6/C57 mouse femurs and
tibias and were cultured at 37˚C and 5% CO2 and matured for 7 days in macrophage medium
with DMEM (HyClone), 10% FBS (HyClone), 20% supernatant from L929 mouse fibroblast as
a source of macrophage colony-stimulating factor (M-CSF), 5% heat inactivated horse serum
(Sigma), 1 mM Na Pyruvate (Gibco by Life Technologies), 1.5 mM L-glutamine (Thermofisher), 1100X Penicillin/Sreptomycin (Gibco by Life Technologies). Harvested cells were plate
in an 8-chamber cover glass where they were loaded with the Listeria monocytogenes peptide
LLO190-205 overnight. For bone marrow derived macrophage isolations, mice were euthanized
using CO2 inhalation.
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Calcium imaging
Naïve T cells were incubated with 1 μM of Fura-2AM (Invitrogen) for 30 minutes at 37˚C and
5% CO2 in Ringers imaging solution (150 mM NaCl, 10mM glucose, 5 mM of HEPES, 5 mM
of KCl, 1mM MgCl2, and 2 mM CaCl2, pH 7.4), washed, and then incubated in Ringers solution for another 30 minutes at 37˚C. 200,000 Fura-2AM loaded naïve CD4+ T cells were
pipetted onto 200,000 bone marrow derived macrophages that were previously incubated with
1 μM of Listeria monocytogenes peptide LLO190-205 overnight. Imaging was performed in Nunc
8-chamber covered glass slides (155411, Thermo Scientific). For day 3 and day 8 stimulation
time points, LLO118 or LLO56 splenocytes were incubated overnight with 1 μM of Listeria
monocytogenes peptide LLO190-205. Calcium imaging was performed at room temperature
using an Olympus IX51 inverted microscope equipped with a xenon arc lamp. Fura-2AM
loaded T cells were excited at 340 nm and 380 nm excitation filters and capture by a florescence microscope camera (Q Imaging Exi Blue) using a 20x objective (N.A. 0.75). Images
(340/380/transmitted) were recorded at 3 second intervals over 20 minutes. Each individual
cell fluorescence was normalized with the first recorded value according to the equation
(F-Fo)/Fo where F is the fluorescence at the specific time point, and Fo is the fluorescence
value at time 0 [34].

Flow cytometry
Calcium mobilization was also measured using flow cytometry and the high affinity calcium
indicator Fluo-4 (ex:470–490 nm and em: 520–540 nm). Cells were surface stained with an
anti-CD4+-APC antibody (17–0041; eBioscience). T cells were loaded for 30 mins as previously
published with pluronic acid and 1mM Fluo-4-acetoxymethyl ester (Invitrogen) in Ringer
solution (150 mM NaCl, 10 mM glucose, 5 mM of HEPES, 5 mM of KCl, 1 mM MgCl2, and 2
mM CaCl2, pH 7.4) [35]. Intracellular calcium mobilization was initiated by adding 50 ng/ml
of PMA (phorbol 12-myristate 13-acetate) and 1 μg/mml of ionomycin [36]. For further analysis done in FlowJo, the lymphocyte population was gated in a forward and side scatter gate and
singlets. From this gate a second gate was created specific for CD4+ T cells [37]. Intracellular
calcium flux was measured in the CD4+ T cell gate using the FlowJo kinetics tool.
For CD5 expression analysis, spleen single cell suspensions from naïve and stimulated (day
3 and day 8) were stained with anti-CD5-PE (12–0051; eBioscience), and anti-CD4-APC (17–
0041; eBioscience) and analyzed on the flow cytometer (BD Accurri C6).

Data analysis
Live cell calcium imaging data was analyzed using CellSens Software from Olympus and the
340:380 ratio calculations were performed on randomly selected cells. The standard deviation
of the calcium levels from the regression line was determined using GraphPad Prism. For calcium flow cytometry measurements, FlowJo kinetics tool was used to determine the area
under the curve (AUC) [35, 38, 39]. All assays were performed at least three times in triplicate
and significant values were determined using student T test in GraphPad Prism.

Results
LLO118 and LLO56 T helper cells have different responses to antigen
and CD5 expression levels
To examine the role of CD5 in regulating calcium signaling in the primary response of helper
T cells, we used LLO56 and LLO118 T cells which are specific for the same epitope of Listeria
monocytogenes (listeriolysin O, LLO190-205) [25]. These LLO118 and LLO56 T cells differ in
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their in vivo responses upon L. monocytogenes infection; LLO118 helper T cells have a better
primary response and LLO56 helper T cells exhibit a better secondary response [25]. Additionally, naïve LLO56 T cells have higher levels of CD5 and produce more IL-2 upon stimulation
compared to those from LLO118 T cells [25, 26]. We hypothesized that these differences in
CD5 levels and T cell function would allow us to better understand the role of CD5 in calcium
signaling and T cell activation in a primary response (See Table 1).

LLO56 naïve helper T cells have higher calcium mobilization in vitro
To determine how CD5 plays a role in the primary immune response of LLO56 and LLO118 T
cells, we first analyzed the calcium signaling of naïve T cells isolated and purified from the
spleens of LLO56 and LLO118 TCR Tg mice. Calcium mobilization was measured using live
cell imaging after loading the T cells with Fura-2AM and adding them to 8-chamber slides
containing antigen presenting cells loaded overnight with the L. monocytogenes peptide
(LLO190-205). A calcium profile was generated by combining measurements (40+ cells) from 4
different experiments taking readings every 3 seconds over a 20-minute time span (Fig 1A).
Upon stimulation with LLO190-205 peptide, LLO56 T helper cells have higher peak calcium
influx levels compared to LLO118 T cells (Fig 1B). There are not any significant differences in
the mean calcium levels and variability (standard deviation) of the calcium signal between
LLO56 and LLO118 T cells (Fig 1C and 1D) [40]. Thus, naïve LLO56 (CD5-high) and naïve
LLO118 (CD5-low) T cells have significantly different peak calcium mobilization profiles.

LLO56 naïve T helper cells have higher levels of CD5 surface
expression
Previous work has shown that naïve LLO56 T cells have higher expression of CD5 compared
to naïve LLO118 T cells [25]. We wanted to know what happened to the levels of CD5 at the
post-stimulation time points (day 3 and day 8) that we examined in this study. As previously
reported, LLO56 naive T helper cells showed higher CD5 expression than naïve LLO118 T
helper cells. However, upon stimulation, the CD5 expression differences between LLO56 and
LLO118 T cells decrease over the course of 8 days of stimulation (Fig 2A and 2B). To further
confirm CD5 expression a mean fluorescent intensity (MFI) profile was done, which confirmed significant CD5 expression levels differences between naïve LLO56 T cells with Day 3
and Day 8, however LLO56 did not have significant differences between Day 3 and Day 8 (Fig
2C and 2D).

LLO118 T cells have higher peak calcium influx on day 3 poststimulation
To determine whether the Ca2+ influx difference seen in naïve T cells were maintained over
the course of a primary response to infection, we measured calcium influx for LLO118 and
LLO56 T helper cells 3 days post-stimulation with L. monocytogenes peptide (LLO190-205)
(Fig 3A). In contrast to naïve T cells, day 3 post-stimulated LLO118 T cells have significantly
Table 1. Summary of differences between LLO56 and LLO118 T cells.

Primary Response

LLO56

LLO118

+

+++

Secondary Response

+++

+

IL-2 Response

+++

++

CD5 Expression (naïve T cells)

+++

+

https://doi.org/10.1371/journal.pone.0178799.t001
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Fig 1. LLO56 naïve helper T cells have higher calcium mobilization in vitro. Naïve T cells from LLO56
and LLO118 TCR transgenic mice were obtained from the spleen using negative selection and calcium levels
were measured using live cell microscopy. T cells were added to antigen presenting cells (bone marrow
derived macrophages) that were loaded overnight with the L. monocytogenes peptide (LLO190-205). A.
Average curves of intracellular Ca2+ mobilization from LLO56 and LLO118 naïve T cells (340/380 ratios)

PLOS ONE | https://doi.org/10.1371/journal.pone.0178799 May 31, 2017

6 / 16

Naïve helper T cells with high CD5 expression have increased calcium signaling

(n = 40+). Error bars show the SEM at the influx peak and every 5 minutes after the peak (n = 40+). B.
Statistical analysis of peak calcium influx of stimulated LLO56 and LLO118 naïve T helper cells (n = 40+). C.
Statistical analysis of the sustained intracellular Ca2+ levels (Average 340/380 values between minutes 5 and
20) after initial stimulation response (n = 40+). D. Standard deviation was determined by linear regression
analysis and shows variability in the calcium signal for each group (n = 40+). (* = p < .05; NS = not significant).
https://doi.org/10.1371/journal.pone.0178799.g001

higher peak levels of calcium influx than LLO56 T helper cells (Fig 3B). While there were
no differences in mean Ca2+ levels (Fig 3C), LLO118 did have significantly higher variability
in the calcium signal (standard deviation). Thus, on day 3 post-stimulation LLO56 T cells
had significantly lower peak calcium influx and lower variability compared to LLO118 T
cells.

Fig 2. Naïve LLO56 T helper cells have higher levels of CD5. Flow cytometry analysis of CD5 expression of LLO56 and LLO118 T helper cells was done
using LLO118 and LLO56 splenocytes at different time points after stimulation with the LLO190-205 peptide from L. monocytogenes. A. Gating strategy for
measuring CD4 and CD5 mean fluorescent intensity on LLO118 and LLO56 T cells. B. CD5 levels of naïve T cells, T cell stimulated for 3 days, and T cells
stimulated for 8 days. T helper cells from LLO56 (red line) overlaid with the CD5 levels from LLO118 (shaded blue). Unstained cells are also included (black
dots). C-D. Comparison of mean fluorescence intensity (MFI) profiles for LLO56 and LLO118 expression levels of CD5 at different time points were
determined by flow cytometry quantitative analysis. (* = p < .05; ** = p < .01; *** = p < .001; NS = not significant).
https://doi.org/10.1371/journal.pone.0178799.g002
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Fig 3. LLO118 helper T cells have higher calcium signaling on day 3 post stimulation. LLO56 and
LLO118 splenocytes were isolated and cultured with the LLO190-205 peptide from L. monocytogenes for 72
hours in vitro. 24 hours before live imaging, a second set of splenocytes were isolated and cultured in an
8-chamber slide loaded with LLO190-205 peptide of L. monocytogenes for use as antigen presenting cells. T
cells were stained with Fura-2AM, added to the antigen presenting cells and Ca2+ influx was measured. A.
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Average curves of intracellular Ca2+ mobilization from stimulated LLO56 and LLO118 splenocytes (340/380
ratios; n = 30) on day 3 post stimulation. Error bars show the SEM at the influx peak. B. Statistical analysis of
peak calcium influx of stimulated LLO56 and LLO118 naïve T helper cells (n = 30+). C. Statistical analysis of
the sustained intracellular Ca2+ levels (Average 340/380 values between minutes 5 and 20) after initial
stimulation response (n = 30+). D. Standard deviation was determined by linear regression analysis and
shows variability in the calcium signal for each group (n = 30+). (** = p < .01; *** = p < .001; NS = not
significant).
https://doi.org/10.1371/journal.pone.0178799.g003

LLO56 and LLO118 have similar in vitro calcium responses on day 8
post stimulation
To further characterize the LLO118 and LLO56 Ca2+ response, we isolated splenocytes and cocultured them with the L. monocytogenes peptide for 8 days. On day 8 post-stimulation, the
average Ca2+ profiles were similar to each other (Fig 4A). Upon evaluation, there were no significant differences between LLO118 and LLO56 T cells in calcium peak, mean, or standard
deviation on day 8 post-stimulation (Fig 4B–4D).

Calcium flow cytometry data correlates with calcium microscopy data
To confirm the results obtained in live cell calcium microscopy and evaluate the role of TCR
independent calcium signaling, we isolated LLO56 and LLO118 T cells and measured Ca2+
mobilization using flow cytometry. Cells were labeled with Flou-4AM and stimulated with
PMA and ionomycin. Flou-4AM fluorescence was examined before and after stimulation.
Measurements were collected for naïve T helper cells, day 3, and day 8 post-stimulated T cells.
The data was consistent with our previous live cell imaging findings in which naïve LLO56 T
helper cells and day 3 post-stimulated LLO118 T cells had higher Ca2+ mobilization compared
to their counterparts while no calcium mobilization differences were seen at day 8 between
LLO118 and LLO56 T cells (Fig 5A–5C and Table 2). Collectively, these data show CD5
expression levels and calcium signaling changes over the course of a primary response in
LLO118 and LLO56 T cells (Table 2, Figs 2 and 5). Our live cell microscopy calcium imaging
and flow cytometry calcium analysis differ in the parameters measured and the stimulation
used (cells were stimulated in a TCR-dependent manner for live cell calcium imaging and in a
TCR-independent manner for flow cytometry analysis). This calcium data is consistent with
the TCR independent cytokine production differences between LLO118 and LLO56 identified
by Persaud et al, in which they demonstrated that the LLO118 and LLO56 naive T cell response
was set during thymic selection. Naive LLO56 T cells have higher expression of CD5, suggesting increased affinity for self-peptide, and produce higher levels of IL-2 even when stimulated
in a TCR independent manner [26].

CD5 expression in naïve LLO56 T helper cells is correlated with higher
Ca2+ mobilization
To further investigate the role CD5 expression plays in Ca2+ mobilization, we measured the
calcium signal in T cells from LLO118-CD5 knockout and LLO56-CD5 knockout mice. We
found in the LLO118 T cells (CD5-low) that calcium mobilization was not significantly different from LLO118-CD5 knockout T cells at any of the three time points (Fig 6A–6C). Conversely, naïve LLO56-CD5 knockout T helper cells had significantly lower calcium levels
compared to the naïve LLO56 T cells (CD5-high) (Fig 6D). There was no calcium mobilization
difference between LLO56 and LLO56-CD5 knockout T cells at day 3 or day 8 post-stimulation (Fig 6E and 6F). Thus, in naïve LLO118 T cells (CD5-low), CD5 does not appear to play a
strong role in regulating calcium mobilization at any of the time points. However, CD5
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Fig 4. No calcium differences between LLO56 and LLO118 on day 8 post stimulation. LLO56 and
LLO118 transgenic splenocytes were isolated and cultured with the LLO190-205 peptide for a week. 24 hours
before live imaging, a second set of splenocytes were isolated and cultured in an 8-chamber slide loaded with
LLO190-205 peptide of L. monocytogenes for use as antigen presenting cells. 8 days stimulated T cells were
stained with Fura-2AM and Ca2+ influx was measured using live imaging microscopy. A. Average curves of
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intracellular Ca2+ mobilization from stimulated LLO56 and LLO118 splenocytes (340/380 ratios; n = 30) on
day 8 post stimulation. Error bars show the SEM at the influx peak. B. Statistical analysis of peak calcium
influx of stimulated LLO56 and LLO118 naïve T helper cells (n = 30+). C. Statistical analysis of the sustained
intracellular Ca2+ levels (Average 340/380 values between minutes 5 and 20) after initial stimulation response
(n = 30+). D. Standard deviation was determined by linear regression analysis and shows variability in the
calcium signal for each group (n = 30+). (NS = not significant).
https://doi.org/10.1371/journal.pone.0178799.g004

expression is important in regulating calcium mobilization in the naïve LLO56 T cells
(CD5-high) during the initial response to antigen, but as CD5 levels decrease over time, its
role in regulating calcium also decreases.

Discussion
In this study, we examined the role of CD5 in regulating T cell activation during a primary
response using two T helper cells, LLO56 and LLO118, which bind to the same L. monocytogenes epitope and have different levels of CD5 on the surface upon completion of thymic development [25, 26]. Because of the described negative regulatory role of CD5 in the thymus and
the prevalence of CD5-high cells in memory cells, we wondered how CD5 influences T cell
immune response at a post-thymic level. We found significantly different Ca2+ signaling levels
between LLO56 and LLO118 T helper cells at the naïve and day 3 time points. The distinct Ca2
+
mobilization patterns of LLO56 and LLO118 likely influence their particular responses to
antigen, similar to observations made in B cells in which unique Ca2+ mobilization controls
distinct B cell activation phenotypes [20, 41]. Previous work has defined the important role of
CD5 during T cell thymic development and that CD5-high cells are enriched in memory T cell
populations, but how CD5 functions during the primary response stage of T helper cells has
not been well defined. Here we characterized the role of CD5 expression and calcium mobilization in these CD5-high and CD5-low T cells over the course of 8 days. We found that naïve
LLO56 T helper cells (CD5-high) have significantly higher calcium mobilization compared
to the LLO56-CD5 knockout T cells, but at later time points the removal of CD5 did not

Fig 5. Flow cytometry calcium analysis confirms improved calcium mobilization for naïve LLO56 T cells and higher calcium mobilization for
LLO118 T cells at day 3 post-stimulation. LLO56 and LLO118 splenocytes were isolated and cultured at different time points with the LLO190-205 peptide.
Calcium levels were quantified using the FlowJo kinetics tool to determine the area under the curve (AUC) for each sample. Calcium mobilization levels for
LLO118 and LLO56 are quantified (mean ± SEM of the area under the curve). A. Statistical analysis of naïve LLO118 and LLO56 T helper cell calcium
mobilization after activation with PMA and Ionomycin. B. Statistical analysis of day 3 post stimulated LLO118 and LLO56 calcium mobilization and C.
Statistical analysis of day 8 post stimulated LLO118 and LLO56 calcium mobilization. (NS = not significant).
https://doi.org/10.1371/journal.pone.0178799.g005
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Table 2. Summary of CD5 and calcium findings for LLO56 and LLO118.
LLO56
CD5 Expression

LLO118
Ca2+ influx

CD5 Expression

Ca2+ mobilization

Naïve T cell

+++

+++

+

+

Day 3

++

++

+

+++

Day 8

++

++

+

++

https://doi.org/10.1371/journal.pone.0178799.t002

significantly alter LLO56 calcium mobilization. Naïve LLO118 T helper cells (CD5-low)
exhibit no differences in Ca2+ mobilization relative to their CD5 knockout counterpart. Thus,
we found naive CD5-high T cells have improved calcium mobilization to an antigen they have
never seen before.
T cell development shapes the T cell population by removing strongly self-reactive cells and
helping determine future immune responses. T cells that are moderately self-reactive may be

Fig 6. CD5 expression in naïve LLO56 T helper cells is correlated with higher Ca2+ mobilization. Flow cytometry analysis was performed to determine
Ca2+ mobilization levels in LLO56, LLO118, LLO56-CD5 knockout and LLO118-CD5 knockout T cells stimulated with the L. monocytogenes peptide (naïve,
day 3, and day 8 time points). Calcium levels were quantified using the FlowJo kinetics tool to determine the area under the curve (AUC) for each sample
(mean ± SEM). A-C. Statistical analysis of calcium mobilization of LLO118 and LLO118-CD5 knockout T cells stimulated with PMA/Ionomycin. Data is shown
for naive (A), day 3 post stimulation (B) and day 8 post stimulation (C). D-F. Statistical analysis of calcium mobilization of naïve LLO56 and LLO56-CD5
knockout T cells stimulated with PMA/Ionomycin. Data is shown for naive (D), day 3 post stimulation (E) and day 8 post stimulation (F). (* = p < .05; NS = not
significant).
https://doi.org/10.1371/journal.pone.0178799.g006
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able to pass positive selection and evade negative selection and circulate in the periphery.
These self-reactive cells, marked by high levels of CD5, appear to be primed to be the best
responders to foreign antigens [26]. CD5 is a known negative regulator of TCR signaling during thymocyte development and its expression is correlated to the relationship of TCR avidity
for self-pMHC [25, 26, 28, 42]. Analysis in thymocytes showed that LLO56 and LLO118 CD5
knockout T cells had increased p-ERK and IL-2 production, providing additional evidence
that CD5 has a negative regulatory effect in developing thymocytes [26]. However, additional
work has demonstrated that CD5-high and CD5-low T cells respond differently to self and foreign antigens, suggesting that CD5 has an important role in thymocyte selection and peripheral T cell function and fate [28, 29].
Recent studies suggest that developing T cell CD5 levels affect naïve T cell responses to foreign antigens in the periphery [15, 43]. While the negative regulatory function of CD5 in the
thymus does not appear to be dependent upon engagement with a ligand, the positive co-stimulatory effect of CD5 in the periphery is likely due to CD5 engagement of a ligand (CD5 or
CD5L) [30–33]. As previously reported, anti-CD5 antibodies enhance TCR-mediated activation and proliferation in peripheral T cells [29, 44, 45]. This calcium difference observed in
naïve T cells is supportive of the previously published finding that LLO56 T cells have significantly higher phosphorylation levels of pERK and production of IL-2 before exposure to antigen, suggesting a role for self-peptide affinity in altering CD5 levels and naive T cell responses.
CD5-high T cells respond strongly upon stimulation in vitro and have increased IL-2 secretion
and greater Erk phosphorylation compared to CD5-low T cells [26]. Since CD5 expression is
set by self-peptide reactivity in the thymus, our finding that naïve CD5-high LLO56 T cells
have higher calcium influx is consistent with other studies that have shown that increased reactivity to self-peptides results in T cells with improved reactivity to foreign antigens [14, 28, 46].
We found that CD5 expression plays an important role in intracellular Ca2+ mobilization
for naïve LLO56 helper T cells (CD5-high). CD5-high T cells have stronger avidity for self-peptide. It has been suggested that the enhanced activation response to foreign pathogens of
CD5-high T cells could be due to their ability to more efficiently use self-peptide as a co-agonist peptide in the periphery [15]. Additionally, CD5-high cells have better basal TCR signaling
and improved functional characteristics which correlate with better response to foreign peptide [28]. Studies in naïve cytotoxic T cells suggest that the gene expression profile of CD5-high
T cells transcriptionally engage into proliferative and effector functions faster than CD5-low T
cells [46]. Furthermore, CD5 appears to help with CD5-high naïve T cell survival after antigen
recognition [47]. In fact, T cells with high CD5 levels may maintain diversity within the memory population, which may outweigh the cost of increased self-reactivity [15]. Additionally, T
cells with high CD5 expression are enriched in memory cell populations, suggesting that when
designing vaccines, CD5 levels and self-peptide and foreign peptide interactions are an important consideration [14, 15].
The data presented here helps to elucidate the role that CD5 plays in regulating calcium signaling in naïve cells early after cell activation during an in vitro primary response. We plan to
further investigate whether the unique Ca2+ profiles of LLO56 and LLO118 T cells are consistent in an in vivo model and further quantify the role CD5 plays in effector and memory T
cells. These future studies will help elucidate how CD5 influences naïve T cell responses and its
potential role in memory T cell generation and maintenance.
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Abstract: Calcium influx is critical for T cell effector function and fate. T cells are activated when
T cell receptors (TCRs) engage peptides presented by antigen-presenting cells (APC), causing an
increase of intracellular calcium (Ca2+ ) concentration. Co-receptors stabilize interactions between
the TCR and its ligand, the peptide-major histocompatibility complex (pMHC), and enhance Ca2+
signaling and T cell activation. Conversely, some co-receptors can dampen Ca2+ signaling and inhibit
T cell activation. Immune checkpoint therapies block inhibitory co-receptors, such as cytotoxic
T-lymphocyte associated antigen 4 (CTLA-4) and programmed death 1 (PD-1), to increase T cell
Ca2+ signaling and promote T cell survival. Similar to CTLA-4 and PD-1, the co-receptor CD5 has
been known to act as a negative regulator of T cell activation and to alter Ca2+ signaling and T cell
function. Though much is known about the role of CD5 in B cells, recent research has expanded
our understanding of CD5 function in T cells. Here we review these recent findings and discuss
how our improved understanding of CD5 Ca2+ signaling regulation could be useful for basic and
clinical research.
Keywords: calcium signaling; T cell receptor (TCR); co-receptors; CD-5; PD-1; CTL-4

1. Introduction
T cells are a critical component of the adaptive immune system. T cell responses are
influenced by signals that modulate the effects of the T cell receptor (TCR) and peptide-major
histocompatibility complex (pMHC) interaction and initiate the transcription of genes involved in
cytokine production, proliferation, and differentiation [1–3]. T cell activation requires multiple signals.
First, the TCR engages the pMHC leading to tyrosine phosphorylation of CD3 and initiation of the
Ca2+ /Calcineurin/Nuclear factor of activated T cells (NFAT) or Protein kinase C-theta (PKCθ)/Nuclear
factor-κ-light chain enhancer of activated B cells (NF-κB) or Mitogen-activated protein kinase (MAP
kinase)/AP-1 pathways [4–6]. Second, cell surface costimulatory molecules, such as co-receptor CD28,
amplify TCR-pMHC complex signals and promote stronger intracellular interactions to prevent T cell
anergy [7,8]. Finally, cytokines such as interleukin-12 (IL-12), interferon α (INFα), and interleukin-1
(IL-1) promote T cell proliferation, differentiation, and effector functions [6].
Co-receptors such as CD4 and CD8 interact with MHC molecules and additional co-receptors
interact with surface ligands present on antigen-presenting cells (APCs) to regulate T cell homeostasis,
survival, and effector functions with stimulatory or inhibitory signals [9]. Altering co-receptor levels,
balance, or function dramatically affects immune responses and their dysfunction is implicated in
autoimmune diseases [10]. Stimulatory co-receptors such as CD28, inducible T cell co-stimulator
(ICOS), Tumor necrosis factor receptor superfamily member 9 (TNFRSF9 or 4-1BB), member of the
TNR-superfamily receptor (CD134 or OX40), glucocorticoid-induced tumor necrosis factor (TNF)
receptor (GITR), CD137, and CD77 promote T cell activation and protective responses [11]. Co-receptor
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signaling is initiated by the phosphorylation of tyrosine residues located in immunoreceptor
tyrosine-based activation motifs (ITAMs) or immunoreceptor tyrosine-based inhibitory motifs
(ITIMs) [7,12]. The phosphorylated tyrosines serve as docking sites for spleen tyrosine kinase (Syk)
family members such as zeta-chain-associated protein kinase 10 (ZAP-70) and Syk which activate the
phospholipase C γ (PLCγ), RAS, and extracellular signal-regulated kinase (ERK) pathways in addition
to mobilizing intracellular Ca2+ stores [13].
One of the best described T cell co-receptors, CD28, is a stimulatory T cell surface receptor from the
Ig superfamily with a single Ig variable-like domain which binds to B7-1 (CD80) and B7-2 (CD86) [2].
Ligand binding phosphorylates CD28 cytoplasmic domain tyrosine motifs such as YMNM and PYAP
and initiates binding and activation of phosphatidylinositide 3 kinase (PI3K) which interacts with
protein kinase B (Akt) and promotes T cell proliferation and survival [1]. CD28 also activates the NFAT
pathway and mobilizes intracellular Ca2+ stores through association with growth factor receptor-bound
protein 2 (GRB2) and the production of phosphatidylinositol 4,5-bisphosphate (PIP2), the substrate
of PLCγ1, respectively [2,14]. Blocking stimulatory co-receptors suppresses T cell effector function.
For example, blocking stimulatory CD28 with anti-CD28 antibodies promotes regulatory T cell function
and represses activation of auto- and allo-reactive T effector cells after organ transplantation [8,15].
T cells also have inhibitory co-receptors which regulate T cell responses [8]. The best characterized
are immunoglobulin (Ig) superfamily members cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)
and programmed cell death protein 1 (PD-1) [8,16]. CTLA-4 binds CD80 and CD86 with greater
avidity than CD28, and its inhibitory role refines early phase activation signals for proliferation and
cytokine production [16–19]. PD-1, another CD28/B7 family member, regulates late phase effector
and memory response [20]. Inhibitory co-receptors such as CTLA-4 and PD-1, known as “immune
checkpoints”, block the interaction between CD28 and its ligands altering downstream secondary T
cell activation signals [19]. Therefore, blocking CTLA-4 or PD-1 promotes effector T cell function in
immunosuppressive environments [19,21].
There are also a number of co-receptors that have differential modulatory properties. For example,
CD5, a lymphocyte glycoprotein expressed on thymocytes and all mature T cells, has contradictory
roles at different time points. CD5 expression is set during thymocyte development and decreases
the perceived strength of TCR-pMHC signaling in naïve T cells by clustering at the TCR-pMHC
complex and reducing TCR downstream signals such as the Ca2+ response when its cytoplasmic
pseudo-ITAM domain is phosphorylated [22–25]. The CD5 cytoplasmic domain has four tyrosine
residues (Y378, Y429, Y411, and Y463), and residues Y429 and Y441 are found in a YSQP-(x8)-YPAL
pseudo ITAM motif while other tyrosine residues make up a pseudo-ITIM domain [23]. Phosphorylated
tyrosines recruit several effector molecules and may sequester activation kinases away from the
TCR complex, effectively reducing activation signaling strength [23]. Recruited proteins include Src
homology-2 protein phosphatase-1 (SHP-1), Ras GTPase protein (rasGAP), CBL, casein kinase II
(CK2), zeta-chain-associated protein kinase 70 (ZAP70), and PI3K which are involved in regulating
both positive and negative TCR-induced responses [26–28]. For example, ZAP-70 phosphorylates
other substrates and eventually recruits effector molecules such as PLC gamma and promotes
Ca2+ signaling and Ras activation which stimulates the ERK pathway and leads to cellular
activation [13,29]. Conversely, SHP1 inhibits Ca2+ signaling and PKC activation via decreased tyrosine
phosphorylation of PLCγ [13,26,30,31]. Further, Y463 serves as a docking site for c-Cb1, a ubiquitin
ligase, which is phosphorylated upon CD3–CD5 ligation and leads to increased ubiquitylation and
lysosomal/proteasomal degradation of TCR downstream signaling effectors and CD5 itself [32].
Thus, CD5 has a mix of downstream effects that both promote and inhibit T cell activation. Curiously,
recent work suggests that in contrast to its initial inhibitory nature, CD5 also co-stimulates resting and
mature T cells by augmenting CD3-mediated signaling [25,33–35].
Ca2+ is an important second messenger in many cells types, including lymphocytes, and plays
a key role in shaping immune responses. In naïve T cells, intracellular Ca2+ is maintained at low
levels, but when TCR-pMHC complexes are formed, inositol triphosphate (IP3) initiates Ca2+ release
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from intracellular stores of the endoplasmic reticulum (ER) which opens the Ca2+ release-activated
Ca2+ channels (CRAC) and initiates influx of extracellular Ca2+ through store-operated Ca2+ entry
(SOCE) [36–41]. The resulting elevation of intracellular Ca2+ levels activates transcription factors
involved in T cell proliferation, differentiation, and cytokine production (e.g., nuclear factor of
activated cells (NFAT)) [36,37]. Thus, impaired Ca2+ mobilization affects T cell development, activation,
differentiation, and function [42,43]. Examples of diseases with impaired Ca2+ signaling in T cells
include systemic lupus erythematosus, type 1 diabetes mellitus, and others [44,45].
In this review, we will focus on CD5 co-receptor signaling and its functional effects on T cell
activation. First, we will discuss how the inhibitory co-receptors CTLA-4 and PD-1 modulate T cell
function. Then we will compare CTLA-4 and PD-1 function to CD5 function, examine recent findings
that expand our understanding of the role of CD5, and assess how these findings apply to T cell
Ca2+ signaling. Finally, we will consider CD5 Ca2+ signaling regulation in T cells and its potential
physiological impact on immunometabolism, cell differentiation, homeostasis, and behavior.
2. Roles of Negative Regulatory T Cell Co-Receptors
2.1. Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4)
Cytotoxic T-lymphocyte antigen-4 (CTLA-4, CD152) inhibits early stages of T cell activation by
recruiting inhibitory proteins such as SHP-2 and type II serine/threonine phosphatase PP2A that
interfere with T cell synapse signaling [21,46–48]. CTLA-4 binds B7, a protein on activated APCs,
with higher affinity than the stimulatory co-receptor CD28; the resulting balance between inhibitory and
stimulatory signals controls T cell activation or anergy [19,49]. In naïve T cells, CTLA-4 is located in
intracellular vesicles which localize at TCR binding sites following antigen recognition and intracellular
Ca2+ mobilization [19,50]. Like CD28, CTLA-4 aggregates to the central supramolecular activation complex
(cSMAC) where it then extrinsically controls activation by decreasing immunological synapse contact
time [51–53]. This suppresses proactivation signals by activating ligands (B7-1 and B7-2) and induces
the enzyme Inoleamine 2,3-dioxygenase (IDO) which impairs Ca2+ mobilization and suppresses T cell
activation, ultimately altering IL-2 production and other effector functions in T cells [51,54,55]. CTLA-4
also stimulates production of regulatory cytokines, such as transforming growth factor beta (TGF-β),
which inhibit APC presentation and T cell effector function [47,52,53]. Compared to effector T cells (Teff ),
CTLA-4 is highly expressed in regulatory T cells (Treg ) and plays a role in maintaining Treg homeostasis,
proliferation, and immune responses [16,56,57]. Total or partial CTLA-4 deficiency inhibits Treg ’s ability
to control cytokine production and can cause immune dysregulation [58–61]. Thus, CTLA-4 has an
important role in the Treg suppressive response [60]. Additionally, CTLA-4 mutations are associated with
autoimmune diseases as thoroughly reviewed by Kristiansen et al. [62].
The loss of CTLA-4 results in removal of CTLA-4 competition with CD28 for B7-1 and B7-2 and
is implicated in autoimmunity and cancer [15,63]. Because CTLA-4 inhibits TCR signaling, CTLA-4
deficiency leads to T cell overactivation as measured by increased CD3ζ phosphorylation and Ca2+
mobilization [64]. Thus, modulating CTLA-4 signaling is an attractive target for immunotherapies
that seek to boost or impair early TCR signaling for cancer and autoinflammatory diseases [65,66].
For example, Ipilimunab, an IgG1 antibody-based melanoma treatment, is a T cell potentiator that
blocks CTLA-4 to stimulate T cell proliferation and stem malignant disease progression by delaying
tumor progression and has been shown to significantly increase life expectancy [19,67,68]. Additionally,
Tremelimumab, a noncomplement fixing IgG2 antibody, has been tested alone or in combination with
other antibodies such as Durvalumab (a PD-1 inhibitor) and improves antitumor activity in patients
with non-small cell lung cancer (NSCLC), melanoma, colon cancer, gastric cancer, and mesothelioma
treatment [69–74].
2.2. Programmed Death 1 (PD-1)
Programmed cell death protein-1 (PD-1, CD279) is a 288-amino acid (50–55 KDa) type I
transmembrane protein and a member of the B7/CD28 immunoglobulin superfamily expressed
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on activated T cells, B cells, and myeloid cells [19,75,76]. PD-1 has two known ligands, PD-L1 and
PD-L2, which inhibit T cell activation signals [77]. Like CTLA-4, PD-1 also inhibits T cell proliferation
and cytokine production (INF-γ, TNF and IL-2) but is expressed at a later phase of T cell activation [19].
PD-1 has an extracellular single immunoglobulin (Ig) superfamily domain and a cytoplasmic domain
containing an ITIM and an immunoreceptor tyrosine-based switch motif (ITSM) subunit critical
for PD-1 inhibitory function [78]. Upon T cell activation, PD-1 is upregulated and initiates ITIM
and ITSM tyrosine interaction with SHP-2 which mediates TCR signaling inhibition by decreasing
ERK phosphorylation and intracellular Ca2+ mobilization [79,80]. PD-1 can block the activation
signaling pathways PI3K-Akt and Ras-Mek-ERK, which inhibit or regulate T cell activation [79,81].
Thus, engagement of PD-1 by its ligand affects intracellular Ca2+ mobilization, IL-2 and TNF-α
production, supporting PD-1’s inhibitory role in TCR strength-mediated signals [82].
PD-1 signaling also affects regulatory T cell (Treg ) homeostasis, expansion, and function [83].
Treg activation and proliferation are impacted by PD-1 expression which enhances their development
and function while inhibiting T effector cells [75,84]. PD-1, PD-L, and Tregs help terminate immune
responses [85]. Thus, PD-1 deficiency results not only in increased T cell activation, but in the
breakdown of tolerance and the development of autoimmunity in diseases such as multiple sclerosis
and systemic lupus erythematosus [85–89]. PD-1 and its ligands protect tissues from autoimmune
attacks by regulating T cell activation and inducing and maintaining peripheral tolerance [90,91].
Studies done in PD-1-deficient mice observed the development of lupus-like glomerulonephritis
and arthritis, cardiomyopathy, autoimmune hydronephrosis, and Type I diabetes, among other
ailments [92–94]. PD-1 protects against autoimmunity and promotes Treg function. [85]. Enhancing
Treg response with a PD-L1 agonist shows therapeutic potential for asthma and other autoimmune
disorders [85,95]. Because PD-1 specifically modulates lymphocyte function, effective FDA-approved
monoclonal antibodies targeting PD-1 are clinically available (i.e., Pembrolizumab and Nivolumab) to
treat advanced malignancies [20]. Not only does blocking PD-1 decrease immunotolerance of tumor
cells, it also increases cytotoxic T lymphocyte antitumor activity [20].
3. CD5: A Contradictory Co-Receptor
3.1. Overview of CD5 Signaling and Ca2+ Mobilization in T Cells
CD5, known as Ly-1 antigen in mice or as Leu-1 in humans, is a type I transmembrane glycoprotein
(67 kDa) expressed on the surface of thymocytes, mature T cells, and a subset of B cells (B-1a) [96,97].
Although CD5 was discovered over 30 years ago, it was only in the last decade that CD5 gained
attention as a key T cell activation regulator [98,99]. CD5 expression is set in the thymus during positive
selection and correlates with how tightly the thymocyte TCR binds to self-peptide-MHC (self-pMHC);
greater TCR affinity for self-peptide leads to increased CD5 expression in double positive (DP)
thymocytes [100]. In other words, DP thymocytes that receive strong activation signals through their
TCR express more CD5 than those DP thymocytes that receive weak TCR signals [100]. CD5 knockout
mice (CD5−/− ) have a defective negative and positive selection process, and therefore their thymocytes
are hyper-responsive to TCR stimulation with increased Ca2+ mobilization, proliferation, and cytokine
production [23,98]. On the other hand, because of the increased TCR avidity for self-pMHC, mature T
cells with high CD5 expression (CD5hi ) (peripheral or postpositive selection T cells) respond to foreign
peptide with increased survival and activation compared to mature T cells with low CD5 expression
(CD5lo ) [34,101]. Therefore, CD5 is a negative regulator of TCR signaling in the thymus and modulates
mature T cell response in the periphery [23,34,100,102].
While CTLA-4 and PD-1 belong to the immunoglobulin (Ig) family, CD5 belongs to group B
of the scavenger receptor cysteine-rich (SRCR) superfamily and contains three extracellular SRCR
domains [30,96,103]. The cytoplasmic tail of CD5 contains several tyrosine residues which mediate the
negative regulatory activity independent of extracellular engagement [100,104,105]. As CD5 physically
associates with TCRζ/CD3 complex upon TCR and pMHC interaction, the tyrosine residues in both
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TCRζ and CD5 are phosphorylated by tyrosine kinases associated with the complex [30,106–110].
This interaction is so intrinsic to T cell signaling that CD5 expression levels are proportional to the
degree of TCRζ phosphorylation, IL-2 production capacity, and ERK phosphorylation which are
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3.2. CD5 as a Ca2+ Signaling Modulator

As previously mentioned, CD5 expression levels are set in the thymus during T cell development
and are maintained on peripheral lymphocytes [117]. CD5 expression in T cells plays an important
role during development and primes naïve T cells for responsiveness in the periphery [35,111,130].
CD5hi T cells have the highest affinity for self-peptides and respond with increased cytokine production
and proliferation to infection [101,131,132].
Our laboratory works with two TCR transgenic mouse lines with different levels of CD5
expression: LLO56 (CD5hi ) and LLO118 (CD5lo ) [111,117,130]. While LLO56 (CD5hi ) and LLO118
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(CD5lo ) have similar affinity for the same immunodominant epitope (listeriolysin O amino acids
190–205 or LLO190–205 ) from Listeria monocytogenes, on day 7 of primary response, LLO118 (CD5lo ) has
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Figure 2. Inhibiting co-receptors modulate T cell activation by increasing (green arrows) or decreasing
activity (red
arrows). CD5modulate
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to the TCR:pMHC
complex
during or decreasing
Figure 2. Inhibiting
co-receptors
T cellT cells
activation
by increasing
(green
arrows)
activation. Initial activation cascades signal for the release of CTLA-4 from vesicles to the cell surface
activity (red arrows). CD5 is present in naïve T cells and localizes to the TCR:pMHC complex during
while the transcription factor NFAT transcribes PD-1. CTLA-4 provides inhibitory signals during
activation. Initial activation cascades signal for the release of CTLA-4 from vesicles to the cell surface
while the transcription factor NFAT transcribes PD-1. CTLA-4 provides inhibitory signals during early
activation while PD-1 is expressed later and inhibits later stages of T cell activation. The initial Ca2+
mobilization is decreased by CTLA-4 and PD-1 downstream signals. A more detailed illustration of the
calcium signaling pathway (i.e., IP3, STIM 1/2, CRAC channel, calmodulin, etc.) is outlined in Figure 3.
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4. Physiological Impact of CD5 Expression in T Cells
4.1. Metabolism
Naive T cells are in a quiescent state and rely on oxidative phosphorylation (OXPHOS) to generate
ATP for survival [136,137]. Upon TCR-pMHC interaction, T cells undergo metabolic reprograming
to meet energetic demands by switching from OXPHOS to glycolysis [138]. Glycolysis is a rapid
source of ATP and regulates posttranscriptional production of INF-γ, a critical effector cytokine [139].
Following the immune response, most effector T cells undergo apoptosis while a subset become
quiescent memory T cells. Memory T cells have lower energetic requirements and rely on OXPHOS
and Fatty Acid Oxidation (FAO) to enhance mitochondrial capacity for maintenance and survival [140].
Ca2+ signaling is a key second messenger in T cell activation and Ca2+ ions also modulate T
cell metabolism through CRAC channel activity and NFAT activation [3,141]. During TCR-pMHC
binding Ca2+ is released from the endoplasmic reticulum (ER) where it is absorbed by the mitochondria
and initiates an influx of extracellular Ca2+ [3]. First, the rise of cytoplasmic Ca2+ activates stromal
interaction molecule 1 (STIM1) located on the ER membrane to interact with the CRAC channel
located on the cell membrane [142]. The release of the ER store and resulting extracellular Ca2+ influx
increases the intracellular Ca2+ concentration and promotes AMPK (adenosine monophosphates
activated protein kinase) expression and CaMKK (calmodulin-dependent protein kinase kinase)
activity [3,142,143]. AMPK senses cellular energy levels through the ratio of AMP to ATP and generates
ATP by inhibiting ATP-dependent pathways and stimulating catabolic pathways [144]. This indirectly
controls T cell fate as AMPK indirectly inhibits mTOR (mammalian target of rapamycin complex) [145].
Because mTOR coordinates the metabolic cues that control T cell homeostasis, it plays a critical role
in T cell fate [146]. T cells that are TSC1 (Tuberous sclerosis complex 1)-deficient show metabolic
alterations through increased glucose uptake and glycolytic flux [147].
The rise of cytoplasmic Ca2+ also encourages mitochondria to uptake cytoplasmic Ca2+ through the
mitochondrial Ca2+ uniporter (MCU) [148]. This MCU uptake increases Ca2+ influx by depleting Ca2+
near the ER which further activates the CRAC channels and promotes STIM1 oligomerization [3,149–151].
Ca2+ uptake in the mitochondria also enhances the function of the tricarboxylic acid cycle (TAC),
which generates more ATP through OXPHOS [152,153]. OXPHOS is maintained by a glycolysis product,
phosphoenolpyruvate (PEP), which sustains TCR-mediated Ca2+ -NFAT signaling by inhibiting the
sarcoendoplasmic reticulum (SR) calcium transport ATPase (SERCA) pump, thus promoting T cell
effector function [154,155]. Downregulation of calmodulin kinase, CaMKK2, which controls NFAT
signaling, decreases glycolytic flux, glucose uptake, and lactate and citrate metabolic processes [156].
Ca2+ may also orchestrate the metabolic reprogramming of naïve T cells by promoting glycolysis and
OXPHOS through the SOCE/calcineurin pathway which controls the expression of glucose transporters
GLUT1/GLUT3 and transcriptional co-regulator proteins important for the expression of electron
transport chain complexes required for mitochondria respiration [141].
Co-receptor stimulation plays a pivotal role in T cell metabolism and function. A decrease in T
cell Ca2+ signaling represses glycolysis and affects T cell effector function [152]. PD-1 and CTLA-4
depress Ca2+ signaling and glycolysis while promoting FAO and antibodies against CTLA-4 and PD-1
increase Ca2+ mobilization and glycolysis during T cell activation [157,158]. Like CTLA-4 and PD-1,
CD5 modulatory function has the potential to influence T cell metabolism. Analysis of gene families
modulated by CD5 in B cells found that CD5 upregulates metabolic-related genes including VEFG,
Wnt signaling pathways genes, MAPK cascade genes, I-kB/NF-kB cascade genes, TGF β signaling
genes, and adipogenesis process genes [159]. Therefore, proliferation differences correlated with CD5
expression in T cells may be caused by improved metabolic function as CD5lo T cells seem to be more
quiescent than CD5hi T cells [160]. Although not much is known about how CD5 alters metabolic
function in T cells, signaling strength differences of CD5hi and CD5lo T cell populations correlate with
intracellular Ca2+ mobilization during activation and influence their immune response [35,111,130].
This implies that different metabolic processes may be initiated which would influence proliferation,
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The field of neuroimmunology examines the interplay between the immune system and the
central nervous system (CNS) [161]. The adaptive immune system does influence the CNS as
4.2. Neuroimmunology
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Following entrance into the CNS, T cells encounter autoantigen-presenting cells and have sustained
Ca2+ mobilization which results in NFAT translocation and T cell activation [166,168]. EAE mice
display reduced social interaction and cognition demonstrating that autoimmune response impairs
neuronal function and organismal behavior [169].
Inhibitory T cell co-receptors are implicated in CNS dysregulation and disease. Varicella
zoster virus (VZV) infection is characterized by lifelong persistence in neurons. VZV increases the
expression of CTLA-4 and PD-1 in infected T cells which reduces IL-2 production and increases T cell
anergy [170,171]. PD-1-deficient mice (Pdcd1−/− ) have increased T cell activation, leading to greater
intracellular Ca2+ mobilization, and as previously discussed, increased glycolysis [86]. PD-1 deficiency
causes elevated concentration of aromatic amino acids in the serum, specifically tryptophan and
tyrosine, which decreases their availability in the brain where they are important for the synthesis of
neurotransmitters such as dopamine and serotonin; consequently, there is an increase in anxiety-like
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behavior and fear in Pdcd1−/− mice [86]. Therefore, increased T cell activation caused by PD-1
deficiency can affect brain function and thus, affects cognitive behavior [86].
4.3. Cancer
T cells are critical components of the immune response to cancer. Helper T cells directly activate
killer T cells to eradicate tumors and are essential in generating a strong antitumor response alone
or in concert with killer T cells by promoting killer T cell activation, infiltration, persistence, and
memory formation [172–177]. Tumor-specific T cells may not mount a robust response towards
cancerous cells because the tumor microenvironment has numerous immunosuppressive factors;
cancerous cells also downregulate cell surface co-stimulatory and MHC proteins which suppresses
T cell activation [178–182]. Potent antitumor immune checkpoint blockade therapies using CTLA-4
and PD-1 monoclonal antibodies augment T cell response by suppressing the co-receptors’ inhibitory
signals, thereby promoting increased Ca2+ mobilization, glycolysis, and activation [183,184]. CTLA-4
monoclonal antibodies such as ipilimumab (Yervoy) and tremelimumab block B7-interaction and
have been used to treat melanoma [47,185,186]. The monoclonal antibody pembrolizumab is highly
selective for PD-1 and prevents PD-1 from engaging PD-L1 and PD-L2, thus enhancing T cell immune
response [19,187,188]. Further research will address whether combining anti-CTLA-4 and anti-PD-1
antibodies will improve cancer treatments [19].
As previously mentioned, Ca2+ is critical for T cell activation and immune response. Manipulating
Ca2+ signaling to enhance T cell-directed immune response against cancer is an intriguing notion,
yet the means to target the Ca2+ response of specific cells without tampering with the metabolic
processes of other cells remains elusive [189]. Antitumor activity of tumor-infiltrating lymphocytes
(TIL) is inversely related to CD5 expression [99]. CD5 levels in naïve T cells are constantly tuned
in the periphery by interactions with self pMHC complexes to maintain homeostasis; therefore,
CD5 expression on TILs can be downregulated in response to low affinity for cancer antigens [190–192].
Thus, the majority of TILs are CD5lo which increase their reactivity while CD5hi TILs do not
elicit a Ca2+ response and become anergic and are unable to eliminate malignant cells [99,192].
While downregulation of CD5 on TILs enhances antitumor T cell activity, CD5lo T cells are also
more likely to experience activation-induced cell death (AICD) as CD5 protects T cells from
overstimulation [23]. To maximize TIL effectiveness, the inhibitory effects of CD5 could be blocked
by neutralizing monoclonal antibodies or soluble CD5-Fc molecules combined with soluble FAS-Fc
molecules to reduce the inherent AICD [23,193,194]. Soluble human CD5 (shCD5) may have a similar
effect but avoids targeting issues by blocking CD5-mediated interaction via a “decoy receptor” effect.
Mice constitutively expressing shCD5 had reduced melanoma and thyoma tumor cell growth and
increased numbers of CD4+ and CD8+ T cells [195]. Wild type mice treated with an injection of
recombinant shCD5 also had reduced tumor growth [195]. Finally, CD5-deficient mice engrafted with
B16-F10 melanoma cells had slower tumor growth compared to wild type C57BL/6 mice [196]. This
evidence suggests that CD5, along with PD-1 and CTLA-4, may be a potential target to specifically
modulate T cell Ca2+ mobilization in an immunosuppressive tumor setting.
4.4. Microbiome
The gut microbiome, including the bacteria and their products, forms a dynamic beneficial
symbiosis with the immune system influencing host genes and cellular response. The gut microbiome
shapes and directs immune responses while the immune system dictates the bacterial composition of
the gut microbiome [197]. As the gut is the major symbiotic system intersecting the immune system
and microbiota, understanding their connection has implications for immune system development
and function as the gut microbiome is involved in protecting against pathogens, influencing states of
inflammation, and even affecting cancer patient outcomes [198,199].
The gut microbiome primes immune responses [200]. Alteration in the microbial composition can
induce changes in T cell function in infectious disease, autoimmunity, and cancer [201]. For example,
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mice treated with antibiotics which restrict or reduce the microbial environment exhibit impaired
immune response because their T cells have altered TCR signaling and compromised intracellular
Ca2+ mobilization in infectious disease and cystic fibrosis models [202–204]. In contrast, administering
oral antibiotics to mice with EAE increases the frequency of CD5+ B cell subpopulations in distal
lymphoid sites and confers disease protection [205]. In cancer, the microbiome also influences patient
response to immune checkpoint inhibitors such as CTLA-4 and PD-1 [206,207]. Mice and melanoma
patients immunized or populated with Bacteriodes fragilis respond better to treatment with Ipilimumab,
a monoclonal antibody against CTLA-4 [198]. Similarly, tumor-specific immunity improved when
anti-PD-1/PD-L1 monoclonal antibodies where used in the presence of Bifidobacterium [208].
Though little is known about how CD5 influences T cell interaction with the microbiome,
some tantalizing details are available. As specific bacterium promotes cancer regression during
CTLA-4 and PD-1 checkpoint blockades, a CD5 blockade in conjunction with bacterial selection may
also improve immune response. Such studies would lead to novel immunotherapeutic treatments for
cancer and autoimmune diseases.
5. Conclusions
CD5, widely known as an inhibitory co-receptor in the thymus, appears to modulate the signaling
intensity of peripheral T cells by increasing Ca2+ signaling activity and efficacy of CD5hi T cells.
CD5 expression levels in the periphery correlates with intracellular Ca2+ mobilization, suggesting
that CD5 promotes peripheral T cell activation and immune response. As such, CD5 may be a novel
checkpoint therapy to regulate T cell activation and metabolism through altering Ca2+ mobilization,
and could be used to affect neurological behavior, alter microbiome interactions, and treat cancer
and autoinflammatory diseases. While this paper focuses on the role of co-receptor CD5 effects on
calcium signaling and activation of T cells, CD5 itself may be regulated through posttranslational
modifications, such as N-glycosylation, which may affect Ca2+ mobilization, T cell metabolism,
activation, and function. In the future it would be interesting to determine the role of other
posttranslational modifications (e.g., N-glycosylation, S-glutathionylation, lipidation) in CD5 signaling.
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AMPK
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SERCA
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Cytotoxic T-lymphocyte antigen 4
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Programmed cell death protein 1
Adenosine monophosphate
Adenosine triphosphate
Calmodulin-dependent protein kinase kinase
AMP-activated protein kinase
Store-operated calcium channels
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Nuclear factor of activated T cells
Interferon gamma
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Tumor necrosis factor
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The nuclear variant of bone
morphogenetic protein 2 (nBMP2)
is expressed in macrophages and
alters calcium response
Claudia M. Tellez Freitas 1, Haley R. Burrell1, Jonard C. Valdoz 2, Garrett J. Hamblin1,
Carlee M. Raymond1, Tyler D. Cox1, Deborah K. Johnson 1, Joshua L. Andersen2,
K. Scott Weber 1 & Laura C. Bridgewater 1
We previously identified a nuclear variant of bone morphogenetic protein 2 (BMP2), named nBMP2,
that is translated from an alternative start codon. Decreased nuclear localization of nBMP2 in the
nBmp2NLStm mouse model leads to muscular, neurological, and immune phenotypes—all of which are
consistent with aberrant intracellular calcium (Ca2+) response. Ca2+ response in these mice, however,
has yet to be measured directly. Because a prior study suggested impairment of macrophage function
in nBmp2NLStm mutant mice, bone marrow derived (BMD) macrophages and splenic macrophages
were isolated from wild type and nBmp2NLStm mutant mice. Immunocytochemistry revealed that
nuclei of both BMD and splenic macrophages from wild type mice contain nBMP2, while the protein
is decreased in nuclei of nBmp2NLStm mutant macrophages. Live-cell Ca2+ imaging and engulfment
assays revealed that Ca2+ response and phagocytosis in response to bacterial supernatant are similar in
BMD macrophages isolated from naïve (uninfected) nBmp2NLStm mutant mice and wild type mice, but
are deficient in splenic macrophages isolated from mutant mice after secondary systemic infection with
Staphylococcus aureus, suggesting progressive impairment as macrophages respond to infection. This
direct evidence of impaired Ca2+ handling in nBMP2 mutant macrophages supports the hypothesis that
nBMP2 plays a role in Ca2+ response.
Our group has reported the existence of a nuclear variant of the growth factor bone morphogenetic protein 2
(BMP2), designated nBMP21. This variant protein is produced by translation from an alternative downstream
start codon that eliminates the N-terminal endoplasmic reticulum signal peptide, thus preventing the protein’s
delivery to the secretory pathway. Instead, nBMP2 is translated in the cytoplasm and translocated to the nucleus
by means of an embedded bipartite nuclear localization signal (NLS)1. Using immunohistochemistry, we have
detected nBMP2 in skeletal muscle nuclei and in the nuclei of CA1 neurons in the hippocampus2,3.
To examine the function of nBMP2, we generated a mutant mouse strain (nBmp2NLStm) in which a
three-amino acid substitution in the NLS inhibits translocation of nBMP2 to the nucleus while still allowing
normal synthesis and secretion of the conventional BMP2 growth factor2. The mice appear overtly normal and are
fertile. They do, however, lack nBMP2 in myonuclei, and electrophysiological studies revealed that skeletal muscle
relaxation is significantly slowed after stimulated twitch contraction, a process that is regulated by intracellular
Ca2+ transport. Consistent with impaired intracellular Ca2+ transport, sarco/endoplasmic reticulum Ca2+ ATPase
(SERCA) activity is decreased in skeletal muscle2. The mutant mice also lack nBMP2 in CA1 hippocampal neurons, and electrophysiological studies revealed reduced long-term potentiation (LTP) in the hippocampus3. LTP
is dependent on intracellular Ca2+ transport and is thought to be the cellular equivalent of learning and memory4–6. Behavioral tests revealed that the nBMP2 mutant mice have impaired object recognition memory3.
Intracellular Ca2+ elevation also regulates the activation and differentiation of several different types of
immune cells including T cells, B cells, dendritic cells, and macrophages7–10. To see if nBmp2NLStm mutants had
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compromised immune response, mice were challenged by systemic infection with Staphylococcus aureus. While
the mutants’ immune response to a primary infection appeared normal, their immune response to a secondary
infection challenge 30 days later resulted in higher levels of bacteremia, increased mortality, and failure of spleens
to enlarge normally11. Although we did not observed differences in the total number of macrophages in spleen,
thymus, or lymph node from wild type compared to mutant mice, we did observe that after the secondary infection, spleen from nBmp2NLStm mutant mice showed fewer hemosiderin-laden macrophages than spleen from
wild type mice11. Macrophages in the spleen accumulate hemosiderin by phagocytosing damaged red blood cells
and hemoglobin, which would be present in the blood stream of S. aureus-challenged mice due to the hemolysins
that S. aureus expresses12–14. The observation of fewer hemosiderin-laden macrophages in the spleens of mutant
mice after a secondary infection suggested to us that macrophage phagocytic activity might be impaired in the
absence of nBMP2, potentially providing us with an accessible cell type in which to directly test our hypothesis
that intracellular Ca2+ response is disrupted in the absence of nBMP2.
To interrogate if nBMP2 might play a role in Ca2+ response, we isolated macrophages from wild type and
nBmp2NLStm mutant mice. These macrophages included bone marrow derived (BMD) macrophages from uninfected mice, and splenic macrophages from mice that had undergone primary and secondary infections with S.
aureus15. Live-cell Ca2+ imaging as well as bead engulfment assays were performed to measure intracellular Ca2+
response and phagocytic activity. These analyses revealed deficient Ca2+ response and phagocytosis in splenic
macrophages isolated from mutant mice after secondary systemic infection with S. aureus, but not in BMD macrophages from naïve mice, suggesting that as nBmp2NLStm mutant cells respond to infection over time, Ca2+
response is progressively impaired.

Results

The nuclear variant nBMP2 is expressed in BMD and splenic macrophages from wild type mice.

To determine whether nBMP2 is expressed in macrophages, BMD macrophages and splenic macrophages were
isolated from naïve (uninfected) wild type and nBmp2NLStm mutant mice and differentiated in vitro, and immunocytochemistry was performed using an anti-BMP2 antibody that binds to both BMP2 and nBMP2. Consistent
with our prior observation of impaired immune response in nBmp2NLStm mutant mice11, nBMP2 was detected
in the nuclei of wild type BMD (Fig. 1a) and splenic (Fig. 1b) macrophages. As expected, nBMP2 was significantly decreased in macrophage nuclei from nBmp2NLStm mutant mice (Fig. 1a,b, mutant). ImageJ software
quantification of immunofluorescence images showed that the density of nuclear BMP2 staining was significantly
more intense in wild type compared to mutant macrophages in both BMD macrophages (p = 0.0005) and splenic
macrophages (p < 0.0001) (Fig. 2). BMP2 staining was visible throughout the cytoplasm of both wild type and
mutant macrophages, as expected, given that nBMP2 is synthesized in the cytosol before being translocated to the
nucleus and that the conventional BMP2 growth factor is synthesized in the rough ER and translocated through
the Golgi before being secreted from the cell.

BMD macrophages from uninfected nBmp2NLStm mutant mice and wild type mice have similar
Ca2+ response. Naïve BMD macrophages isolated from femurs and tibias of uninfected mice were differen-

tiated and activated in vitro then plated for live-cell Ca2+ imaging. Plated cells were loaded with Fura-2AM, a
UV-excitable ratiometric calcium indicator that changes its excitation in response to Ca2+ binding; Fura-2AM
emits at 380 nm when Ca2+ is not bound, and at 340 nm when Ca2+ binds to the dye. The fluorescence ratio
(F340/F380), increases as cytosolic Ca2+ levels increase16. At the 2 min time point, supernatant from Escherichia
coli (ECS) cultures was added to stimulate Ca2+ flux (Fig. 3a)17–19. Following this stimulation, there were no
observable differences between naïve mutant and wild type BMD macrophages in peak Ca2+ response (Fig. 3b)
or sustained Ca2+ levels (Fig. 3c).

Splenic macrophages isolated from nBmp2NLStm mutant mice after secondary infection show
impaired Ca2+ response. In our prior study, immune deficiencies in nBMP2NLStm mice were detectable

only after the mice received a secondary infection with S. aureus11. Because our current experiments revealed no
significant differences in Ca2+ response in naïve BMD macrophages from mutant compared to wild type mice, we
decided to replicate the in vivo conditions of our previous work by examining splenic macrophage harvested from
mice after a secondary infection with S. aureus, and by using S. aureus supernatant as the stimulus to trigger Ca2+
flux11. Although S. aureus is a gram positive bacteria that does not produce LPS, it does produce liphoteichoic
acid (LTA), which is similarly able to activate macrophages20,21. Thirty-five days after primary systemic S. aureus
infections, mice were given a second injection of S. aureus, and splenic macrophages were isolated 3 days later.
After one week in vitro maturation, splenic macrophages were loaded with Fura-2AM for live-cell Ca2+
imaging experiments. S. aureus supernatant (SAS) was used to stimulate Ca2+ flux at the 2-min time point
(Fig. 4a). Compared to the lack of a difference in naïve BMD macrophages, it is particularly striking that peak
Ca2+ response was significantly decreased (p = 0.0335) in mutant splenic macrophages after secondary infection
(Fig. 4b). Sustained Ca2+ levels as measured by the area under the curve (AUC) from minutes 3–10 was also significantly decreased (p = 0.0008) (Fig. 4c).

BMD macrophages from uninfected nBmp2NLStm mutant mice and wild type mice show similar phagocytic activity. To test phagocytic activity of naïve BMD macrophages (meaning macrophages
that were isolated from uninfected mice) from nBmp2NLStm mutant compared to wild type mice, we measured
fluorescent bead engulfment by CD11b and F4/80 positive cells with flow cytometry (Fig. 5a)22–28. We observed
no differences in the phagocytic activity of naïve BMD macrophages from nBmp2NLStm mutant compared to wild
type mice (Fig. 5b–e).
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Figure 1. BMD macrophages and splenic macrophages express nBMP2, which is decreased in the nuclei of
nBmp2NLStm mutant macrophages. (a) BMD macrophages and (b) splenic macrophages were stained with
anti-BMP2 antibody (green) and counterstained with DAPI (blue), demonstrating that nBMP2 is expressed
and localized to the nucleus in wild type macrophages, and that nuclear translocation of nBMP2 is inhibited
in mutant macrophages. BMP2 labeling within the cytoplasm is present in both wild type and mutant cells as
expected, because the targeted mutation allows translation of nBMP2 in the cytoplasm but inhibits nuclear
translocation, and it allows normal synthesis and secretion of conventional BMP2.

Splenic macrophages from nBmp2NLStm mutant mice show impaired phagocytic activity. To

test phagocytic activity in macrophages isolated from mice after secondary infection, splenic macrophages were
isolated from wild type and nBmp2NLStm mutant mice 3 days after mice received a second systemic infection
with S. aureus, and fluorescent bead engulfment was measured as described above. While differences between
wild type and mutant macrophages did not reach significance when subgroups that engulfed 1, 2, or 3 or more
beads were analyzed individually (Fig. 6a–c), there was a significant reduction in overall mutant phagocytic activity (p = 0.0176) when the subgroups were pooled (Fig. 6d). These data suggest a possible relationship between the
decreased Ca2+ response and reduced phagocytosis in nBmp2NLStm mutant splenic macrophages.
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Figure 2. Quantification of nBMP2 nuclear staining intensity. Five images each were analyzed for wild
type and mutant BMD macrophages and for mutant splenic macrophages. Four images were analyzed for
wild type splenic macrophages. Each image contained between 10 and 93 cells, and the number of cells
analyzed per group ranged from 100 to 337. ImageJ was used to outline DAPI-stained regions and quantify
BMP2 immunostaining as the sum of pixel intensities within each nucleus. The mean density of BMP2
immunostaining was then calculated for all nuclei in an image. An unpaired, two-tailed t-test was performed
to compare nuclear staining between wild type and mutant cells. For BMD wild type vs. mutant macrophages,
p = 0.0005. For splenic wild type vs mutant macrophages, p < 0.0001.

Figure 3. Naïve bone marrow derived (BMD) macrophages from nBmp2NLStm mutant mice and wild type
mice have a similar Ca2+ response. Naïve BMD macrophages from wild type (WT) and nBmp2NLStm mutant
(MT) mice were loaded with Fura-2AM for live-cell Ca2+ imaging. During imaging, cells were stimulated at
2 min with E. coli supernatant (ECS), then at 10 min with ionomycin as a positive control. (a) Average curves
showing intracellular Ca2+ response in wild type and nBmp2NLStm mutant BMD macrophages. Fluorescence
ratios (F340/F380) were measured at 3 sec intervals from 0–12 min (n = 38 cells). Error bars (s.e.m.) are shown
at one min intervals. (b) Average (±s.e.m.) of peak Ca2+ influx (F340/F380) in wild type and nBmp2NLStm
mutant BMD macrophages (n = 38 cells). (c) Area under the curve (AUC) of F340/F380 ratios from minutes 3
to 10 min shows sustained intracellular Ca2+ levels (n = 38 cells). NS, not significant.
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Figure 4. Splenic macrophages collected from nBmp2NLStm mutant mice after secondary infection have an
impaired Ca2+ response. Splenic macrophages from wild type (WT) and nBmp2NLStm mutant (MT) mice were
loaded with Fura-2AM for live-cell Ca2+ imaging. During imaging, cells were stimulated at 2 min with S. aureus
supernatant (SAS), then at 10 min with ionomycin as a positive control. (a) Average curves showing intracellular
Ca2+ response in wild type and nBmp2NLStm mutant splenic macrophages. Fluorescence ratios (F340/
F380) were measured at 3 sec intervals from 0-12 min (n = 44 cells). Error bars (s.e.m.) are shown at one min
intervals. (b) Average ± s.e.m. of peak Ca2+ influx (F340/F380) in wild type and nBmp2NLStm mutant splenic
macrophages shows a significant difference (n = 44 cells). (c) AUC of F340/F380 ratios from minutes 3 to
10 min shows a significant difference in sustained intracellular Ca2+ levels (n = 44 cells). *p < 0.05, **p < 0.01,
***p < 0.0001.

Discussion

The role of BMP2 in macrophages is unknown and remains an area of active research. BMP2 has been reported to
be constitutively expressed in M1 (inflammatory) macrophages29. Other studies have shown that BMP2 expression is upregulated as macrophages shift toward the pro-healing/anti-inflammatory M2 phenotype30,31. BMP2
secretion by macrophages promotes migration of vascular smooth muscle cells, and macrophages in the intestinal
muscularis secrete BMP2 to signal enteric neurons32,33. Reports of BMP2 expression by hematopoietic cells, in
particular macrophages, are relevant to this study because nBMP2 can be produced from the same mRNA as
the conventional secreted BMP2 growth factor—any time BMP2 mRNA or BMP2 growth factor is detected, the
potential for nBMP2 synthesis exists1. Accordingly, we have demonstrated by immunofluorescence that both
BMD macrophages and splenic macrophages express the nuclear variant of BMP2, nBMP2, and that nBMP2 is
decreased in the nuclei of macrophages from nBmp2NLStm mutant mice.
Previously, we demonstrated that deficiency of nBMP2 in the nucleus impairs secondary immune response as
evidenced by diminished spleen enlargement, poor clearance of S. aureus from the bloodstream, and increased
mortality after secondary infection11. We have also shown that deficiency of nBMP2 in myonuclei is correlated
with slowed skeletal muscle relaxation after contraction, and deficiency of nBMP2 in the nuclei of hippocampal
neurons is correlated with learning/memory deficits2,3. Each of these phenotypes is consistent with deficiencies
in intracellular Ca2+ transport, but until now, no direct measurements of intracellular Ca2+ have been performed
in cells from nBmp2NLStm mutant mice. The discovery that macrophages express nBMP2 (Fig. 1) provided an
accessible cell type in which to directly address the question of whether nBMP2 plays a role in intracellular Ca2+
response.
We found that intracellular Ca2+ response was impaired in mutant splenic macrophages after secondary infection with S. aureus, but not in mutant BMD macrophages isolated from uninfected mice, even though both macrophage types expressed nBMP2. Recent work has revealed that innate immune cells can undergo memory-like
adaptive responses to increasing pathogen load, and the deficient Ca2+ response in splenic macrophages after secondary infection might represent a failure of those adaptive responses34,35. Alternatively, it may be that the effects
of nBMP2 deficiency in the nucleus are simply cumulative, causing a Ca2+-handling phenotype that becomes
progressively more severe as cells differentiate and mature. A progressive phenotype is consistent with our previously reported observation that hippocampal long-term potentiation (LTP) was normal in 3-week-old nBmp2NLStm mutant mice but deficient in 3-month-old mice3. Progressive impairment of intracellular Ca2+ response
has received attention recently as a potential mechanism for both brain and muscle aging36–38, suggesting that
nBMP2 dysfunction could contribute to premature aging or aging-related diseases.
Deficiency of nBMP2 in the nucleus also produced a significant decrease in the total phagocytic activity of
splenic macrophages from nBmp2NLStm mutant mice, suggesting that mutant cells may be less effective at clearing pathogens from the blood stream. This is consistent with prior studies suggesting that intracellular Ca2+
mobilization plays a role in macrophage phagocytic activity. For example, impaired Ca2+ response in macrophages from Trpm4(−/−) mutant mice led to decreased phagocytic activity, resulting in bacterial overgrowth
and translocation to the bloodstream39. Intracellular Ca2+ levels increase during Fcɣ receptor (FcR)-mediated
phagocytosis40–42, and the loss of CaMKK2, a calcium-dependent kinase, left macrophages unable to phagocytose
bacteria or synthesize cytokines in response to bacterial lipopolysaccharide (LPS)43.
Although evidence supports the involvement of Ca2+ response in macrophage phagocytic activity, the scale
of the decreased phagocytosis by splenic macrophages observed in our study seems insufficient to account for
the markedly increased mortality of nBmp2NLStm mutant mice after secondary infection3. We cannot rule out
the possibility that the bead engulfment assay did not fully reflect the severity of phagocytosis impairment in
splenic macrophages. Liver macrophages also play a role in bacterial clearance, and it is possible that the absence
of nBMP2 in the nucleus affects their function more severely44,45. In addition, the absence of nBMP2 in the
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Figure 5. Naïve bone marrow derived (BMD) macrophages from nBmp2NLStm mutant mice and wild type
mice show similar phagocytic activity. After incubation with fluorescent microspheres, macrophages were
analyzed by flow cytometry. (a) A representative analysis is shown. The F4/80 and CD11b double positive
population was selected, and from this gate a histogram was produced to identify macrophages that had
engulfed 1, 2, or 3 or more beads. The percentages of total double positive cells represented within each peak
are indicated. (b) Percent of cells engulfing 1 bead, (c) percent of cells engulfing 2 beads, and (d) percent of cells
engulfing 3 or more beads. (e) Percent of cells engulfing one or more beads. N = 3 pairs of wild type and 3 pairs
of mutant mice. NS, not significant.
nucleus might affect other immune system cell types besides macrophages, and it is possible that another cell
type, or perhaps several cell types together, account for the increased mortality of nBmp2NLStm mutant mice after
secondary infection3. Indeed, BMP2 (and therefore potentially nBMP2) is expressed by a specialized endothelial
population in the early embryo, termed hemogenic endothelium, that gives rise to hematopoietic stem cells46.
The absence of nBMP2 at the earliest stages of hemogenesis could therefore impact a wide range of immune cell
types. BMP2 is also expressed in human cord blood cells, including those that express CD34, a hematopoietic
progenitor cell antigen47, and acute bleeding triggers upregulation of BMP2 expression in hematopoietic stem
cells48. BMP2 expression is also found in mature B cells, where it is upregulated in response to infection with
Aggregatibacter actinomycetemcomitans49. It is possible, therefore, that nBMP2 impacts the activation or function
of other immune cell types in addition to macrophages, and the combined functional deficits account for the
increased mortality in nBmp2NLStm mutant mice after secondary infection.
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Figure 6. Splenic macrophages collected from nBmp2NLStm mutant mice after secondary infection show
impaired engulfment activity. After incubation with fluorescent microspheres, macrophages were analyzed by
flow cytometry as described in Fig. 3. (a) Percent of cells engulfing 1 bead, (b) percent of cells engulfing 2 beads
and, (c) percent of cells engulfing 3 or more beads. (d) Percent of cells engulfing one or more beads. N = 3 pairs
of wild type and 3 pairs of mutant mice. NS, not significant. *p < 0.05.

It will be important, in future work, to elucidate the molecular mechanisms underlying the Ca2+ response
differences between macrophages from wild type and nBMP2 mutant mice. Differences may stem from impaired
uptake or release of Ca2+ from endoplasmic reticulum stores, as suggested by the decreased SERCA activity
observed in skeletal muscle of nBMP2 mutant mice2. Alternatively, transport of Ca2+ could be impaired at the
macrophage cell membrane, consistent with observations that increasing extracellular Ca2+ levels can improve
phagocytosis50,51. Neurons and muscle cells are excitable cells and are therefore equipped with a different set of
ion channels and transporters than are macrophages, and so it will be important to examine molecular details
of the Ca2+ handling defect in all three cell types. This work has thus opened the way for future studies into the
molecular interactions and activities of nBMP2.
Questions about how nBMP2 functions from inside the nucleus to affect Ca2+ response also remain to be
answered. The novel protein nBMP2 was first identified from among nuclear proteins that had been isolated using
DNA affinity chromatography, but subsequent experiments failed to show direct binding of nBMP2 to DNA, and
the amino acid sequence of nBMP2 contains no predicted DNA-binding domain1. It is possible that nBMP2 interacts indirectly with DNA through a transcription factor, and future studies of nBMP2’s impact on the expression
of genes involved in Ca2+ signaling will be informative.
In summary, this study supports our working hypothesis that aberrant intracellular Ca2+ response is the
mechanism that unites the otherwise disparate muscle, neurological, and immune phenotypes observed in
nBmp2NLStm mutant mice2,3,11,52–54. In doing so, this study has paved the way for future work to elucidate the precise molecular nature of the Ca2+ signaling disruptions in nBMP2 mutant cells and to understand how nBMP2’s
interactions in the nucleus impact Ca2+ signaling.

Materials and Methods
Research Animals.

This study was carried out in strict accordance with recommendations in the Guide for
the Care and Use of Laboratory Animals55. The protocol was approved by the Institutional Animal Care and Use
Committee (IACUC) of Brigham Young University (protocol numbers 15-0107 and 15-0603).
Mice were housed in a temperature-controlled (21–22 °C) room with a 12:12 hr light-dark cycle and fed standard rodent chow and water ad libitum. The nBmp2NLStm mice were constructed on a Bl6/129 background, as
described2. The homozygous wild type and mutant mice used in this study were obtained by breeding heterozygotes, and genotyping was performed as previously described3. All experiments were performed with male mice
at least 6 months of age.
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BMD and Splenic Macrophage Isolation.

BMD macrophages were obtained from femurs and tibias of
wild type and nBmp2NLStm mutant mice and were differentiated in culture at 37 °C with 5% CO2 for 7 days in
macrophage medium (DMEM (HyClone), 10% fetal bovine serum (FBS) (HyClone), 20% supernatant from L929
mouse fibroblast as a source of macrophage colony-stimulating factor (M-CSF), 5% heat inactivated horse serum
(Sigma), 1 mM sodium pyruvate (Gibco by Life Technologies), 1.5 mM L-glutamine (Thermofisher), 10 u/ml
penicillin, 10 μg/ml streptomycin (Gibco by Life Technologies)) prior to plating for immunocytochemistry, Ca2+
imaging or engulfment assays.
Spleens from wild type and nBmp2NLStm mutant mice were homogenized in phosphate buffered saline (PBS).
The homogenate was filtered, pelleted at 450 × g for 5 min, suspended in lysis buffer (155 mM NH2Cl, 10 mM
KHCO3, 0.1 mM EDTA) on ice for 3–5 min to lyse erythrocytes, and then washed with 37 °C macrophage media
and plated in macrophage medium in 6-well plates. After 3 days of culture at 37 °C in 5% CO2, medium was
replaced to remove non-adherent cells56. On day 4, 100 ng/ml lipopolysaccharide (LPS) was added to the culture
medium to stimulate differentiation, and cells were incubated for 3–4 more days57. Differentiated cells were then
plated for immunocytochemistry, Ca2+ imaging, or engulfment assays.

Immunocytochemistry.

Immunocytochemistry was performed using BMD and splenic macrophages.
Following macrophage isolation and 7-day differentiation as described above, cells were plated on coverslips
that were pre-treated with 0.025% HCl in PBS for 20 min to facilitate cell attachment. Cells were cultured for 1–2
days to reach 70–90% confluence, then fixed at 37 °C in 4% paraformaldehyde for 10 min. Epitopes were exposed
through antigen retrieval using 5% sodium citrate and 0.25% Tween-20 in ddH2O, pH 6.0, at 95 °C for 10 min.
Cells were permeabilized using 0.1% Triton X-100 then blocked for 1.5 hr at room temperature (RT) using SEA
BLOCK blocking buffer (ThermoFisher Scientific, 37527). The samples were then probed with 1:50 anti-BMP2
antibody (Novus Biologicals, NBP1-19751) diluted in 10% SEA BLOCK blocking buffer in 0.1% Tween-20/PBS
(PBS-T), overnight at 4 °C. The probed slides were then stained with anti-rabbit Alexa Fluor 488 (ThermoFisher
Scientific, A-11034) for 1 hr at RT. Afterwards, nuclei were stained by incubating the slides in 1:5000 DAPI in
PBS-T for 15 min., then slides were mounted using ProlongTM Gold Antifade Mountant (Life Technologies,
P10144) and cured overnight prior to microscopic imaging. Cells were imaged using a Leica TCS-SP8 confocal
microscope with 63X magnification, using the same laser intensities for all samples. Appropriate laser lines were
used such as 405 nm for DAPI and 488 nm for BMP2-Alexa Fluor 488.
Comparison of nuclear BMP2 staining intensity between wild type and mutant cells was performed on tiff
versions of confocal microscope images using ImageJ to create tracings of DAPI-stained regions and to calculate
the mean pixel intensity of nBMP2 staining within each nucleus. Mean nuclear staining intensity was calculated
for each image, and groups were compared using an unpaired, two-tailed t-test in GraphPad Prism.

S. aureus Bacterial Infections. S. aureus ATCC strain 12600 was cultured in tryptic soy broth liquid culture alternating with standard streak plating on mannitol salt agar (Thermo Fisher Scientific) for counting. To
prepare bacteria for injections, 100 µl of overnight liquid culture was transferred into a new 15 ml broth culture
and grown until OD600 reached 1.0, then pelleted and resuspended in 15 ml of PBS with 20% glycerol, aliquoted,
and stored at −80 °C for 3 weeks before injection. Frozen stock concentration was verified one day before the
infection by thawing a single aliquot and performing standard serial dilution plate counts. On the day of infection, S. aureus was diluted from the frozen stock to the desired concentration in PBS, and mice received a 200 μl
retroorbital injection using a 1 ml syringe and 27-gauge needle. The injected volume contained a priming dose
of 1 × 104 CFU/g body weight on day 0 (primary infection), and a dose of 3 × 105 CFU/g body weight on day 35
(secondary infection). Macrophages were harvested three days later.
Bacterial Supernatant Preparation. Bacterial supernatant obtained from E. coli K12 and S. aureus 12600
was used to stimulate Ca2+ fluxes in BMD and splenic macrophages19,58. A single colony was picked from an agar
plate and inoculated into liquid broth overnight culture. The next day, 1 ml of the overnight culture was inoculated into 15 ml liquid broth and incubated with shaking at 37 °C until culture reach an OD600 of 1–1.3. Cells were
then pelleted by centrifugation at 1,800 × g for 12 min at 4 °C, and supernatant was collected.
Calcium Imaging.

BMD and splenic macrophages were isolated and differentiated in culture for 7 days as
described above, then seeded on 8-chambered coverglasses (Nunc 155411, Thermo Scientific) and incubated
overnight in macrophage medium at 37 °C in 5% CO2. For BMD macrophages, 10 ng/ml LPS from E. coli O55:B5
(Sigma) was included in the overnight incubation to activate cells. The next day, cells were loaded with 3 μM
Fura-2AM (Invitrogen) in Ringers solution containing Ca2+ to be used as an extracellular source during the
Ca2+ imaging assay (150 mM NaCl, 10 mM glucose, 5 mM HEPES, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, pH
7.4) for 30 min at 37 °C in 5% CO2, washed with Ringers solution, then incubated for another 30 minutes at 37 °C
in Ringers solution. Calcium imaging was performed at room temperature using an Olympus IX51 inverted
microscope equipped with a xenon arc lamp. Fura-2AM loaded macrophages were excited using 340 nm and
380 nm excitation filters, and images of 340 nm, 380 nm, and transmitted light were capture using a florescence
microscope camera (Q Imaging Exi Blue) with a 20x objective (N.A. 0.75) at 3-sec intervals. At the 2-min time
point in each imaging protocol, 20 μl of bacterial supernatant was added to stimulate Ca2+ flux. Ionomycin (1
μM final concentration) was added at the 10-min time point as a positive control. 10–20 representative cells were
selected as regions of interest in each frame, and F340:F380 ratios were calculated and analyzed using CellSens
software from Olympus. Each individual cell’s fluorescence was normalized to its first recorded value according
to the equation (F-Fo)/Fo, where F is the fluorescence at the specific time point, and Fo is the fluorescence value
at time 019,59.
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Engulfment Assay. BMD and splenic macrophages were isolated and differentiated in culture for 7 days as
described above, then seeded in 12-well culture plates for flow cytometry-based engulfment assays22–28. 100% FBS
was used to resuspend 2.0 μm phycoerythrin-conjugated polychromatic red latex microspheres (Polysciences,
Inc.) to prevent beads from sticking to the cell membranes during engulfment23. The ~109 particles/ml concentration was chosen to ensure that beads were not a limiting factor in phagocytosis rates23. Macrophages were then
activated by adding LPS from E. coli O55:B5 (Sigma) to a final concentration of 10 ng/ml and incubated for 1 hour
at 37 °C and 5% CO2. Media was removed and cells were rinsed with cold PBS, then collected and analyzed by
flow cytometry using an Attune flow cytometer (Applied Biosystems by Life technologies). Cells were pre-treated
with anti-CD16/32 antibodies (14-0161-85 eBioscience) to prevent non-specific antibody binding, then surface
stained with APC-conjugated anti-CD11b antibodies (17-0112-82 eBioscience) and FITC-conjugated anti-F4/80
antibodies (11-4801-82 eBioscience). Doublets were removed based on forward scatter width (FSC-W)/forward
scatter area (FSC-A), and the F4/80 and CD11b double positive population was selected. From within this gate,
engulfing macrophages were distinguished from non-engulfing macrophages based on phycoerythrin fluorescence, and macrophages could be further distinguished based on the engulfment of one, two, or three or more
beads. Results were analyzed using FlowJo software (Tree Star).
Data Analysis. All assays were performed as at least three independent repeats, each in triplicate. Area under
the curve (AUC) was determined using GraphPad Prism. Statistical significance was assessed using unpaired
two-tailed Students T test in GraphPad Prism.

Data Availability

All data generated or analyzed during this study are included in this published article. Biological reagents will be
made available on request.
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Abstract
Flavonoids are dietary compounds with potential anti-diabetes activities. Many flavonoids have poor bioavailability and thus low circulating concentrations.
Unabsorbed flavonoids are metabolized by the gut microbiota to smaller metabolites, which are more bioavailable than their precursors. The activities of these
metabolites may be partly responsible for associations between flavonoids and health. However, these activities remain poorly understood. We investigated
bioactivities of flavonoid microbial metabolites [hippuric acid (HA), homovanillic acid (HVA), and 5-phenylvaleric acid (5PVA)] in primary skeletal muscle and β-cells
compared to a native flavonoid [(−)-epicatechin, EC]. In muscle, EC was the most potent stimulator of glucose oxidation, while 5PVA and HA simulated glucose
metabolism at 25 μM, and all compounds preserved mitochondrial function after insult. However, EC and the metabolites did not uncouple mitochonndrial respiration,
with the exception of 5PVA at10 μM. In β-cells, all metabolites more potently enhanced glucose-stimulated insulin secretion (GSIS) compared to EC. Unlike EC,
the metabolites appear to enhance GSIS without enhancing β-cell mitochondrial respiration or increasing expression of mitochondrial electron transport
chain components, and with varying effects on β-cell insulin content. The present results demonstrate the activities of flavonoid microbial metabolites for preservation
of β-cell function and glucose utilization. Additionally, our data suggest that metabolites and native compounds may act by distinct mechanisms, suggesting
complementary and synergistic activities in vivo which warrant further investigation. This raises the intriguing prospect that bioavailability of native dietary flavonoids
may not be as critical of a limiting factor to bioactivity as previously thought.
© 2018 Elsevier Inc. All rights reserved.
Keywords: Hippuric acid; Homovanillic acid; 5-Phenylvaleric acid; (−)-Epicatechin; Insulin; Respiration
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Incidence rates of type-2 diabetes and obesity are rising worldwide. In addition to traditional medical interventions, complementary
lifestyle strategies such as diet and exercise are needed to blunt this
epidemic. Flavonoids from cocoa, fruit, tea and other sources have
been identiﬁed as dietary bioactive compounds with potential antiobesity and anti-diabetes activities. Many of these ﬂavonoids, such as
quercetin [1] and procyanidins [2], have poor oral bioavailability and
thus low circulating concentrations. Non-extractable/bound ﬂavonoids (from cocoa, etc.) and oxidized ﬂavonoids, such as theaﬂavins
and thearubigins from oolong and black teas, have extremely limited
oral bioavailability [3,4] and vanishing low circulating concentrations.
As an extreme example, consumption of 700 mg theaﬂavins
(equivalent to~30 cups of black tea), produced maximal blood
concentrations of only 1 μg/L (~1.8 nM) in humans [3]. Therefore,
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Fig. 1. (A) Schematic showing representative sequential metabolism of representative ﬂavonoids [a dimeric procyanidin, and (−)-epicatechin monomer] by the gut microbiota. (B)
Structures of (−)-epicatechin and the three representative ﬂavonoid microbial metabolites employed in this present study.

circulating concentrations of the native species may represent a very
small fraction of the ingested dose, whereas the majority reaches the
colon unabsorbed. Unabsorbed ﬂavonoids are extensively metabolized by the gut microbiota to a series of smaller metabolites such as
valerolactones, phenylalkyl acids, and smaller aromatics (Fig. 1A)
[4–9]. While some metabolites are unique to individual ﬂavonoid
compounds or subclasses, dozens of metabolites are common to most
ﬂavonoids [10,11]. These metabolites are comparatively more bioavailable than their native ﬂavonoid precursors, and in many cases
represent the predominant circulating forms following ﬂavonoid
consumption [10]. For example, a recent study of pharmacokinetics
following consumption of grape pomace demonstrated that anthocyanins and procyanidins were not detected in blood and catechins and
their phase-II conjugates exhibited maximum blood levels of 7–136
nM (with only 1 compound reaching at least 100 nM), while microbial
metabolites exhibited maximum blood levels of 3–1170 nM (with 8
compounds reaching at least 100 nM) [12]. In an extreme example,
consumption of 6 cups of green or black tea resulted in circulating
metabolite levels in the mM range (hippuric acid, HA, reached 2.3
mM) [13]. This highlights the comparative importance of these
metabolites as potential bioactives in circulation following the
consumption of ﬂavonoids.
Even ﬂavonoids with comparatively high bioavailability (monomeric catechins, etc.) are only present in the bloodstream at nM to
very low μM levels following consumption of typical doses in foods
and supplements [14,15]. These doses are generally lower than the
range of concentrations typically used to study mechanisms in cell
culture models (1–100 μM, or sometimes higher). Despite poor
bioavailability and low circulating concentrations, many of these
compounds (and foods rich in them) appear to effectively prevent or
ameliorate metabolic syndrome even at low dietary doses in animals
[16] and humans [17]. Dietary efﬁcacy, despite poor bioavailability
and/or low circulating concentrations of the native forms, suggests
three mechanisms by which ingested ﬂavonoids exert their activities:
(1) native ﬂavonoids primarily exert their activities in the gut lumen

(inhibition of digestive enzymes, alteration of microbiome composition and function, etc.) [18,19] and/or epithelium (improving barrier
function, immune development, etc.) [20] where they are at highest
concentrations (μM-mM range), (2) native ﬂavonoids primarily exert
their activity in peripheral tissues even at the very low (pM-low μM
range) circulating levels achieved, or (3) microbial metabolites of
ﬂavonoids generated by commensal microbiota in the lower gut exert
activities locally in the gut and systemically [21,22].
Considering the relatively high concentrations of microbial
metabolites documented in plasma compared to the native compounds, it is plausible that these metabolites may be responsible, at
least in part, for observed associations between dietary ﬂavonoids and
health outcomes. While all of the three possible scenarios identiﬁed
above likely occur simultaneously, the potential anti-diabetic and
anti-obesity activities of microbial metabolites formed from unabsorbed ﬂavonoids remain poorly understood.
Recent provocative evidence has strengthened the argument that
native ﬂavonoids may exert their effects independent of systemic
bioavailability: either directly on the microbiota, or by formation of
bioavailable microbial metabolites that then act in peripheral tissues
[23]. In vitro, 3-(3-hydroxyphenyl)propionoic acid (a microbial
metabolite common to many ﬂavonoids) prevented loss of insulinstimulated nitric oxide synthesis and activity under high glucose
concentrations in human aortic endothelial cells [24]. In human
skeletal muscle myotubes, various microbial metabolites stimulated
glucose and oleic acid uptake [25]. Recent studies demonstrated that
phenylacetic and phenylpropionic acid have protective activities in
pancreatic β-cells and islets [26,27] and protect hepatocytes from
acetaminophen injury [28]. Two recent studies demonstrated that
valerolactones inhibited monocyte adhesion to endothelial cells [29].
A key animal study demonstrated that administration of antibiotics
(depletion of gut microbiota and their associated metabolites)
abolished the ability of procyanidin-rich grape seed extract to prevent
inﬂammation, insulin resistance, hyperglycemia and weight gain in a
high-fat feeding mouse model [30]. Furthermore, antibiotic
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administration reversed the ability of blackcurrant anthocyanins to
ameliorate diet-induced obesity in mice [31]. Finally, digestion and
microbial metabolism of berry ﬂavonoids did not diminish their
protective activities against colon cancer [32]. While the in vivo
studies did not measure metabolite production, they strongly suggest
that these effects are mediated by the microbiota and/or their
metabolites produced from the native dietary ﬂavonoids. Perhaps
the most well-known microbial metabolites, the phenylalkyl acids
(phenylacetic, phenyl propionic, and phenylvaleric acids) have not
been well studied, and the phenylvaleric acids have not been studied
at all to our knowledge. Some compounds that are microbial
metabolites have been studied, but only because they also exist as
native compounds in foods, such as the cinnamic acids and small
aromatics such as vanillic acid. These compounds have been shown to
possess anti-diabetic and anti-obesity activities in β-cell, skeletal
muscle, hepatocyte and adipose models (see Supplementary Information). Finally, some microbial metabolites of ﬂavonoids have been
shown to possess enhanced anti-tumor and anti-platelet aggregation
activities compared to the native forms [33].
Despite these promising ﬁndings, relatively little work has been
done to characterize the effects of these metabolites in cell or animal
models, in comparison to the exhaustive body of literature on the
bioactivities of native ﬂavonoids. The majority of research that does
exist on these metabolites has focused on their formation, but not their
activities nor mechanisms of action. Our objectives were therefore to
1) investigate the anti-diabetic activities of microbial ﬂavonoid
metabolites (including a poorly-studied class, phenylvaleric acids) in
β-cells and primary skeletal muscle cells, 2) compare these activities
to those of a control native ﬂavonoid, and 3) suggest potential
mechanisms by which these activities may occur. Our ﬁndings
demonstrate that these metabolites possess potent bioactivities, and
may contribute to the observed peripheral tissue effects of dietary
ﬂavonoids.
2. Materials and methods
2.1. Materials
Three representative metabolites representative of three distinct classes of
metabolites common to a variety of dietary ﬂavonoids were selected for investigation:
hippuric acid (HA, 98%), homovanillic acid (HVA), and 5-phenylvaleric acid (5PVA, 99%)
were obtained from Sigma (St. Louis, MO). A native ﬂavanol, (−)-epicatechin (EC,
Sigma), was used as a positive control; note that the three selected metabolites can be
obtained by metabolism of EC and related compounds [9]. Structures of these
compounds are shown in Fig. 1B. All compounds were tested over a range of 0–100
μM (depending upon the speciﬁc assay) in water or DMSO, with equal ﬁnal
concentrations of DMSO in cell media for all treatments. Generally, doses of 5–25 μM
were employed, which are easily obtainable in circulation for metabolites but which
represent the extreme upper end of what is attainable for native ﬂavonoids [13,34].
Microbial metabolites, similar to those of native ﬂavonoids, exhibit pharmacokinetic
curves that depend on a variety of factors and circulating concentrations necessarily
ﬂuctuate over time based on consumption frequency. The levels employed herein are
attainable following ﬂavonoid consumption but are not continuously present, similar to
those of native dietary ﬂavonoids. Furthermore, while compounds and doses were
uniform across experiments, differences in some aspects (treatment times, etc.) were
necessary due to the use of established, robust experimental protocols for each
model system.
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experiments were performed on day 7 of differentiation following overnight serum
deprivation. The compounds tested were treated for 24 h prior to assessment of
substrate metabolism. Fatty acid oxidation was assessed by measuring and summing
14
CO2 production (complete) and 14C-labeled acid-soluble metabolites (incomplete)
from the oxidation of [1-14C] palmitic acid (American Radiolabeled Chemicals, St. Louis,
MO, USA). Brieﬂy, cells were incubated in media containing radiolabeled substrate
along with the compound at 5 or 10 μM, or vehicle only (0 μM, 0.1% DMSO) for 3 h at 37
°C, 5% CO2. Following incubation media was removed and acidiﬁed with 45% perchloric
acid to elute gaseous 14CO2. 14CO2 was trapped in 1 M NaOH over the course of 1 h. The
NaOH was then placed in a liquid scintillation counter and counted. Data were
expressed as means±S.E.M. and is normalized to total protein content. Glucose
oxidation was assessed by measuring 14CO2 production from the oxidation of [U-14C]
glucose (American Radiolabeled Chemicals, St. Louis, MO, USA) in a manner similar to
fatty acid oxidation expect for the substitution of glucose in place of palmitic acid.
Compounds were tested at 10 and 25 μM.
2.2.2. Skeletal muscle cell respiration
Oxygen consumption rate (OCR) was measured with our established protocols [37]
using a XF96 Seahorse Extracellular Flux Analyzer (Agilent Technologies, Santa Clara,
CA, USA). C2C12 myoblast studies are commonly used by our groups as a fast and
practical model to screen for compound efﬁcacy. Because differentiating cells into
myotubes takes 7 days continuously in the SeaHorse plate, we utilized the myoblasts as
a more feasible approach. Cultured C2C12 muscle cells were seeded at a density of
1.5×104 per well in supplemented DMEM media [4.5 g/L D-Glucose, L-Glutamine, and
110 mg/L Sodium Pyruvate supplemented with 10% Fetal Bovine Serum (FBS) and 1%
Penicillin Streptomycin (PSA)] on a Seahorse XF96 Cell Culture Microplate. Cells were
then incubated overnight at 37 °C in 5% CO2 to allow for adherence. Following
adherence, cells were pretreated for 4 h with 10% FBS/1% PSA DMEM containing the test
compounds (5 and 10 μM) or vehicle only (≤0.1% DMSO). After the 4-h pretreatment,
500 μM H2O2 was added to injure the cells, and the microplate was subsequently
incubated for an additional 4 h. Following incubation, the cells were washed with
supplemented XF media (XF base media plus 1 mM pyruvate, 2 mM glutamine, 10 mM
glucose) twice before adding a ﬁnal volume of 180 μL per well. A XF Cell Mitochondrial
Stress Test was completed to assess the bioenergetic status of the cells by injecting ATP
synthase inhibitor oligomycin (1 μg/mL), inner membrane uncoupler ﬂuorocarbonyl
cyanide (FCCP, 2 μM), and complex III inhibitor antimycin A (2 μM). Oxygen
consumption rate data were normalized by subtracting non-mitochondrial rates of
respiration (after antimycin A), and are expressed as pmol O2 per minute per 1.5 x 104
cells. Mitochondrial coupling efﬁciency was calculated by taking the ATP-dependent
respiration (baseline-oligomycin) and dividing by the basal rates for internal
normalization.
2.3. β-Cell experiments
β-cell metabolism experiments were conducted per previously published methods,
with modiﬁcations [38,39].
2.3.1. INS-1832/13 β-cell culture
Cell culture was performed per our established protocols [40–44]. The INS-1
derived 832/13 rat β-cell line was maintained in complete RPMI 1640 medium with Lglutamine and 11.2 mM glucose supplemented with 50 U/ml penicillin, 50 μg/ml
streptomycin, 10 mM HEPES, 10% fetal bovine serum, and INS-1 supplement, as
previously described. For all glucose-stimulated insulin secretion and respiration assays
using the 832/13 β-cells, cells were plated at 0 h, treated with test compounds at 24 h,
and harvested at 48 h. Stock solutions of test compounds were made at 100 mM, and
diluted in media for assays at ﬁnal concentrations of 0–100 μM (0.1% DMSO in all
treatments).

Skeletal muscle metabolism experiments were conducted per previously published
methods [35,36], with modiﬁcations. Primary human muscle cells were cultured for
measuring palmitate and glucose oxidation. Cultures of primary human muscle cells
were obtained from a singler subject who provided written informed consent under an
approved protocol by Virginia Polytechnic Institute and State University Institutional
Review Board (approval #11–770). The subject was a healthy Caucasian male, age 22
years, with a BMI of 23.6 and 20.9% body fat.

2.3.2. Glucose-stimulated insulin secretion
Glucose-stimulated insulin secretion (GSIS) was performed as previously described
[40]. Brieﬂy, INS-1832/13 β-cells were plated and grown to conﬂuency in standard 24well plates. Upon reaching conﬂuency, cells were cultured with test compounds at
0–100 μM in complete media for 24 h. Following the 24 h treatment, cells were washed
with PBS and preincubated in secretion assay buffer (SAB) for 1.5 h (114 mM NaCl,
4.7 mM KCl, 1.2 mM KH2PO4 1.16 mM MgSO4, 20 mM HEPES, 2.5 mM CaCl2, 0.2% BSA, pH
7.2) containing 2.5 mM glucose. GSIS was performed by incubating quadruplicate
replicate wells of cells previously cultured with test compounds in SAB containing 2.5
mM glucose for 1 h (basal), followed by 1 h in SAB with 16.7 mM glucose (glucose
stimulation), followed by collection of the respective buffers, as previously described.
For total insulin content, β-cells stimulated with 16.7 mM glucose for 1 h were lysed in
RIPA buffer with protease inhibitors (Life Technologies). Secreted insulin and total
insulin was measured in SAB using a rat insulin RIA kit (MP Biomedicals), and
normalized to total cellular protein concentration (determined by BCA assay), as
previously described.

2.2.1. Skeletal muscle substrate metabolism
Cells were grown in low glucose DMEM supplemented with 10% fetal bovine serum
and SkGM SingleQuots (Lonza, Walkersville, MD, USA). Upon reaching~80% conﬂuence
in standard 12-well plates, cells were differentiated for 7 days in 2% horse serum. All

2.3.3. INS-1832/13 β-cell oxygen consumption rate
Oxygen consumption rate (OCR) was measured using an XFp Extracellular Flux
Analyzer (Agilent Technologies). INS-1832/13 β-cells were seeded at 2.0 x 104 cells/well
in complete 832/13 RPMI 1640 medium (L-glutamine, 11.2 mM glucose supplemented,

2.2. Skeletal muscle experiments
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Fig. 2. Fatty acid oxidation in primary human skeletal muscle cells treated with either hippuric acid, homovanillic acid, 5-phenylvaleric acid, or epicatechin. Complete oxidation
represents evolution of 14CO2 from 14C-labeled palmitate. Incomplete oxidation represents production of 14C-labeled acid-soluble metabolites (ASMs) from 14C-labeled palmitate. Total
oxidation represents the sum of complete and incomplete oxidation. Values represent mean±S.E.M. from n=4 replicates, normalized to vehicle (vehicle expressed as 1). Data were
analyzed by one-way ANOVA. If a signiﬁcant treatment effect was detected, Dunnett's post hoc test was performed within each compound to compare each dose to the vehicle control.
Signiﬁcance vs. vehicle control is indicated by: *P ≤ 0.05, **P ≤ 0.01.

50 U/ml penicillin, 50 μg/ml streptomycin, 10 mM HEPES, 10% fetal bovine serum, and
INS-1 supplement) on a Seahorse XFp Cell Culture Microplate. Cells were incubated
overnight and then treated with test compounds at 10 μM, 5 μM or 0 μM in complete
RPMI 1640 media. Following 24 h of culture with the compounds, cells were incubated
in 2.5 mM glucose SAB for 3 h. Following incubation, buffer was exchanged for 180 μL
fresh pre-warmed 2.5 mM glucose SAB per well. A XF Cell Mitochondrial Stress Test was
completed to assess the bioenergetic status of the cells by injecting glucose (16.7 mM, in
order to examine respiration under glucose stimulation), oligomycin (4 μM), FCCP (2.5
μM), and antimycin A with rotenone (2.5 μM). Residual oxygen consumption was
determined following inhibition of complex III with the addition of rotenone and
antimycin A. This state of residual oxygen consumption served as a baseline correction
for all of the other states. All data were normalized to protein content of each well,
determined by BCA assay.
2.3.4. Western blotting
832/13 beta cells were plated in standard 6-welll plates, grown to conﬂuency, and
cultured overnight in media containing each test compound at 10 μM or vehicle control
(0.1% DMSO in both). Cells were washed in PBS and harvested in RIPA buffer followed by
sonication. Protein concentration was quantiﬁed by BCA, and 30 μg was run per sample.
Western blotting and transfer was performed as previously described [38,40,41]. Blot
were probed using the Anti Rt/Ms. Total OxPhos Complex Kit (1:250, Life Technologies,
Carlsbad, CA) which contains a cocktail of antibodies for the electron transport chain
(ETC) components ATP5A (Complex V), UQCR2 (Complex III), MTCO1 (Complex IV),
SDHB (Complex II) and NDUFB8 (Complex I). Blot was imaged in the linear range using a
LI-COR Odyssey CLx (LI-COR Biotechnology, Lincoln, NE). Blotting was performed on
triplicate samples.
2.4. Statistics
All results are expressed as mean±S.E.M. For activity assays, data were analyzed by
1- or 2-way ANOVA as appropriate. For 2-way ANOVAs, if a signiﬁcant main effect of
treatment compound dose was detected, Dunnett's post hoc test was performed within
the high-glucose treatments to compare each dose to the vehicle (0 μM) control. For
one-way ANOVAs, if a signiﬁcant treatment effect was detected, Dunnett's post hoc test

was performed within each compound to compare each dose to the vehicle controls.
Signiﬁcance was deﬁned a priori as Pb.05. Statistical analyses were performed on Prism
v6.0f (GraphPad, La Jolla, CA).

3. Results and discussion
3.1. Skeletal muscle
3.1.1. Skeletal muscle metabolism
The ability of EC (+ control, native ﬂavonoid) and three
representative metabolites (HA, HVA and 5PVA) to inﬂuence fatty
acid or glucose uptake and metabolism was examined in primary
human skeletal muscle cells. As shown in Fig. 2, these compounds
exhibited minimal ability to alter fatty acid oxidation. The only
statistically signiﬁcant ﬁndings were that HA was able to increase
complete fatty acid oxidation at 25 μM (Fig. 2D) and increase the ratio
of complete:incomplete oxidation at 10 μM (Fig. 2P). While these
results suggest that HA has more potent activities than EC, overall the
enhancement of fatty acid oxidation does not seem to be a signiﬁcant
mechanism of action for these metabolites. These results suggest that,
despite a reported ﬁnding that metabolites increased oleic acid uptake
in human skeletal muscle myotubes [25], alteration of fatty acid
oxidation in skeletal muscle may not be a primary mechanism by
which ﬂavonoid microbial metabolites exert anti-diabetic and antiobesity activities.
Glucose oxidation results (Fig. 3) were more promising than fatty
acid oxidation. EC appeared to be the most potent stimulator of
glucose utilization, increasing activity at both 10 and 25 μM (Fig. 3A).
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Fig. 3. Glucose oxidation in primary human skeletal muscle cells treated with either hippuric acid, homovanillic acid, 5-phenylvaleric acid, or epicatechin. Oxidation represents evolution
of 14CO2 from 14C-labeled glucose. Values represent mean±S.E.M. from n=4 replicates, normalized to vehicle (vehicle expressed as 1). Data were analyzed by one-way ANOVA. If a
signiﬁcant treatment effect was detected, Dunnett's post hoc test was performed within each compound to compare each dose to the vehicle control. Signiﬁcance vs. vehicle control is
indicated by: *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001.

While HVA had no apparent activity, both 5PVA and HA were able to
simulate glucose metabolism at 25 μM (Fig. 3B-D). While the EC
activity at lower concentrations suggests that it is more potent than
the metabolites on an equal concentration basis, it is important to keep
in mind that the metabolites tend to exist in circulation at higher levels
than the native forms. Thus, the observed increase in glucose oxidation
for 5PVA and HA, combined with previous reports that microbial
metabolites stimulate glucose uptake [25], suggest promise for the
ability of these metabolites to exert signiﬁcant beneﬁts on blood
glucose levels in vivo.
3.1.2. Skeletal muscle cell respiration
The effects of EC and the three metabolites on respiration in
normal, uninjured C2C12 cells are shown in Fig. 4. We utilized a
peroxide stress paradigm since heightened mitochondrial ROS
burdens are observed in skeletal muscle from humans and animal
models of diabetes, often before the onset of overt systemic
hyperglycemia [45]. Respiration curves for controls and each dose,
including basal, leak (oligomycin) and maximal (FCCP) respiration,
are shown in Fig. 4A and B. None of the compounds tested signiﬁcantly
enhanced basal respiration (Fig. 4C), ATP-dependent respiration
(Fig. 4E), maximal respiration (Fig. 4F), or respiratory reserve (the
difference between basal and maximal respiration, which reﬂects
reserve bioenergetic capacity available to the cell, Fig. 4G) compared
to the control at either 5 or 10 μM compared to vehicle control.
Coupling efﬁciency was not inﬂuenced by any of the compounds at any
concentration, with the exception of 5PVA at 10 μM (Fig. 4H). HA and
5PVA both modestly enhanced ‘leak’ respiration at 10 μM (Fig. 4D),

suggesting either slight mitochondrial injury (potentially due to minor
pro-oxidant effects at these higher doses) or mitochondrial uncoupling. The data in uninjured cells generally suggest that EC and the
metabolites do not alter skeletal muscle respiration under normal
conditions at low doses, and indicate that do not appear to acutely
uncouple mitochondria or partially inhibit the respiratory chain (both
of which have been postulated as a strategy to treat obesity/diabetes
for decades) with the possible exception of HA and 5PVA at high
doses [46,47].
The effects of EC and the metabolites on C2C12 cells exposed to
peroxide challenge (i.e. injured) are presented in Fig. 5. Peroxide
treatment induced mitochondrial injury as assessed by increased ‘leak’
respiration (respiration after oligomycin roughly doubled) (Fig. 5D)
and lower rates of maximal respiration (FCCP), ATP-dependent
respiration (Fig. 5E), respiratory reserve capacity (Fig. 5G), and
coupling efﬁciency (Fig. 5H) for H2O2 treated cells (red bars)
compared to control (blue bars). While there were some differences
in basal respiration, this can be due to slight respiratory uncoupling
due to the injury and should be interpreted with caution. Each of the
compounds studied signiﬁcantly protected against peroxidemediated injury at 5 μM, reﬂected by reduced leak respiration, and
preserved maximal respiration respiratory reserve and/or coupling
efﬁciency at the same level as the uninjured control despite peroxide
challenge (Fig. 5D-H). As observed for uninjured cells, one metabolite
actually worsened cell injury as measured by leak respiration,
although in this case it was 10 μM HVA (as opposed to HA and PVA
in uninjured cells), again suggesting either cellular injury or
uncoupling. Interestingly, while HA and 5PVA increased leak

100

B.F. Bitner et al. / Journal of Nutritional Biochemistry 62 (2018) 95–107

Fig. 4. Corrected mitochondrial respiration data for C2C12 cells cultured acutely (4 h) in the presence of hippuric acid (HA), homovanillic acid (HVA), 5-phenylvaleric acid (5PVA), or
epicatechin (EC): oxygen consumption rate (OCR) curves for treatments at 5 μM (A) and 10 μM (B), basal respiration (C), leak respiration (after oligomycin, D), ATP-dependent
respiration (E), maximal respiration (after FCCP, F) respiratory reserve (maximal − basal, G), and coupling efﬁciency (ATP-dependent respiration/basal respiration, H). Oxygen
consumption rate data were normalized by subtracting non-mitochondrial rates of respiration (after antimycin A, not shown), and are expressed as pmol O2 per minute per 1.5×104
cells. Values represent mean±S.E.M. from n=8 replicates. Data were analyzed by one-way ANOVA. If a signiﬁcant treatment effect was detected, Dunnett's post hoc test was performed
within each compound to compare each dose to the vehicle control (H2O). Signiﬁcance vs. vehicle control is indicated by: *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001.

respiration in the absence of H2O2, there was only a slight additional
increase in leak respiration with H2O2 treatment. These data indicate
that HA and 5PVA may have pro-oxidant effects similar to H2O2, but
that these metabolites did not exacerbate leak respiration when
combined with H2O2 stress. Future studies that further examine the
effects of HA and 5PVA will advance our understanding of these
compounds on mitochondrial bioenergetics. The 10 μM dose was
generally ineffective for all compounds except HA, which partly
preserved respiratory reserve (Fig. 5E). These results suggest that EC
and the ﬂavonoid microbial metabolites preserve skeletal mitochondrial function after oxidative insult, notably at lower micromolar
concentrations.

3.2. β-Cells
3.2.1. β-Cell glucose-stimulated insulin secretion
In addition to substrate utilization in skeletal muscle, β-cell
function is a critical target at all stages of diabetes development. We
sought to examine the impact of EC and representative ﬂavonoid
metabolites on GSIS in a β-cell model (Fig. 6). We have previously
demonstrated that the epicatechin-rich fraction from cocoa enhances
β-cell GSIS at 25 μg/ml [38]. In the present experiment, EC was able to
enhance GSIS in INS-1832/13 β-cells but only at 100 μM (Fig. 6A),
which is not physiologically relevant, suggesting minimal relevance
for activity in vivo. Interestingly, all three microbial metabolites
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Fig. 5. Corrected mitochondrial respiration data for H2O2-injured C2C12 cells cultured acutely (4 h) in the presence of hippuric acid (HA), homovanillic acid (HVA), 5-phenylvaleric acid
(5PVA), or epicatechin (EC): oxygen consumption rate (OCR) curves for treatments at 5 μM (A) and 10 μM (B), basal respiration (C), leak respiration (after oligomycin, D), ATPdependent respiration (E), maximal respiration (after FCCP, F) respiratory reserve (maximal − basal, G), and coupling efﬁciency (ATP-dependent respiration/basal respiration, H).
Oxygen consumption rate data were normalized by subtracting non-mitochondrial rates of respiration (after antimycin A, not shown), and are expressed as pmol O2 per minute per
1.5×104 cells. Values represent mean±S.E.M. from n=8 replicates. Data were analyzed by one-way ANOVA. If a signiﬁcant treatment effect was detected, Dunnett's post hoc test was
performed within each compound to compare each dose to the vehicle control (H2O) as well as injury control (H2O + H2O2). Signiﬁcance vs. vehicle control is indicated by: *P≤0.05,
**P≤0.01, ***P≤0.001, ****P≤0.0001; signiﬁcance vs. injury control is indicated by: †P ≤ 0.05, ††P ≤ 0.01, †††P ≤ 0.001, ††††††P ≤ 0.0001.

demonstrated signiﬁcant induction of GSIS at concentrations from
5–100 μM (Fig. 6B-D) except HA, which induced GSIS at 5–50 μM but
not 100 μM). These data demonstrate that the metabolites increase
GSIS at much lower (and physiologically relevant) concentrations
compared to EC, suggesting that the metabolites are more potent
stimulators of GSIS than native EC. This fact, combined with the greater
bioavailability of microbial metabolites than the parent compound,
point towards the potential contribution of microbial metabolites to
the observed effects of dietary ﬂavanoids.
To further investigate the effects of these compounds on INS-1832/
13 β-cells, we examined the cellular insulin content under stimulatory
conditions (16.7 mM glucose) to determine if treatment impacted

insulin expression (Fig. 7). An increase in insulin content, concomitant
with an increase in insulin secretion would indicate greater insulin
expression, while a decrease in insulin content with no change in
insulin secretion would indicate an impediment in insulin production.
EC exhibited small increases in insulin content (Fig. 7A), but the effect
was inconsistent across doses. Interestingly, increases in insulin
content were vastly different across the metabolites (Fig. 7B-D),
despite similarities observed in GSIS. 5PVA and HVA stimulated
greater insulin content, particularly at lower doses. HA exhibited a
slight increase in insulin content at 50 μM. These results are intriguing,
as they suggest distinct mechanism at play that impinges on β-cell
insulin secretion. The results for EC are consistent with our previous
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Fig. 6. Glucose-stimulated insulin secretion in INS-1 derived 832/13 rat β-cells treated with either hippuric acid, homovanillic acid, 5-phenylvaleric acid, or epicatechin. Values represent
mean±S.E.M. from n=6 replicates. Data were analyzed by 2-way ANOVA. If a signiﬁcant main effect of treatment compound dose was detected, Dunnett's post hoc test was performed
within the high-glucose treatments to compare each dose to the untreated (0 μM) control. Signiﬁcance vs. untreated control is indicated by: *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001,
****P ≤ 0.0001.

results demonstrating increased insulin secretion at high doses,
without concurrent increase in insulin content [38]. For 5PVA and
HVA we observed increased GSIS and increased cellular insulin
content. The increased insulin content could be due to greater insulin
gene expression, enhanced insulin processing, or improved insulin
stability. As has been previously shown, increased cellular insulin
content can be sufﬁcient to enhance GSIS [48]. Therefore, the
enhanced insulin secretion from β-cells treated with these metabolites, particularly at lower doses, may be due to an increased insulin
load, rather than modulation of the β-cell glucose sensing machinery.
The GSIS observed by HA occurs with minimal changes to insulin
content. The data suggest that ﬂavonoid microbial metabolites may
exert signiﬁcant effects on β-cell function by increasing both β-cell
insulin production and insulin secretion. These distinct mechanisms
suggest complementary and synergistic activities of various metabolites present simultaneously following ﬂavonoid consumption, and
thus warrant further investigation in vitro and in vivo.
3.2.2. β-Cell respiration
Given our previous data demonstrating enhanced β-cell mitochondrial respiration due to exposure to EC from cocoa [38,39], we
sought to deﬁne the effect of culture in the presence of EC and
microbial metabolites on β-cell mitochondrial respiration under basal
conditions (low glucose) and glucose stimulation (Fig. 8). Basal
respiration rate was signiﬁcantly increased by 10 μM EC, and appeared
to be somewhat reduced (albeit not statistically signiﬁcantly) by 5 and
10 μM HA (Fig. 8C). The same results were also observed under glucose

stimulation and maximal respiration (although the level of glucose
induced respiration is surprisingly less than what has been observed in
other studies) (Fig. 8D-E). None of the compounds tested signiﬁcantly
affected respiratory reserve (Fig. 8F). It is important to note that the
low means and comparatively high S.E.M.'s for respiratory reserve in
this case are indicative of the fact that these cells were essentially
already operating near maximal respiration in the basal state (Fig. 8AB, F). Note that uncoupling and ATP-dependent respiration were not
plotted individually from these data due to differences in the question
being asked between the β-cells (do these compounds enhance
respiration as a means to improve β-cell function?) vs. the skeletal
muscle cells (do these compounds enhance respiration via uncoupling
as a means to improve energy expenditure, and do they protect from
injury?). The ﬁnding that EC enhances respiration is consistent with
our previous data [38,39]. Coupled with the GSIS data (Fig. 6), these
respiration data suggest several novel ﬁndings. First, EC does not
enhance GSIS except at extremely high doses despite enhancing β-cell
respiration at lower doses. Second, HA enhances GSIS despite
inhibition of β-cell respiration (although these reductions were not
statistically signiﬁcant, this trend appears to be of practical signiﬁcance as suggested by Fig. 8C-E). Third, HVA and 5PVA enhance GSIS
despite not affecting β-cell respiration. Thus, these data demonstrate
that while each of the epicatechin metabolites enhances GSIS; their
individual mechanisms do not all increase insulin release through
modulating mitochondrial respiration. Therefore, the mechanisms by
which these compounds exert their effects are likely distinct and thus
warrant further investigation.
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Fig. 7. Total insulin content of INS-1 derived 832/13 rat β-cells cultured in 16.7 mM glucose treated with either hippuric acid, homovanillic acid, 5-phenylvaleric acid, or epicatechin.
Values represent mean±S.E.M. from n=6 replicates. Data were analyzed by one-way ANOVA. If a signiﬁcant treatment effect was detected, Dunnett's post hoc test was performed to
compare each dose to the untreated (0 μM) control. Signiﬁcance vs. untreated control is indicated by: *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001.

3.2.3. Expression of ETC components
To validate the changes that we observed in β-cell respiration after
treatment with EC or the gut metabolites, we measured protein levels
of select ETC components (Fig. 9). Similar to what was observed in our
mitochondrial respiration studies, only treatment with EC changed
protein levels of ETC components. These data validate our previous
ﬁndings that while the metabolites do enhance glucose stimulated
insulin secretion, it appears to be through extra mitochondrial
modiﬁcations.
3.3. Discussion
The premise of this study was to explore the possibility that the
unique activities of microbial ﬂavonoid metabolites on peripheral
tissues may contribute to the observed bioactivities of native dietary
ﬂavonoids. In other words, can dietary ﬂavonoids exert signiﬁcant
bioactivities despite poor bioavailability, or is bioavailability of the
native dietary species at peripheral target tissues indeed the primary
limiting factor for bioactivity in vivo? Our central hypothesis, spanning
this study and others in progress, is that the systemic, peripheral tissue
activities of microbial metabolites may account for a signiﬁcant
portion of observed bioactivity following dietary ﬂavonoid exposure
in vivo.
The present results demonstrate the potent activities of ﬂavonoid
microbial metabolites, particularly for preservation of β-cell function,
enhancement of skeletal muscle glucose utilization and protection of
skeletal muscle respiratory function from oxidative injury, Therefore,
these data suggest that further investigation of the anti-diabetic

activities of ﬂavonoid microbial metabolites is warranted. Additionally, our data suggest that metabolites and native compounds may act
by distinct mechanisms, suggesting complementary and synergistic
activities in vivo. Speciﬁcally, our data demonstrate that the gut
metabolites enhance β-cell glucose stimulated insulin secretion more
effectively than EC. Furthermore, unlike EC, these metabolites appear
to do this without enhancing mitochondrial respiration or increasing
expression of mitochondrial electron transport chain components,
and with varying effects on β-cell insulin content. Insulin secretion is
dependent on ATP production in the β-cell due to glycolysis, TCA cycle
and the ETC. In addition, the increases in ATP closes K+ channels which
cause membrane depolarization and opening of Ca2+ channels which
allow Ca2+ inﬂux. The modulation of these two channels is an area of
future interest in determining how the metabolites enhance glucose
stimulated insulin secretion. In skeletal muscle, these compounds
appear to enhance glucose utilization, but do not appear to enhance
respiration under normal conditions. Therefore, mitochondrial uncoupling does not appear to be a mechanism by which these compounds
can prevent obesity and glucose intolerance, with the exception of HA
and 5PVA at high doses. However, they do appear to signiﬁcantly
protect respiratory function against oxidative injury. The objective of
these respiration experiments was to evaluate the impacts of the
selected compounds on overall respiration. Future mechanistic
experiments, including use of ETC complex inhibitors as well as
comparing intact cells, permeabilized cells and isolated mitochondria,
will be useful to elucidate the speciﬁc mechanisms by which the
microbial metabolites exert these effects on respiration. Future work
will also provide new insight that address some of the current study
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Fig. 8. Corrected mitochondrial respiration measured after culturing INS-1832/13 β-cells for 24 h in the presence of 0, 5 or 10 μM hippuric acid (HA), homovanillic acid (HVA), 5phenylvaleric acid (5PVA), or epicatechin (EC): (A) 0 (Ctrl) and 5 μM, (B) 0 (Ctrl) and 10 μM, (C) Basal respiration (2 min), (D) glucose-stimulated respiration (21 min), (E) maximal
respiration (61 min) and (F) respiratory reserve (maximal − basal). Oxygen consumption rate data were normalized by subtracting non-mitochondrial rates of respiration (after
antimycin A, not shown), and are expressed as pmol O2 per minute, normalizer per μg protein. Values represent mean±S.E.M. from n=5 replicates. Signiﬁcance vs. untreated control is
indicated by: *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001.

limitations, such as examining compound efﬁcacy in differentiated
muscle myotubes from mouse and human (to compliment myoblast
studies that were conducted herein).
The results presented here make signiﬁcant additions to the small,
yet growing, body of published data indicating that ﬂavonoid
microbial metabolites likely account for a signiﬁcant fraction of
many observed bioactivities of dietary ﬂavonoids, particularly those
with poor oral bioavailability of the native forms. These data help to
explain epidemiological and experimental data suggesting that some
dietary ﬂavonoids (and potentially other classes of compounds, such
as curcuminoids)possess potent bioactivities despite poor oral
bioavailability. These results also suggest that the metabolites may
be equally important to, if not more important than (in some cases),

the native forms for in vitro mechanistic studies in cell culture models
that attempt to recapitulate effects in peripheral tissues (hepatic,
adipose, pancreatic, skeletal muscle, endothelial and other cell
models). This is particularly true at compound doses in the mid to
high μM range, which are commonly used for bioactives in cell culture
but which are much more likely to be obtained by the microbial
metabolites than the native dietary forms.
Moving forward, there is a need to further identify the most active
individual metabolites (or metabolite proﬁles) that confer systemic
beneﬁts, to understand the characteristics of the microbiome that
facilitate generation of these proﬁles, and to understand how interindividual variability in microbial metabolism affects subsequent
metabolite proﬁles and bioactivities [49]. This knowledge will be
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as well as synthetic approaches. These will need to be performed in
order to complete our understanding of the potential bioactivities of
ﬂavonoid microbial metabolites.
It is also important to note that these microbial metabolites exist in
circulation in the unconjugated forms studied, as well as Phase-II
conjugates (sulfate, O-methyl and glucuronide forms) produced in
enterocytes and hepatocytes following their absorption [50]. While
the present work focused on the unconjugated forms, future work
needs to be performed to elucidate the bioactivities of the conjugated
forms. Such transformations can be performed using enterocytes,
hepatocytes, liver microsomes, or isolated conjugating enzymes. Such
studies will further advance the overall objective of the present work
which is to understand the bioactivities of the actual circulating proﬁle
of compounds (unconjugated and phase-II conjugates of both native
dietary ﬂavonoids and their microbial metabolites) as opposed to just
the native, unconjugated forms (i.e. the majority of existing studies).
4. Conclusion

Fig. 9. (A) Expression levels of electron transport chain components ATP5A (Complex
V), UQCR2 (Complex III), MTCO1 (Complex IV), SDHB (Complex II) and NDUFB8
(Complex I) as quantiﬁed by Western blotting. Values are presented as mean±S.E.M.
from n=3 replicates per condition. Data were analyzed by one-way ANOVA. If a
signiﬁcant treatment effect was detected, Dunnett's post hoc test was performed to
compare each dose to the untreated (0 μM) control. Signiﬁcance vs. untreated control is
indicated by: *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001. (B) Representative
Western blot.

critical for development of strategies to fully exploit the potential
health beneﬁts of dietary ﬂavonoids. While initial studies have used
antibiotics to eliminate the effect of the microbiome and microbiomederived metabolites [30,31], germ-free and other gnotobiotic models
will be instrumental in elucidation of the role of the microbiome in
mediating the beneﬁcial effects of poorly-bioavailable ﬂavonoids.
Furthermore, large-scale screening of several dozen (if not libraries of
several hundred) microbial metabolites in peripheral tissue cell
culture models will need to be performed in order to understand the
tissue-speciﬁc mechanisms by which these compounds exert their
activities. This will require advances in commercial availability of
some metabolites, speciﬁcally the valerolactones, which to our
knowledge are not currently available. It will also be important to
conduct full dose-dependence studies of these metabolites. Furthermore, in vitro anaerobic fecal fermentations of ﬂavonoids, with
assessment of the bioactivity before and after fermentation in vitro
and in vivo (via i.p. administration of ﬁlter-sterilized supernatants)
will be useful to identify broad effects of microbial transformation.
It is important to note that we did not study valerolactones, which
are among the early microbial metabolites of ﬂavonoids. These
compounds are present in high concentrations in circulation following
ﬂavonoid intake, and represent important compounds that may
possess signiﬁcant bioactivities. We did not study these compounds
due to the lack of commercial availability, which is a signiﬁcant
obstacle for understanding their activities. Due to the provocative data
in the present work, future work is needed to generate, isolate, and
elucidate the activity of valerolactones. Two possible approaches
include isolation from in vivo or ex vivo fecal fermentation mixtures,

In summary, our data demonstrate that ﬂavonoid microbial
metabolites stimulate β-cell function, as well as glucose utilization
and mitochondrial respiration in skeletal muscle. These data support
the hypothesis that dietary ﬂavonoids may exert signiﬁcant activity
despite poor bioavailability via their microbial metabolites. This raises
the intriguing prospect that bioavailability of native ﬂavonoids may
not be as critical of a limiting factor to bioactivity as previously
thought. If, in fact, bioavailability of native ﬂavonoids is not as crucial
as currently thought, this would represent a paradigm shift in the
thinking regarding how to exploit the activities of ﬂavonoids in the
diet. While development of strategies to enhance bioavailability of
native compounds should not be discontinued, exploration of
strategies that do not require bioavailability should receive extensive
consideration as a parallel complementary approach to solving the
same problem. Our overall logic for the proposed experiments moving
forward is that we are quickly approaching an asymptote (diminishing
novel returns) in terms of what we can learn from further studies
focusing on the activities of native ﬂavonoids. New approaches are
now needed to answer the complex questions remaining.
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